Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:1,3-thiazoles
go back to main search page
Accession:CHEBI:38418 term browser browse the term
Synonyms:alt_id: CHEBI:26949;   CHEBI:38417



show annotations for term's descendants           Sort by:
(E)-thiamethoxam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Alpl alkaline phosphatase, biomineralization associated increases activity
multiple interactions
EXP Thiamethoxam results in increased activity of ALPL protein
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of ALPL protein]
CTD PMID:30621503 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167
JBrowse link
G Anxa10 annexin A10 increases expression ISO Thiamethoxam results in increased expression of ANXA10 mRNA CTD PMID:32194361 NCBI chr16:32,505,025...32,571,961
Ensembl chr16:32,467,126...32,571,961
JBrowse link
G Ar androgen receptor affects binding ISO Thiamethoxam binds to AR protein CTD PMID:31550567 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467
JBrowse link
G Arg1 arginase 1 decreases expression ISO Thiamethoxam results in decreased expression of ARG1 mRNA CTD PMID:32194361 NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
JBrowse link
G Atf3 activating transcription factor 3 increases expression ISO Thiamethoxam results in increased expression of ATF3 mRNA CTD PMID:33533595 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression ISO Thiamethoxam results in increased expression of BAX protein CTD PMID:33533595 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression ISO Thiamethoxam results in decreased expression of BCL2 protein CTD PMID:33533595 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Bcl6 BCL6, transcription repressor decreases expression ISO Thiamethoxam results in decreased expression of BCL6 mRNA CTD PMID:33533595 NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047
JBrowse link
G Btg1 BTG anti-proliferation factor 1 increases expression ISO Thiamethoxam results in increased expression of BTG1 mRNA CTD PMID:33533595 NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406
JBrowse link
G Casp3 caspase 3 increases cleavage ISO Thiamethoxam results in increased cleavage of CASP3 protein CTD PMID:33533595 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Cat catalase increases expression
decreases expression
multiple interactions
decreases activity
ISO
EXP
Thiamethoxam results in increased expression of CAT mRNA
Thiamethoxam results in decreased expression of CAT mRNA
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Plant Extracts inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of CAT mRNA]
CTD PMID:30621503 PMID:33533595 PMID:34181816 PMID:36958429 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression ISO Thiamethoxam results in increased expression of CCL2 mRNA CTD PMID:33533595 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
JBrowse link
G Chrnb2 cholinergic receptor nicotinic beta 2 subunit multiple interactions EXP Thiamethoxam results in increased activity of [NACHRALPHA1 protein co-treated with CHRNB2 protein] CTD PMID:16981889 NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:177,479,091...177,491,326
JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 decreases expression
multiple interactions
EXP Thiamethoxam results in decreased expression of CYP11A1 mRNA
Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of CYP11A1 mRNA]
CTD PMID:34181816 NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196
JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions
decreases expression
EXP Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of CYP17A1 mRNA] CTD PMID:34181816 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974
JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 increases expression
multiple interactions
increases activity
EXP
ISO
Thiamethoxam results in increased expression of CYP19A1 mRNA
Plant Extracts inhibits the reaction [Thiamethoxam results in increased expression of CYP19A1 mRNA]
Thiamethoxam results in increased activity of CYP19A1 protein
CTD PMID:26464060 PMID:28750898 PMID:34181816 NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 decreases expression ISO Thiamethoxam results in decreased expression of CYP2C19 protein CTD PMID:32194361 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions ISO [NADP co-treated with CYP3A4 protein] results in increased activity of Thiamethoxam CTD PMID:16153789 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 decreases expression ISO Thiamethoxam results in decreased expression of CYP7A1 protein CTD PMID:32194361 NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression ISO Thiamethoxam results in increased expression of DDIT3 mRNA; Thiamethoxam results in increased expression of DDIT3 protein CTD PMID:33533595 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
JBrowse link
G Esr1 estrogen receptor 1 affects binding
decreases expression
ISO Thiamethoxam binds to ESR1 protein
Thiamethoxam results in decreased expression of ESR1 protein
CTD PMID:31550567 PMID:33533595 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
JBrowse link
G Foxo3 forkhead box O3 increases expression ISO Thiamethoxam results in increased expression of FOXO3 mRNA CTD PMID:33533595 NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845
JBrowse link
G Fshr follicle stimulating hormone receptor decreases expression ISO Thiamethoxam results in decreased expression of FSHR protein CTD PMID:33533595 NCBI chr 6:10,952,329...11,160,288
Ensembl chr 6:10,952,329...11,160,288
JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 decreases expression ISO Thiamethoxam results in decreased expression of G6PC1 mRNA CTD PMID:32194361 NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta decreases expression ISO Thiamethoxam results in decreased expression of GADD45B mRNA CTD PMID:33533595 NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 increases activity
multiple interactions
EXP Thiamethoxam results in increased activity of GOT1 protein
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of GOT1 protein]
CTD PMID:30621503 NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
JBrowse link
G Gpt glutamic--pyruvic transaminase decreases activity EXP Thiamethoxam results in decreased activity of GPT protein CTD PMID:29197058 NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions
decreases expression
decreases activity
increases expression
EXP
ISO
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of GPX1 protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of GPX1 mRNA]
Thiamethoxam results in increased expression of GPX1 mRNA
CTD PMID:30621503 PMID:33533595 PMID:36958429 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 multiple interactions
decreases expression
EXP Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of HSD3B1 mRNA] CTD PMID:34181816 NCBI chr 2:188,858,574...188,864,694 JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 increases expression ISO Thiamethoxam results in increased expression of HSPA5 mRNA; Thiamethoxam results in increased expression of HSPA5 protein CTD PMID:33533595 NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
JBrowse link
G Il1b interleukin 1 beta multiple interactions
increases expression
EXP Silymarin inhibits the reaction [Thiamethoxam results in increased expression of IL1B protein]
Thiamethoxam results in increased expression of IL1B mRNA; Thiamethoxam results in increased expression of IL1B protein
CTD PMID:36958429 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression
EXP Silymarin inhibits the reaction [Thiamethoxam results in increased expression of IL6 mRNA] CTD PMID:36958429 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor, type 1 decreases expression ISO Thiamethoxam results in decreased expression of ITPR1 mRNA CTD PMID:33533595 NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:142,743,334...143,066,504
JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit decreases expression ISO Thiamethoxam results in decreased expression of JUNB mRNA CTD PMID:33533595 NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218
JBrowse link
G Ldha lactate dehydrogenase A increases activity
multiple interactions
EXP Thiamethoxam results in increased activity of LDHA protein
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of LDHA protein]
CTD PMID:30621503 NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521
JBrowse link
G Lhcgr luteinizing hormone/choriogonadotropin receptor decreases expression
multiple interactions
increases expression
ISO
EXP
Thiamethoxam results in decreased expression of LHCGR protein
Plant Extracts inhibits the reaction [Thiamethoxam results in increased expression of LHCGR mRNA]
CTD PMID:33533595 PMID:34181816 NCBI chr 6:11,415,361...11,480,834
Ensembl chr 6:11,415,415...11,478,061
JBrowse link
G Lst1 leukocyte specific transcript 1 increases expression ISO Thiamethoxam results in increased expression of LST1 mRNA CTD PMID:33533595 NCBI chr20:3,639,353...3,644,399
Ensembl chr20:3,639,341...3,642,669
JBrowse link
G Mc4r melanocortin 4 receptor decreases expression ISO Thiamethoxam results in decreased expression of MC4R mRNA CTD PMID:33533595 NCBI chr18:62,689,798...62,691,685 JBrowse link
G Mmp7 matrix metallopeptidase 7 increases expression ISO Thiamethoxam results in increased expression of MMP7 mRNA CTD PMID:33533595 NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755
JBrowse link
G Nos2 nitric oxide synthase 2 increases expression
multiple interactions
decreases activity
EXP
ISO
Thiamethoxam results in increased expression of NOS2 mRNA
Silymarin inhibits the reaction [Thiamethoxam results in increased expression of NOS2 mRNA]
Thiamethoxam metabolite results in decreased activity of NOS2 protein
[Thiamethoxam metabolite results in decreased activity of NOS2 protein] which results in increased chemical synthesis of Formaldehyde
CTD PMID:29197058 PMID:36958429 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
JBrowse link
G Plcg2 phospholipase C, gamma 2 decreases expression ISO Thiamethoxam results in decreased expression of PLCG2 mRNA CTD PMID:33533595 NCBI chr19:62,456,196...62,592,684
Ensembl chr19:62,453,259...62,592,684
JBrowse link
G Prnp prion protein increases expression ISO Thiamethoxam results in increased expression of PRNP mRNA CTD PMID:33533595 NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:139,630,144...139,658,436
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression ISO Thiamethoxam results in decreased expression of PTGS2 mRNA CTD PMID:33533595 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
JBrowse link
G Pthlh parathyroid hormone-like hormone decreases expression ISO Thiamethoxam results in decreased expression of PTHLH mRNA CTD PMID:33533595 NCBI chr 4:181,919,400...181,930,454
Ensembl chr 4:181,919,400...181,930,454
JBrowse link
G Ptx3 pentraxin 3 increases expression ISO Thiamethoxam results in increased expression of PTX3 mRNA CTD PMID:33533595 NCBI chr 2:152,797,563...152,803,372
Ensembl chr 2:152,781,955...152,803,372
JBrowse link
G Scarb1 scavenger receptor class B, member 1 multiple interactions
decreases expression
EXP Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of SCARB1 mRNA] CTD PMID:34181816 NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980
JBrowse link
G Sesn2 sestrin 2 increases expression ISO Thiamethoxam results in increased expression of SESN2 mRNA CTD PMID:33533595 NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255
JBrowse link
G Slc22a2 solute carrier family 22 member 2 decreases activity ISO Thiamethoxam results in decreased activity of SLC22A2 protein CTD PMID:31364238 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression ISO Thiamethoxam results in increased expression of SLC7A11 mRNA CTD PMID:33533595 NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
JBrowse link
G Sod1 superoxide dismutase 1 decreases activity
decreases expression
multiple interactions
EXP Thiamethoxam results in decreased activity of SOD1 protein
Thiamethoxam results in decreased expression of SOD1 mRNA
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of SOD1 protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of SOD1 mRNA]
CTD PMID:30621503 PMID:36958429 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
JBrowse link
G Star steroidogenic acute regulatory protein decreases expression
multiple interactions
EXP Thiamethoxam results in decreased expression of STAR mRNA
Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of STAR mRNA]
CTD PMID:34181816 NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
JBrowse link
G Stc2 stanniocalcin 2 increases expression ISO Thiamethoxam results in increased expression of STC2 mRNA CTD PMID:33533595 NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,755,267...16,767,447
JBrowse link
G Thbs4 thrombospondin 4 decreases expression ISO Thiamethoxam results in decreased expression of THBS4 mRNA CTD PMID:33533595 NCBI chr 2:25,718,219...25,760,345
Ensembl chr 2:25,718,219...25,761,369
JBrowse link
G Thra thyroid hormone receptor alpha affects binding ISO Thiamethoxam binds to THRA protein CTD PMID:31550567 NCBI chr10:84,198,141...84,225,659
Ensembl chr10:84,197,011...84,225,657
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression
EXP Silymarin inhibits the reaction [Thiamethoxam results in increased expression of TNF mRNA]; Silymarin inhibits the reaction [Thiamethoxam results in increased expression of TNF protein]
Thiamethoxam results in increased expression of TNF mRNA; Thiamethoxam results in increased expression of TNF protein
CTD PMID:36958429 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
G Tnnt2 troponin T2, cardiac type increases secretion
multiple interactions
EXP Thiamethoxam results in increased secretion of TNNT2 protein
fenugreek seed meal inhibits the reaction [Thiamethoxam results in increased secretion of TNNT2 protein]; Polysaccharides inhibits the reaction [Thiamethoxam results in increased secretion of TNNT2 protein]
CTD PMID:30520268 NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125
JBrowse link
1-(4-methoxybenzyl)-3-(5-nitro-1,3-thiazol-2-yl)urea term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Atf3 activating transcription factor 3 multiple interactions ISO N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [deoxynivalenol results in decreased degradation of ATF3 protein] CTD PMID:19101521 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions ISO [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of BAX protein] CTD PMID:20540935 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
JBrowse link
G Casp3 caspase 3 multiple interactions ISO
EXP
[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of CASP3 protein]
N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Colchicine results in increased activity of CASP3 protein]
CTD PMID:20300959 PMID:20540935 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Casp9 caspase 9 multiple interactions ISO [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of CASP9 protein] CTD PMID:20540935 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Ccnb1 cyclin B1 multiple interactions ISO [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CCNB1 protein] CTD PMID:20540935 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
JBrowse link
G Ccnd1 cyclin D1 multiple interactions ISO [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CCND1 protein] CTD PMID:20540935 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
JBrowse link
G Ccne1 cyclin E1 multiple interactions ISO [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CCNE1 protein] CTD PMID:20540935 NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822
JBrowse link
G Cdk2 cyclin dependent kinase 2 multiple interactions ISO [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CDK2 protein] CTD PMID:20540935 NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
JBrowse link
G Cdk4 cyclin-dependent kinase 4 multiple interactions ISO [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CDK4 protein] CTD PMID:20540935 NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
JBrowse link
G Ctnnb1 catenin beta 1 multiple interactions ISO N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein] CTD PMID:32305283 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 affects localization EXP N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea affects the localization of GRIA1 protein CTD PMID:20534517 NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309
JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 affects localization EXP N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea affects the localization of GRIA2 protein CTD PMID:20534517 NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616
JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions
decreases activity
ISO
EXP
[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] inhibits the reaction [Okadaic Acid results in increased phosphorylation of MAPT protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in decreased expression of CCNB1 protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in decreased expression of CCND1 protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in decreased expression of CCNE1 protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in decreased expression of CDK2 protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in decreased expression of CDK4 protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in increased expression of BAX protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in increased expression of CASP3 protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in increased expression of CASP9 protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] which results in decreased susceptibility to Okadaic Acid; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] which results in decreased susceptibility to Proadifen; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] which results in increased susceptibility to Troglitazone; N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of GSK3B protein]; N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein modified form]; N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Okadaic Acid results in increased expression of GSK3B protein] CTD PMID:16202587 PMID:20540935 PMID:21715663 PMID:22683934 PMID:32305283 NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
JBrowse link
G Mapt microtubule-associated protein tau multiple interactions ISO [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] inhibits the reaction [Okadaic Acid results in increased phosphorylation of MAPT protein] CTD PMID:21715663 NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
JBrowse link
G Mcl1 MCL1 apoptosis regulator, BCL2 family member multiple interactions ISO N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 protein] CTD PMID:32305283 NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:185,908,168...185,938,782
JBrowse link
apratoxin A term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Hsf1 heat shock transcription factor 1 increases activity ISO apratoxin A results in increased activity of HSF1 protein CTD PMID:34170685 NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665
JBrowse link
benfotiamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Gclm glutamate cysteine ligase, modifier subunit multiple interactions
increases expression
ISO NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of GCLM mRNA]; NFE2L2 protein affects the reaction [benphothiamine results in increased expression of GCLM mRNA]
benphothiamine metabolite results in increased expression of GCLM mRNA; benphothiamine results in increased expression of GCLM mRNA
CTD PMID:29860433 NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions
increases expression
ISO NFE2L2 protein affects the reaction [benphothiamine results in increased expression of GSR mRNA] CTD PMID:29860433 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
JBrowse link
G Hmox1 heme oxygenase 1 increases expression
multiple interactions
ISO benphothiamine metabolite results in increased expression of HMOX1 mRNA; benphothiamine results in increased expression of HMOX1 mRNA
benphothiamine inhibits the reaction [MAPT protein results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [benphothiamine results in increased expression of HMOX1 mRNA]
CTD PMID:29860433 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [benphothiamine co-treated with MAPT protein] results in decreased expression of IL1B protein CTD PMID:29860433 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Mapt microtubule-associated protein tau decreases phosphorylation
multiple interactions
ISO benphothiamine results in decreased phosphorylation of MAPT protein
[benphothiamine co-treated with MAPT protein] results in decreased expression of IL1B protein; [benphothiamine co-treated with MAPT protein] results in decreased expression of NOS2 protein; [benphothiamine co-treated with MAPT protein] results in decreased expression of PTGS2 protein; [benphothiamine co-treated with MAPT protein] results in decreased expression of RELA protein; [benphothiamine co-treated with MAPT protein] results in decreased expression of TNF protein; [benphothiamine co-treated with MAPT protein] results in increased expression of NQO1 mRNA; [benphothiamine co-treated with MAPT protein] results in increased expression of TXN mRNA; benphothiamine inhibits the reaction [MAPT protein results in decreased activity of TKT protein]; benphothiamine inhibits the reaction [MAPT protein results in decreased expression of NOS2 mRNA]; benphothiamine inhibits the reaction [MAPT protein results in decreased expression of PPARGC1A protein]; benphothiamine inhibits the reaction [MAPT protein results in decreased expression of SOD1 protein]; benphothiamine inhibits the reaction [MAPT protein results in increased expression of HMOX1 mRNA]
CTD PMID:29860433 NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions ISO NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of GCLM mRNA]; NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of NQO1 mRNA]; NFE2L2 protein affects the reaction [benphothiamine results in increased expression of GCLM mRNA]; NFE2L2 protein affects the reaction [benphothiamine results in increased expression of GSR mRNA]; NFE2L2 protein affects the reaction [benphothiamine results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [benphothiamine results in increased expression of NQO1 mRNA] CTD PMID:29860433 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO [benphothiamine co-treated with MAPT protein] results in decreased expression of NOS2 protein; benphothiamine inhibits the reaction [MAPT protein results in decreased expression of NOS2 mRNA] CTD PMID:29860433 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression
multiple interactions
ISO benphothiamine metabolite results in increased expression of NQO1 mRNA; benphothiamine results in increased expression of NQO1 mRNA
[benphothiamine co-treated with MAPT protein] results in increased expression of NQO1 mRNA; NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of NQO1 mRNA]; NFE2L2 protein affects the reaction [benphothiamine results in increased expression of NQO1 mRNA]
CTD PMID:29860433 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
JBrowse link
G Ppargc1a PPARG coactivator 1 alpha multiple interactions ISO benphothiamine inhibits the reaction [MAPT protein results in decreased expression of PPARGC1A protein] CTD PMID:29860433 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO [benphothiamine co-treated with MAPT protein] results in decreased expression of PTGS2 protein CTD PMID:29860433 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO [benphothiamine co-treated with MAPT protein] results in decreased expression of RELA protein CTD PMID:29860433 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions ISO benphothiamine inhibits the reaction [MAPT protein results in decreased expression of SOD1 protein] CTD PMID:29860433 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
JBrowse link
G Tkt transketolase multiple interactions EXP
ISO
[benphothiamine co-treated with Streptozocin] results in increased activity of TKT protein
benphothiamine inhibits the reaction [MAPT protein results in decreased activity of TKT protein]
CTD PMID:12592403 PMID:29860433 NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,729,991...5,756,431
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO [benphothiamine co-treated with MAPT protein] results in decreased expression of TNF protein CTD PMID:29860433 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
G Txn1 thioredoxin 1 multiple interactions ISO [benphothiamine co-treated with MAPT protein] results in increased expression of TXN mRNA CTD PMID:29860433 NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307
JBrowse link
camalexin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bax BCL2 associated X, apoptosis regulator increases expression ISO camalexin metabolite results in increased expression of BAX mRNA CTD PMID:23339777 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression ISO camalexin metabolite results in decreased expression of BCL2 mRNA CTD PMID:23339777 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Bcl2l1 Bcl2-like 1 decreases expression ISO camalexin metabolite results in decreased expression of BCL2L1 mRNA CTD PMID:23339777 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907
JBrowse link
cefoselis sulfate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Slc22a6 solute carrier family 22 member 6 multiple interactions ISO cefoselis inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] CTD PMID:16098483 NCBI chr 1:214,951,493...214,960,317
Ensembl chr 1:214,951,867...214,960,311
JBrowse link
G Slc22a8 solute carrier family 22 member 8 increases uptake
multiple interactions
ISO SLC22A8 protein results in increased uptake of cefoselis
cefoselis inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD PMID:16098483 NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588
JBrowse link
cefotaxime term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bax BCL2 associated X, apoptosis regulator increases expression ISO Cefotaxime results in increased expression of BAX protein CTD PMID:15012731 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
JBrowse link
G Il10 interleukin 10 multiple interactions ISO Cefotaxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] CTD PMID:16939481 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
JBrowse link
G Pgd phosphogluconate dehydrogenase decreases activity EXP Cefotaxime results in decreased activity of PGD protein CTD PMID:15558954 NCBI chr 5:164,865,830...164,882,029
Ensembl chr 5:164,865,830...164,882,029
JBrowse link
G RT1-CE5 RT1 class I, locus CE5 affects expression ISO Cefotaxime affects the expression of HLA-F mRNA CTD PMID:25811541 NCBI chr20:3,407,880...3,484,130 JBrowse link
G Tp53 tumor protein p53 increases expression ISO Cefotaxime results in increased expression of TP53 protein CTD PMID:15012731 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
JBrowse link
ceftaroline term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Defb5 defensin beta 5 multiple interactions ISO Ceftaroline inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Tobacco Smoke Pollution] results in decreased secretion of DEFB4A protein]; Ceftaroline inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of and results in decreased secretion of DEFB4A protein]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in decreased secretion of DEFB4A protein] CTD PMID:27397760 PMID:28720485 NCBI chr16:77,315,424...77,317,828
Ensembl chr16:77,315,424...77,317,828
JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO Ceftaroline inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]] CTD PMID:27397760 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Tlr2 toll-like receptor 2 multiple interactions ISO Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in increased expression of TLR2 protein] CTD PMID:27397760 NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in increased expression of TLR4 protein] CTD PMID:28720485 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO Ceftaroline inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Tobacco Smoke Pollution] results in increased secretion of TNF protein]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of TNF protein] CTD PMID:28720485 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
ceftriaxone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ace2 angiotensin converting enzyme 2 decreases expression EXP Ceftriaxone results in decreased expression of ACE2 mRNA CTD PMID:29745864 NCBI chr  X:33,925,458...33,972,851
Ensembl chr  X:33,925,458...33,971,596
JBrowse link
G Actb actin, beta increases expression EXP Ceftriaxone results in increased expression of ACTB mRNA CTD PMID:29745864 NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242
JBrowse link
G Bace1 beta-secretase 1 decreases expression EXP Ceftriaxone results in decreased expression of BACE1 mRNA CTD PMID:29745864 NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:55,038,823...55,064,918
JBrowse link
G Cat catalase decreases expression
multiple interactions
ISO
EXP
Ceftriaxone results in decreased expression of CAT protein
Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]]
CTD PMID:19442074 PMID:25053526 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
JBrowse link
G Dhfr dihydrofolate reductase decreases activity ISO Ceftriaxone results in decreased activity of DHFR protein CTD PMID:25418905 NCBI chr 2:25,320,895...25,346,004 JBrowse link
G Ece1 endothelin converting enzyme 1 increases expression EXP Ceftriaxone results in increased expression of ECE1 mRNA CTD PMID:29745864 NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:155,360,639...155,462,719
JBrowse link
G Epo erythropoietin increases expression EXP Ceftriaxone results in increased expression of EPO mRNA CTD PMID:29745864 NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725
JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 multiple interactions EXP Ceftriaxone inhibits the reaction [Cocaine increases expression of Gria1 protein in the nucleus accumbens] RGD PMID:28495973 RGD:405650670 NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309
JBrowse link
G Ide insulin degrading enzyme increases expression EXP Ceftriaxone results in increased expression of IDE mRNA CTD PMID:29745864 NCBI chr 1:244,415,495...244,516,925
Ensembl chr 1:244,416,343...244,514,526
JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]] CTD PMID:25053526 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Mme membrane metallo-endopeptidase increases expression EXP Ceftriaxone results in increased expression of MME mRNA CTD PMID:29745864 NCBI chr 2:149,806,826...149,957,381
Ensembl chr 2:149,872,291...149,953,463
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit increases expression EXP ceftriaxone increases expression of Rela protein in dorsal striatum RGD PMID:31100299 RGD:598150313 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
JBrowse link
G Slc1a2 solute carrier family 1 member 2 increases expression
multiple interactions
increases expression
EXP ceftriaxone increases expression of Slc1a2 protein in prefrontal cortex and nucleus accumbens
[ceftriaxone co-treated with ethanol] results in increased expression of Slc1a2 protein in prefrontal cortex and nucleus accumbens
Ceftriaxone cotreated with ethanol increases expression of Slc1a2 protein in nucleus accumbens, amygdala and prefrontal cortex
Ceftriaxone cotreated ethanol increases expression of Slc1a2 protein in nucleus accumbens and prefrontal cortex
ceftriaxone inhibits the reaction [ethanol decreases expression of Slc1a2 protein in the shell of nucleus accumbens]
ceftriaxone increases expression of Slc1a2 protein in hippocampus
Ceftriaxone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [JZL195 results in decreased expression of and affects the folding of SLC1A2 protein]; Ceftriaxone promotes the reaction [Kainic Acid results in increased expression of SLC1A2 protein]
Ceftriaxone results in increased expression of SLC1A2 protein
CTD
RGD
PMID:19625514 PMID:19717140 PMID:28257918 PMID:29045497 PMID:29432698 More... RGD:598108052, RGD:598150309, RGD:598150065, RGD:598148181, RGD:598276809, RGD:598150313 NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:109,459,630...109,605,249
JBrowse link
G Slc2a1 solute carrier family 2 member 1 multiple interactions EXP [ceftriaxone co-treated with ethanol] results in increased expression of Slc2a1 protein in prefrontal cortex RGD PMID:21422004 RGD:598154603 NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742
JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression
multiple interactions
EXP Ceftriaxone cotreated with ethanol increases expression of Slc7a11 protein in nucleus accumbens, amydgala and prefrontal cortex
Ceftriaxone increases expression of Slc7a11 protein in dorsal striatum
[ceftriaxone co-treated with ethanol] results in increased expression of Slc7a11 protein in prefrontal cortex and nucleus accumbens
Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein]
CTD
RGD
PMID:19717140 PMID:24535561 PMID:31100299 PMID:25619881 RGD:598150065, RGD:598150313, RGD:598154596 NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]] CTD PMID:25053526 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
clothianidin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abca13 ATP binding cassette subfamily A member 13 increases expression ISO clothianidin results in increased expression of ABCA13 mRNA CTD PMID:31626844 NCBI chr14:88,087,146...88,589,868
Ensembl chr14:88,087,801...88,589,392
JBrowse link
G Abcb6 ATP binding cassette subfamily B member 6 decreases expression ISO clothianidin results in decreased expression of ABCB6 mRNA CTD PMID:29044138 NCBI chr 9:84,117,222...84,125,939
Ensembl chr 9:84,117,220...84,125,526
JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 increases expression ISO clothianidin results in increased expression of ABCC1 mRNA CTD PMID:31626844 NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404
JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 multiple interactions
increases expression
EXP [enilconazole co-treated with clothianidin] results in increased expression of ABCC3 mRNA; [thiacloprid co-treated with clothianidin] results in increased expression of ABCC3 mRNA
clothianidin results in increased expression of ABCC3 mRNA
CTD PMID:33426623 NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
JBrowse link
G Abcd2 ATP binding cassette subfamily D member 2 decreases expression ISO clothianidin results in decreased expression of ABCD2 mRNA CTD PMID:31626844 NCBI chr 7:124,142,597...124,191,202
Ensembl chr 7:124,142,595...124,191,202
JBrowse link
G Abcd3 ATP binding cassette subfamily D member 3 decreases expression ISO clothianidin results in decreased expression of ABCD3 mRNA CTD PMID:31626844 NCBI chr 2:212,536,791...212,590,379
Ensembl chr 2:212,536,791...212,590,504
JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 decreases expression ISO clothianidin results in decreased expression of ABCG1 mRNA CTD PMID:29044138 NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,127,803...9,186,563
JBrowse link
G Abhd4 abhydrolase domain containing 4, N-acyl phospholipase B decreases expression ISO clothianidin results in decreased expression of ABHD4 mRNA CTD PMID:31626844 NCBI chr15:31,674,090...31,686,051
Ensembl chr15:31,674,143...31,687,007
JBrowse link
G Abi3bp ABI family member 3 binding protein decreases expression ISO clothianidin results in decreased expression of ABI3BP mRNA CTD PMID:31626844 NCBI chr11:57,381,282...57,597,989
Ensembl chr11:57,381,422...57,598,120
JBrowse link
G Ache acetylcholinesterase decreases expression ISO clothianidin results in decreased expression of ACHE mRNA CTD PMID:35264496 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
JBrowse link
G Adcy2 adenylate cyclase 2 increases expression ISO clothianidin results in increased expression of ADCY2 mRNA CTD PMID:31626844 NCBI chr 1:36,204,054...36,650,645
Ensembl chr 1:36,204,054...36,650,645
JBrowse link
G Adcy4 adenylate cyclase 4 decreases expression ISO clothianidin results in decreased expression of ADCY4 mRNA CTD PMID:29044138 NCBI chr15:33,236,201...33,252,070
Ensembl chr15:33,236,208...33,252,026
JBrowse link
G Adgrb2 adhesion G protein-coupled receptor B2 decreases expression ISO clothianidin results in decreased expression of ADGRB2 mRNA CTD PMID:31626844 NCBI chr 5:147,581,573...147,646,726
Ensembl chr 5:147,611,580...147,646,726
JBrowse link
G Adgrf5 adhesion G protein-coupled receptor F5 decreases expression ISO clothianidin results in decreased expression of ADGRF5 mRNA CTD PMID:31626844 NCBI chr 9:25,014,861...25,128,045
Ensembl chr 9:25,018,277...25,121,237
JBrowse link
G Adgrg6 adhesion G protein-coupled receptor G6 decreases expression ISO clothianidin results in decreased expression of ADGRG6 mRNA CTD PMID:31626844 NCBI chr 1:10,633,004...10,774,685
Ensembl chr 1:10,631,829...10,774,023
JBrowse link
G Adrb2 adrenoceptor beta 2 decreases expression ISO clothianidin results in decreased expression of ADRB2 mRNA CTD PMID:31626844 NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803
JBrowse link
G Agbl3 AGBL carboxypeptidase 3 increases expression ISO clothianidin results in increased expression of AGBL3 mRNA CTD PMID:31626844 NCBI chr 4:64,416,139...64,498,987
Ensembl chr 4:64,421,397...64,498,985
JBrowse link
G Akr1b7 aldo-keto reductase family 1, member B7 increases expression ISO clothianidin results in increased expression of AKR1B7 mRNA CTD PMID:33563863 NCBI chr 4:64,043,901...64,083,751
Ensembl chr 4:64,020,686...64,064,909
JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 increases expression
multiple interactions
EXP clothianidin results in increased expression of ALDH1A1 mRNA
[enilconazole co-treated with clothianidin] results in increased expression of ALDH1A1 mRNA; [thiacloprid co-treated with clothianidin] results in increased expression of ALDH1A1 mRNA
CTD PMID:33426623 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500
JBrowse link
G Amz1 archaelysin family metallopeptidase 1 increases expression ISO clothianidin results in increased expression of AMZ1 mRNA CTD PMID:31626844 NCBI chr12:19,000,448...19,038,625
Ensembl chr12:19,000,448...19,037,925
JBrowse link
G Ank3 ankyrin 3 decreases expression ISO clothianidin results in decreased expression of ANK3 mRNA CTD PMID:31626844 NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,601,826...19,084,879
JBrowse link
G Ankrd37 ankyrin repeat domain 37 decreases expression ISO clothianidin results in decreased expression of ANKRD37 mRNA CTD PMID:31626844 NCBI chr16:53,001,487...53,004,545
Ensembl chr16:52,994,740...53,004,545
JBrowse link
G Aplf aprataxin and PNKP like factor increases expression ISO clothianidin results in increased expression of APLF mRNA CTD PMID:31626844 NCBI chr 4:121,627,800...121,679,980
Ensembl chr 4:121,627,800...121,679,961
JBrowse link
G Arhgap17 Rho GTPase activating protein 17 increases expression ISO clothianidin results in increased expression of ARHGAP17 mRNA CTD PMID:31626844 NCBI chr 1:187,238,675...187,328,093
Ensembl chr 1:187,238,380...187,327,936
JBrowse link
G Arhgef2 Rho/Rac guanine nucleotide exchange factor 2 increases expression ISO clothianidin results in increased expression of ARHGEF2 mRNA CTD PMID:31626844 NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646
JBrowse link
G Arl11 ARF like GTPase 11 increases expression ISO clothianidin results in increased expression of ARL11 mRNA CTD PMID:31626844 NCBI chr15:39,659,404...39,661,651
Ensembl chr15:39,656,050...39,664,105
JBrowse link
G Arl14 ARF like GTPase 14 increases expression ISO clothianidin results in increased expression of ARL14 mRNA CTD PMID:35690182 NCBI chr 2:155,778,826...155,780,065
Ensembl chr 2:155,778,826...155,780,065
JBrowse link
G Arl6 ARF like GTPase 6 increases expression ISO clothianidin results in increased expression of ARL6 mRNA CTD PMID:31626844 NCBI chr11:54,180,271...54,207,136
Ensembl chr11:54,181,241...54,210,813
JBrowse link
G Asb11 ankyrin repeat and SOCS box containing 11 increases expression ISO clothianidin results in increased expression of ASB11 mRNA CTD PMID:31626844 NCBI chr  X:33,646,389...33,669,790
Ensembl chr  X:33,624,394...33,669,934
JBrowse link
G Asphd1 aspartate beta-hydroxylase domain containing 1 decreases expression ISO clothianidin results in decreased expression of ASPHD1 mRNA CTD PMID:31626844 NCBI chr 1:190,983,506...190,987,440
Ensembl chr 1:190,983,506...190,987,440
JBrowse link
G Atp1a2 ATPase Na+/K+ transporting subunit alpha 2 decreases expression ISO clothianidin results in decreased expression of ATP1A2 mRNA CTD PMID:29044138 NCBI chr13:87,261,964...87,286,911
Ensembl chr13:87,261,968...87,286,911
JBrowse link
G Atp23 ATP23 metallopeptidase and ATP synthase assembly factor homolog increases expression ISO clothianidin results in increased expression of XRCC6BP1 mRNA CTD PMID:31626844 NCBI chr 7:64,600,100...64,615,240
Ensembl chr 7:64,600,100...64,615,392
JBrowse link
G Atp2b3 ATPase plasma membrane Ca2+ transporting 3 decreases expression ISO clothianidin results in decreased expression of ATP2B3 mRNA CTD PMID:29044138 NCBI chr  X:156,367,582...156,464,085
Ensembl chr  X:156,367,852...156,438,153
JBrowse link
G Atp6v0d2 ATPase H+ transporting V0 subunit D2 increases expression ISO clothianidin results in increased expression of ATP6V0D2 mRNA CTD PMID:31626844 NCBI chr 5:38,133,151...38,182,245
Ensembl chr 5:38,133,158...38,182,245
JBrowse link
G Awat1 acyl-CoA wax alcohol acyltransferase 1 increases expression ISO clothianidin results in increased expression of AWAT1 mRNA CTD PMID:31626844 NCBI chr  X:69,708,286...69,714,531
Ensembl chr  X:69,708,286...69,714,531
JBrowse link
G Axin1 axin 1 decreases expression ISO clothianidin results in decreased expression of AXIN1 mRNA CTD PMID:31626844 NCBI chr10:15,667,894...15,720,092
Ensembl chr10:15,667,958...15,720,092
JBrowse link
G Azin2 antizyme inhibitor 2 decreases expression ISO clothianidin results in decreased expression of AZIN2 mRNA CTD PMID:29044138 NCBI chr 5:146,568,187...146,594,777
Ensembl chr 5:146,565,437...146,594,777
JBrowse link
G Barhl1 BarH-like homeobox 1 increases expression ISO clothianidin results in increased expression of BARHL1 mRNA CTD PMID:31626844 NCBI chr 3:32,639,283...32,646,605
Ensembl chr 3:32,638,644...32,646,605
JBrowse link
G Bcr BCR activator of RhoGEF and GTPase decreases expression ISO clothianidin results in decreased expression of BCR mRNA CTD PMID:31626844 NCBI chr20:13,468,732...13,596,333
Ensembl chr20:13,468,732...13,596,333
JBrowse link
G Bicd2 BICD cargo adaptor 2 decreases expression ISO clothianidin results in decreased expression of BICD2 mRNA CTD PMID:31626844 NCBI chr17:15,449,011...15,511,423
Ensembl chr17:15,435,894...15,511,305
JBrowse link
G Bricd5 BRICHOS domain containing 5 decreases expression ISO clothianidin results in decreased expression of BRICD5 mRNA CTD PMID:29044138 NCBI chr10:14,003,276...14,004,809
Ensembl chr10:14,003,130...14,004,809
JBrowse link
G C11h21orf140 similar to human chromosome 21 open reading frame 140 increases expression ISO clothianidin results in increased expression of C21ORF140 mRNA CTD PMID:31626844 NCBI chr11:45,035,613...45,038,181
Ensembl chr11:45,023,033...45,038,353
JBrowse link
G C14h22orf31 similar to human chromosome 22 open reading frame 31 decreases expression ISO clothianidin results in decreased expression of C22ORF31 mRNA CTD PMID:31626844 NCBI chr14:84,373,414...84,374,948 JBrowse link
G C14h4orf36 similar to human chromosome 4 open reading frame 36 decreases expression ISO clothianidin results in decreased expression of C4ORF36 mRNA CTD PMID:31626844 NCBI chr14:6,363,170...6,370,479
Ensembl chr14:6,363,215...6,370,478
JBrowse link
G C18h5orf46 similar to human chromosome 5 open reading frame 46 increases expression ISO clothianidin results in increased expression of C5ORF46 mRNA CTD PMID:31626844 NCBI chr18:36,199,309...36,220,409
Ensembl chr18:36,199,309...36,220,409
JBrowse link
G C19h16orf74 similar to human chromosome 16 open reading frame 74 decreases expression ISO clothianidin results in decreased expression of C16ORF74 mRNA CTD PMID:31626844 NCBI chr19:65,568,997...65,594,994
Ensembl chr19:65,568,997...65,595,460
JBrowse link
G C20h21orf58 similar to human chromosome 21 open reading frame 58 decreases expression ISO clothianidin results in decreased expression of C21ORF58 mRNA CTD PMID:31626844 NCBI chr20:12,165,853...12,187,271
Ensembl chr20:12,174,928...12,186,503
JBrowse link
G C2cd4b C2 calcium-dependent domain containing 4B increases expression ISO clothianidin results in increased expression of C2CD4B mRNA CTD PMID:31626844 NCBI chr 8:77,254,327...77,277,620
Ensembl chr 8:77,238,551...77,279,879
JBrowse link
G C2h5orf34 similar to human chromosome 5 open reading frame 34 increases expression ISO clothianidin results in increased expression of C5ORF34 mRNA CTD PMID:29044138 NCBI chr 2:53,287,353...53,309,804
Ensembl chr 2:53,287,957...53,309,806
JBrowse link
G Ca3 carbonic anhydrase 3 increases expression ISO clothianidin results in increased expression of CA3 mRNA CTD PMID:31626844 NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524
JBrowse link
G Cacnb2 calcium voltage-gated channel auxiliary subunit beta 2 decreases expression ISO clothianidin results in decreased expression of CACNB2 mRNA CTD PMID:31626844 NCBI chr17:82,473,097...82,818,564
Ensembl chr17:82,473,129...82,818,564
JBrowse link
G Calhm3 calcium homeostasis modulator 3 increases expression ISO clothianidin results in increased expression of CALHM3 mRNA CTD PMID:31626844 NCBI chr 1:255,984,593...255,989,594
Ensembl chr 1:255,983,410...256,007,697
JBrowse link
G Capn5 calpain 5 increases expression ISO clothianidin results in increased expression of CAPN5 mRNA CTD PMID:29044138 NCBI chr 1:161,827,474...161,884,142
Ensembl chr 1:161,827,474...161,884,142
JBrowse link
G Caps calcyphosine decreases expression ISO clothianidin results in decreased expression of CAPS mRNA CTD PMID:29044138 NCBI chr 9:1,630,871...1,632,758 JBrowse link
G Carmil1 capping protein regulator and myosin 1 linker 1 decreases expression ISO clothianidin results in decreased expression of CARMIL1 mRNA CTD PMID:31626844 NCBI chr17:41,235,819...41,516,204
Ensembl chr17:41,236,229...41,516,221
JBrowse link
G Carmil3 capping protein regulator and myosin 1 linker 3 increases expression ISO clothianidin results in increased expression of CARMIL3 mRNA CTD PMID:29044138 NCBI chr15:32,948,228...32,965,829
Ensembl chr15:32,948,856...32,965,811
JBrowse link
G Ccdc17 coiled-coil domain containing 17 decreases expression ISO clothianidin results in decreased expression of CCDC17 mRNA CTD PMID:29044138 NCBI chr 5:135,288,799...135,293,339
Ensembl chr 5:135,289,576...135,293,336
JBrowse link
G Ccdc8 coiled-coil domain containing 8 increases expression ISO clothianidin results in increased expression of CCDC8 mRNA CTD PMID:31626844 NCBI chr 1:86,807,607...86,810,935
Ensembl chr 1:86,806,942...86,814,204
JBrowse link
G Ccser1 coiled-coil serine-rich protein 1 decreases expression ISO clothianidin results in decreased expression of CCSER1 mRNA CTD PMID:31626844 NCBI chr 4:91,483,896...92,720,439
Ensembl chr 4:91,483,770...92,718,789
JBrowse link
G Cd226 CD226 molecule decreases expression ISO clothianidin results in decreased expression of CD226 mRNA CTD PMID:31626844 NCBI chr18:84,723,330...84,819,836
Ensembl chr18:84,725,242...84,819,835
JBrowse link
G Cd34 CD34 molecule increases expression ISO clothianidin results in increased expression of CD34 mRNA CTD PMID:31626844 NCBI chr13:109,008,786...109,029,317
Ensembl chr13:109,008,623...109,029,315
JBrowse link
G Cd74 CD74 molecule increases expression ISO clothianidin results in increased expression of CD74 mRNA CTD PMID:31626844 NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410
JBrowse link
G Cd8b CD8 subunit beta increases expression ISO clothianidin results in increased expression of CD8B mRNA CTD PMID:31626844 NCBI chr 4:104,870,911...104,886,838
Ensembl chr 4:104,870,893...104,886,868
JBrowse link
G Cdh8 cadherin 8 decreases expression ISO clothianidin results in decreased expression of CDH8 mRNA CTD PMID:31626844 NCBI chr19:5,494,552...5,901,950
Ensembl chr19:5,500,221...5,902,627
JBrowse link
G Cdrt15l2 CMT1A duplicated region transcript 15 like 2 increases expression ISO clothianidin results in increased expression of CDRT15L2 mRNA CTD PMID:31626844 NCBI chr16:11,232,244...11,238,199 JBrowse link
G Ceacam6 CEA cell adhesion molecule 6 increases expression ISO clothianidin results in increased expression of CEACAM6 mRNA CTD PMID:31626844 NCBI chr 1:89,544,415...89,562,552
Ensembl chr 1:89,544,400...89,562,552
JBrowse link
G Cemip cell migration inducing hyaluronidase 1 increases expression ISO clothianidin results in increased expression of CEMIP mRNA CTD PMID:31626844 NCBI chr 1:147,316,052...147,471,552
Ensembl chr 1:147,316,052...147,471,768
JBrowse link
G Ces2h carboxylesterase 2H multiple interactions ISO [clothianidin co-treated with thiacloprid] results in increased expression of CES2 protein CTD PMID:32201337 NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752
JBrowse link
G Cfap107 cilia and flagella associated protein 107 decreases expression ISO clothianidin results in decreased expression of CFAP107 mRNA CTD PMID:31626844 NCBI chr 5:161,495,655...161,514,751
Ensembl chr 5:161,495,655...161,514,751
JBrowse link
G Chat choline O-acetyltransferase decreases expression ISO clothianidin results in decreased expression of CHAT mRNA CTD PMID:35264496 NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,663,665...7,723,416
JBrowse link
G Chrna4 cholinergic receptor nicotinic alpha 4 subunit multiple interactions ISO clothianidin promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] CTD PMID:21538459 NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
JBrowse link
G Chrna7 cholinergic receptor nicotinic alpha 7 subunit decreases expression
increases activity
ISO clothianidin results in decreased expression of CHRNA7 mRNA
clothianidin results in increased activity of CHRNA7 protein; clothianidin results in increased activity of CHRNA7 protein mutant form
CTD PMID:35264496 PMID:39393466 NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:126,123,425...126,446,858
JBrowse link
G Chrnb2 cholinergic receptor nicotinic beta 2 subunit multiple interactions EXP
ISO
clothianidin results in increased activity of [NACHRA8 protein co-treated with CHRNB2 protein]; clothianidin results in increased activity of [NACHRALPHA1 protein co-treated with CHRNB2 protein]
clothianidin promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]
CTD PMID:16981889 PMID:21538459 PMID:25459289 NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:177,479,091...177,491,326
JBrowse link
G Chst3 carbohydrate sulfotransferase 3 increases expression ISO clothianidin results in increased expression of CHST3 mRNA CTD PMID:29044138 NCBI chr20:28,657,308...28,694,976
Ensembl chr20:28,657,308...28,694,526
JBrowse link
G Cldn14 claudin 14 decreases expression ISO clothianidin results in decreased expression of CLDN14 mRNA CTD PMID:35690182 NCBI chr11:46,701,940...46,799,049
Ensembl chr11:46,701,940...46,799,096
JBrowse link
G Clec3b C-type lectin domain family 3, member B increases expression ISO clothianidin results in increased expression of CLEC3B mRNA CTD PMID:31626844 NCBI chr 8:131,687,575...131,693,292 JBrowse link
G Cmtm5 CKLF-like MARVEL transmembrane domain containing 5 increases expression ISO clothianidin results in increased expression of CMTM5 mRNA CTD PMID:31626844 NCBI chr15:32,382,171...32,385,288
Ensembl chr15:32,382,608...32,385,271
JBrowse link
G Cntnap1 contactin associated protein 1 decreases expression ISO clothianidin results in decreased expression of CNTNAP1 mRNA CTD PMID:31626844 NCBI chr10:86,610,140...86,625,896
Ensembl chr10:86,611,890...86,631,730
JBrowse link
G Col12a1 collagen type XII alpha 1 chain decreases expression ISO clothianidin results in decreased expression of COL12A1 mRNA CTD PMID:31626844 NCBI chr 8:89,427,834...89,545,886
Ensembl chr 8:89,427,834...89,545,711
JBrowse link
G Col1a1 collagen type I alpha 1 chain decreases expression ISO clothianidin results in decreased expression of COL1A1 mRNA CTD PMID:29044138 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
JBrowse link
G Col5a2 collagen type V alpha 2 chain decreases expression ISO clothianidin results in decreased expression of COL5A2 mRNA CTD PMID:35690182 NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:54,940,764...55,090,150
JBrowse link
G Col6a2 collagen type VI alpha 2 chain increases expression ISO clothianidin results in increased expression of COL6A2 mRNA CTD PMID:31626844 NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,265...12,057,042
JBrowse link
G Col7a1 collagen type VII alpha 1 chain decreases expression ISO clothianidin results in decreased expression of COL7A1 mRNA CTD PMID:29044138 NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439
JBrowse link
G Coro2b coronin 2B decreases expression ISO clothianidin results in decreased expression of CORO2B mRNA CTD PMID:31626844 NCBI chr 8:71,802,329...71,912,739
Ensembl chr 8:71,802,329...71,912,739
JBrowse link
G Cpeb3 cytoplasmic polyadenylation element binding protein 3 decreases expression ISO clothianidin results in decreased expression of CPEB3 mRNA CTD PMID:31626844 NCBI chr 1:244,161,690...244,343,765
Ensembl chr 1:244,161,690...244,343,561
JBrowse link
G Cpne4 copine 4 increases expression ISO clothianidin results in increased expression of CPNE4 mRNA CTD PMID:31626844 NCBI chr 8:114,056,152...114,531,855
Ensembl chr 8:113,993,703...114,531,855
JBrowse link
G Csmd1 CUB and Sushi multiple domains 1 increases expression ISO clothianidin results in increased expression of CSMD1 mRNA CTD PMID:31626844 NCBI chr16:78,920,549...80,520,710
Ensembl chr16:78,921,002...80,519,944
JBrowse link
G Cxadr CXADR, Ig-like cell adhesion molecule increases expression ISO clothianidin results in increased expression of CXADR mRNA CTD PMID:29044138 NCBI chr11:30,469,778...30,516,990
Ensembl chr11:30,469,526...30,516,988
JBrowse link
G Cyba cytochrome b-245 alpha chain decreases expression ISO clothianidin results in decreased expression of CYBA mRNA CTD PMID:35690182 NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 affects expression ISO clothianidin affects the expression of CYP19A1 mRNA CTD PMID:33563863 NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
increases expression
ISO [clothianidin co-treated with enilconazole] results in increased expression of CYP1A2 mRNA; [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in increased expression of CYP1A2 mRNA
clothianidin results in increased expression of CYP1A2 mRNA
CTD PMID:32201337 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions ISO [clothianidin co-treated with enilconazole] results in increased expression of CYP1B1 protein CTD PMID:32201337 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 increases expression
multiple interactions
EXP clothianidin results in increased expression of CYP2B2 mRNA
[enilconazole co-treated with clothianidin] results in increased expression of CYP2B2 mRNA; [thiacloprid co-treated with clothianidin] results in increased expression of CYP2B2 mRNA
CTD PMID:33426623 NCBI chr 1:90,722,243...90,736,272 JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions ISO [clothianidin co-treated with thiacloprid] results in increased expression of CYP2B6 protein CTD PMID:32201337 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 decreases expression
multiple interactions
ISO clothianidin results in decreased expression of CYP2E1 mRNA
[clothianidin co-treated with enilconazole] results in decreased expression of CYP2E1 mRNA; [clothianidin co-treated with thiacloprid] results in increased expression of CYP2E1 protein; [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in decreased expression of CYP2E1 mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of CYP2E1 mRNA
CTD PMID:32201337 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression
multiple interactions
ISO clothianidin results in increased expression of CYP3A4 mRNA
[clothianidin co-treated with enilconazole] results in increased expression of CYP3A4 mRNA; [clothianidin co-treated with enilconazole] results in increased expression of CYP3A4 protein; [clothianidin co-treated with thiacloprid] results in increased expression of CYP3A4 protein; [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in increased expression of CYP3A4 mRNA
CTD PMID:32201337 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 multiple interactions
increases expression
EXP [enilconazole co-treated with clothianidin] results in increased expression of CYP3A23-3A1 mRNA; [thiacloprid co-treated with clothianidin] results in increased expression of CYP3A23-3A1 mRNA
clothianidin results in increased expression of CYP3A23-3A1 mRNA
CTD PMID:33426623 NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813
JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 multiple interactions
increases expression
ISO [clothianidin co-treated with enilconazole] results in increased expression of CYP3A5 protein; [thiacloprid co-treated with clothianidin] results in increased expression of CYP3A5 mRNA
clothianidin results in increased expression of CYP3A5 mRNA
CTD PMID:32201337 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 multiple interactions
decreases expression
EXP [enilconazole co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA
clothianidin results in decreased expression of CYP7A1 mRNA
CTD PMID:33426623 NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
JBrowse link
G Cyth4 cytohesin 4 increases expression ISO clothianidin results in increased expression of CYTH4 mRNA CTD PMID:31626844 NCBI chr 7:112,032,711...112,057,204
Ensembl chr 7:112,032,775...112,057,204
JBrowse link
G Dact1 dishevelled-binding antagonist of beta-catenin 1 decreases expression ISO clothianidin results in decreased expression of DACT1 mRNA CTD PMID:31626844 NCBI chr 6:95,526,645...95,538,625
Ensembl chr 6:95,526,690...95,551,053
JBrowse link
G Defa5 defensin alpha 5 decreases expression ISO clothianidin results in decreased expression of DEFA5 mRNA CTD PMID:31626844 NCBI chr16:77,044,994...77,047,318
Ensembl chr16:77,044,994...77,047,318
JBrowse link
G Des desmin increases expression ISO clothianidin results in increased expression of DES mRNA CTD PMID:31626844 NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:84,298,447...84,307,347
JBrowse link
G Dgkd diacylglycerol kinase, delta increases expression ISO clothianidin results in increased expression of DGKD mRNA CTD PMID:31626844 NCBI chr 9:95,964,507...96,055,160
Ensembl chr 9:95,964,148...96,055,160
JBrowse link
G Dio3 iodothyronine deiodinase 3 increases expression ISO clothianidin results in increased expression of DIO3 mRNA CTD PMID:31626844 NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:135,107,074...135,107,985
JBrowse link
G Dll3 delta like canonical Notch ligand 3 decreases expression ISO clothianidin results in decreased expression of DLL3 mRNA CTD PMID:31626844 NCBI chr 1:92,689,577...92,698,125
Ensembl chr 1:92,689,577...92,697,406
JBrowse link
G Dnai7 dynein axonemal intermediate chain 7 decreases expression ISO clothianidin results in decreased expression of DNAI7 mRNA CTD PMID:31626844 NCBI chr 4:179,874,338...179,910,716
Ensembl chr 4:179,873,522...179,910,780
JBrowse link
G Dnajc21 DnaJ heat shock protein family (Hsp40) member C21 increases expression ISO clothianidin results in increased expression of DNAJC21 mRNA CTD PMID:31626844 NCBI chr 2:61,146,669...61,173,908
Ensembl chr 2:61,145,142...61,174,126
JBrowse link
G Dnajc28 DnaJ heat shock protein family (Hsp40) member C28 decreases expression ISO clothianidin results in decreased expression of DNAJC28 mRNA CTD PMID:31626844 NCBI chr11:44,341,528...44,344,348
Ensembl chr11:44,338,646...44,344,482
JBrowse link
G Dnajc5g DnaJ heat shock protein family (Hsp40) member C5 gamma increases expression ISO clothianidin results in increased expression of DNAJC5G mRNA CTD PMID:31626844 NCBI chr 6:30,980,051...30,984,218
Ensembl chr 6:30,979,869...30,984,115
JBrowse link
G Dnase1l2 deoxyribonuclease 1 like 2 decreases expression ISO clothianidin results in decreased expression of DNASE1L2 mRNA CTD PMID:29044138 NCBI chr10:13,976,012...13,978,574
Ensembl chr10:13,976,012...13,978,366
JBrowse link
G Dnhd1 dynein heavy chain domain 1 decreases expression ISO clothianidin results in decreased expression of DNHD1 mRNA CTD PMID:29044138 NCBI chr 1:169,402,615...169,486,684
Ensembl chr 1:169,394,884...169,487,646
JBrowse link
G Dok5 docking protein 5 decreases expression ISO clothianidin results in decreased expression of DOK5 mRNA CTD PMID:31626844 NCBI chr 3:179,934,419...180,071,334
Ensembl chr 3:179,934,552...180,071,333
JBrowse link
G Dus3l dihydrouridine synthase 3-like increases expression ISO clothianidin results in increased expression of DUS3L mRNA CTD PMID:31626844 NCBI chr 9:1,680,619...1,685,784
Ensembl chr 9:1,675,819...1,686,367
JBrowse link
G Dusp15 dual specificity phosphatase 15 increases expression ISO clothianidin results in increased expression of DUSP15 mRNA CTD PMID:29044138 NCBI chr 3:161,868,746...161,880,432
Ensembl chr 3:161,868,749...161,879,250
JBrowse link
G Dusp16 dual specificity phosphatase 16 decreases expression ISO clothianidin results in decreased expression of DUSP16 mRNA CTD PMID:31626844 NCBI chr 4:169,278,118...169,361,508
Ensembl chr 4:169,278,118...169,361,508
JBrowse link
G Eaf2 ELL associated factor 2 decreases expression ISO clothianidin results in decreased expression of EAF2 mRNA CTD PMID:31626844 NCBI chr11:77,465,585...77,509,993
Ensembl chr11:77,406,020...77,509,993
JBrowse link
G Ece2 endothelin-converting enzyme 2 increases expression ISO clothianidin results in increased expression of ECE2 mRNA CTD PMID:31626844 NCBI chr11:93,767,559...93,782,896
Ensembl chr11:93,767,559...93,793,292
JBrowse link
G Efcab12 EF-hand calcium binding domain 12 decreases expression ISO clothianidin results in decreased expression of EFCAB12 mRNA CTD PMID:29044138 NCBI chr 4:150,541,983...150,563,973
Ensembl chr 4:150,541,982...150,563,286
JBrowse link
G Efs embryonal Fyn-associated substrate decreases expression ISO clothianidin results in decreased expression of EFS mRNA CTD PMID:31626844 NCBI chr15:32,362,401...32,374,490
Ensembl chr15:32,361,843...32,371,743
JBrowse link
G Eif3f eukaryotic translation initiation factor 3, subunit F decreases expression ISO clothianidin results in decreased expression of EIF3F mRNA CTD PMID:31626844 NCBI chr 1:172,369,062...172,378,043
Ensembl chr 1:172,369,062...172,378,041
JBrowse link
G Elf1 E74 like ETS transcription factor 1 increases expression ISO clothianidin results in increased expression of ELF1 mRNA CTD PMID:31626844 NCBI chr15:61,354,026...61,395,762
Ensembl chr15:61,330,877...61,395,758
JBrowse link
G Elmod1 ELMO domain containing 1 decreases expression ISO clothianidin results in decreased expression of ELMOD1 mRNA CTD PMID:31626844 NCBI chr 8:63,194,539...63,251,526
Ensembl chr 8:63,137,295...63,251,322
JBrowse link
G Eln elastin multiple interactions
decreases expression
EXP [enilconazole co-treated with clothianidin] results in decreased expression of ELN mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of ELN mRNA
clothianidin results in decreased expression of ELN mRNA
CTD PMID:33426623 NCBI chr12:27,604,983...27,648,413
Ensembl chr12:27,604,680...27,648,413
JBrowse link
G Enox1 ecto-NOX disulfide-thiol exchanger 1 increases expression ISO clothianidin results in increased expression of ENOX1 mRNA CTD PMID:35690182 NCBI chr15:58,924,519...59,488,919
Ensembl chr15:59,215,018...59,488,918
JBrowse link
G Enpp4 ectonucleotide pyrophosphatase/phosphodiesterase 4 increases expression ISO clothianidin results in increased expression of ENPP4 mRNA CTD PMID:29044138 NCBI chr 9:24,386,351...24,396,248
Ensembl chr 9:24,360,272...24,396,152
JBrowse link
G Epdr1 ependymin related 1 increases expression ISO clothianidin results in increased expression of EPDR1 mRNA CTD PMID:29044138 NCBI chr17:50,029,591...50,054,254
Ensembl chr17:50,029,256...50,054,250
JBrowse link
G Epn3 epsin 3 decreases expression ISO clothianidin results in decreased expression of EPN3 mRNA CTD PMID:31626844 NCBI chr10:79,935,857...79,946,121
Ensembl chr10:79,935,857...79,944,235
JBrowse link
G Eps8 EGFR pathway substrate 8, signaling adaptor increases expression ISO clothianidin results in increased expression of EPS8 mRNA CTD PMID:29044138 NCBI chr 4:172,119,497...172,291,670
Ensembl chr 4:172,119,497...172,218,160
JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 increases expression ISO clothianidin results in increased expression of ERBB3 mRNA CTD PMID:31626844 NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:1,579,816...1,601,120
JBrowse link
G Ergic1 endoplasmic reticulum-golgi intermediate compartment 1 increases expression ISO clothianidin results in increased expression of ERGIC1 mRNA CTD PMID:31626844 NCBI chr10:17,035,615...17,131,411
Ensembl chr10:17,035,615...17,131,376
JBrowse link
G Exoc4 exocyst complex component 4 decreases expression ISO clothianidin results in decreased expression of EXOC4 mRNA CTD PMID:31626844 NCBI chr 4:62,774,896...63,551,541
Ensembl chr 4:62,774,935...63,552,943
JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit decreases expression ISO clothianidin results in decreased expression of EZH2 mRNA CTD PMID:31626844 NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183
JBrowse link
G F2 coagulation factor II, thrombin decreases expression ISO clothianidin results in decreased expression of F2 mRNA CTD PMID:31626844 NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246
JBrowse link
G Fam110c family with sequence similarity 110, member C increases expression ISO clothianidin results in increased expression of FAM110C mRNA CTD PMID:31626844 NCBI chr 6:53,366,013...53,372,270
Ensembl chr 6:53,352,870...53,401,117
JBrowse link
G Fam131a family with sequence similarity 131, member A decreases expression ISO clothianidin results in decreased expression of FAM131A mRNA CTD PMID:31626844 NCBI chr11:93,715,979...93,725,930
Ensembl chr11:93,716,002...93,725,919
JBrowse link
G Fam151b family with sequence similarity 151, member B decreases expression ISO clothianidin results in decreased expression of FAM151B mRNA CTD PMID:31626844 NCBI chr 2:25,409,382...25,446,225
Ensembl chr 2:25,409,383...25,445,466
JBrowse link
G Fam169a family with sequence similarity 169, member A increases expression ISO clothianidin results in increased expression of FAM169A mRNA CTD PMID:29044138 NCBI chr 2:30,115,307...30,175,972
Ensembl chr 2:30,119,381...30,175,962
JBrowse link
G Fam229a family with sequence similarity 229, member A decreases expression ISO clothianidin results in decreased expression of FAM229A mRNA CTD PMID:29044138 NCBI chr 5:147,114,054...147,115,043
Ensembl chr 5:147,113,997...147,114,785
JBrowse link
G Faslg Fas ligand increases expression ISO clothianidin results in increased expression of FASLG mRNA CTD PMID:35264496 NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
JBrowse link
G Fbxo33 F-box protein 33 decreases expression ISO clothianidin results in decreased expression of FBXO33 mRNA CTD PMID:31626844 NCBI chr 6:82,635,509...82,669,441
Ensembl chr 6:82,635,521...82,667,440
JBrowse link
G Fer1l4 fer-1-like family member 4 decreases expression ISO clothianidin results in decreased expression of FER1L4 mRNA CTD PMID:29044138 NCBI chr 3:164,996,183...165,031,719
Ensembl chr 3:164,996,183...165,031,719
JBrowse link
G Fgfr1 Fibroblast growth factor receptor 1 increases expression ISO clothianidin results in increased expression of FGFR1 mRNA CTD PMID:36858607 NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855
JBrowse link
G Fhit fragile histidine triad diadenosine triphosphatase increases expression ISO clothianidin results in increased expression of FHIT mRNA CTD PMID:35690182 NCBI chr15:16,365,401...17,872,901
Ensembl chr15:16,747,338...17,872,621
JBrowse link
G Filip1 filamin A interacting protein 1 increases expression ISO clothianidin results in increased expression of FILIP1 mRNA CTD PMID:31626844 NCBI chr 8:89,641,509...89,836,772
Ensembl chr 8:89,644,579...89,802,771
JBrowse link
G Fitm1 fat storage-inducing transmembrane protein 1 increases expression ISO clothianidin results in increased expression of FITM1 mRNA CTD PMID:31626844 NCBI chr15:33,034,705...33,035,974
Ensembl chr15:33,034,688...33,035,974
JBrowse link
G Folr2 folate receptor beta increases expression ISO clothianidin results in increased expression of FOLR2 mRNA CTD PMID:31626844 NCBI chr 1:165,612,047...165,630,382
Ensembl chr 1:165,612,063...165,617,731
JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression ISO clothianidin results in increased expression of FOSL1 mRNA CTD PMID:35690182 NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391
JBrowse link
G Foxo1 forkhead box O1 increases expression ISO clothianidin results in increased expression of FOXO1 mRNA CTD PMID:31626844 NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
JBrowse link
G Foxo4 forkhead box O4 decreases expression ISO clothianidin results in decreased expression of FOXO4 mRNA CTD PMID:29044138 NCBI chr  X:70,425,218...70,432,120
Ensembl chr  X:70,425,563...70,432,120
JBrowse link
G Fyb1 FYN binding protein 1 decreases expression ISO clothianidin results in decreased expression of FYB1 mRNA CTD PMID:31626844 NCBI chr 2:57,360,084...57,508,609
Ensembl chr 2:57,360,096...57,508,608
JBrowse link
G Gabrg1 gamma-aminobutyric acid type A receptor subunit gamma 1 increases expression ISO clothianidin results in increased expression of GABRG1 mRNA CTD PMID:35264496 NCBI chr14:37,750,292...37,821,651
Ensembl chr14:37,750,292...37,989,945
JBrowse link
G Gabrp gamma-aminobutyric acid type A receptor subunit pi decreases expression ISO clothianidin results in decreased expression of GABRP mRNA CTD PMID:35264496 NCBI chr10:18,647,243...18,673,806
Ensembl chr10:18,647,243...18,673,727
JBrowse link
G Gask1a golgi associated kinase 1A increases expression ISO clothianidin results in increased expression of FAM198A mRNA CTD PMID:31626844 NCBI chr 8:130,488,279...130,521,242
Ensembl chr 8:130,488,354...130,521,242
JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO clothianidin results in increased expression of GDF15 mRNA CTD PMID:35690182 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
JBrowse link
G Ghrhr growth hormone releasing hormone receptor increases expression ISO clothianidin results in increased expression of GHRHR mRNA CTD PMID:31626844 NCBI chr 4:85,830,345...85,863,127
Ensembl chr 4:85,830,486...85,863,127
JBrowse link
G Gli1 GLI family zinc finger 1 decreases expression ISO clothianidin results in decreased expression of GLI1 mRNA CTD PMID:31626844 NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540
JBrowse link
G Gngt1 G protein subunit gamma transducin 1 decreases expression ISO clothianidin results in decreased expression of GNGT1 mRNA CTD PMID:31626844 NCBI chr 4:32,960,945...32,963,930
Ensembl chr 4:32,960,945...32,963,930
JBrowse link
G Gnmt glycine N-methyltransferase decreases expression ISO clothianidin results in decreased expression of GNMT mRNA CTD PMID:35690182 NCBI chr 9:21,752,235...21,756,368
Ensembl chr 9:21,752,266...21,755,692
JBrowse link
G Gpc6 glypican 6 increases expression ISO clothianidin results in increased expression of GPC6 mRNA CTD PMID:31626844 NCBI chr15:100,437,415...101,435,038
Ensembl chr15:100,437,943...101,435,027
JBrowse link
G Gpcpd1 glycerophosphocholine phosphodiesterase 1 increases expression ISO clothianidin results in increased expression of GPCPD1 mRNA CTD PMID:31626844 NCBI chr 3:140,240,574...140,285,469
Ensembl chr 3:140,240,575...140,285,372
JBrowse link
G Gpihbp1 glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 increases expression ISO clothianidin results in increased expression of GPIHBP1 mRNA CTD PMID:31626844 NCBI chr 7:109,166,334...109,169,448
Ensembl chr 7:109,163,160...109,169,448
JBrowse link
G Gpr15lg G protein-coupled receptor 15 ligand decreases expression ISO clothianidin results in decreased expression of GPR15LG mRNA CTD PMID:31626844 NCBI chr16:12,888,528...12,896,134
Ensembl chr16:12,888,528...12,896,134
JBrowse link
G Gpx4 glutathione peroxidase 4 decreases expression ISO clothianidin results in decreased expression of GPX4 protein CTD PMID:25960033 PMID:33563863 NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
JBrowse link
G Gramd1c GRAM domain containing 1C decreases expression ISO clothianidin results in decreased expression of GRAMD1C mRNA CTD PMID:31626844 NCBI chr11:70,139,076...70,224,478
Ensembl chr11:70,139,184...70,224,478
JBrowse link
G Gramd2a GRAM domain containing 2A decreases expression ISO clothianidin results in decreased expression of GRAMD2A mRNA CTD PMID:31626844 NCBI chr 8:68,975,529...69,013,575
Ensembl chr 8:69,003,807...69,013,573
JBrowse link
G Gskip GSK3B interacting protein increases expression ISO clothianidin results in increased expression of GSKIP mRNA CTD PMID:29044138 NCBI chr 6:130,357,241...130,373,221
Ensembl chr 6:130,370,042...130,373,873
JBrowse link
G Gtf3c5 general transcription factor IIIC subunit 5 increases expression ISO clothianidin results in increased expression of GTF3C5 mRNA CTD PMID:31626844 NCBI chr 3:32,291,851...32,312,188
Ensembl chr 3:32,291,859...32,312,164
JBrowse link
G Gtsf1l gametocyte specific factor 1-like increases expression ISO clothianidin results in increased expression of GTSF1L mRNA CTD PMID:31626844 NCBI chr 3:172,155,533...172,158,228
Ensembl chr 3:172,154,100...172,162,042
JBrowse link
G Gypc glycophorin C increases expression ISO clothianidin results in increased expression of GYPC mRNA CTD PMID:31626844 NCBI chr18:24,434,921...24,467,592
Ensembl chr18:24,434,922...24,440,053
JBrowse link
G H1f7 H1.7 linker histone increases expression ISO clothianidin results in increased expression of H1-7 mRNA CTD PMID:31626844 NCBI chr 7:131,287,569...131,288,936
Ensembl chr 7:131,286,654...131,289,110
JBrowse link
G Hacd2 3-hydroxyacyl-CoA dehydratase 2 increases expression ISO clothianidin results in increased expression of HACD2 mRNA CTD PMID:29044138 NCBI chr11:79,175,470...79,268,975
Ensembl chr11:79,175,482...79,268,126
JBrowse link
G Hck HCK proto-oncogene, Src family tyrosine kinase increases expression ISO clothianidin results in increased expression of HCK mRNA CTD PMID:31626844 NCBI chr 3:162,031,833...162,074,933
Ensembl chr 3:162,031,817...162,074,935
JBrowse link
G Hectd2 HECT domain E3 ubiquitin protein ligase 2 increases expression ISO clothianidin results in increased expression of HECTD2 mRNA CTD PMID:29044138 NCBI chr 1:243,687,248...243,756,069
Ensembl chr 1:243,687,923...243,756,069
JBrowse link
G Hecw2 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 decreases expression ISO clothianidin results in decreased expression of HECW2 mRNA CTD PMID:31626844 NCBI chr 9:62,853,904...63,247,472
Ensembl chr 9:62,859,645...63,074,758
JBrowse link
G Hgf hepatocyte growth factor decreases expression ISO clothianidin results in decreased expression of HGF mRNA CTD PMID:31626844 NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
JBrowse link
G Hid1 HID1 domain containing decreases expression ISO clothianidin results in decreased expression of HID1 mRNA CTD PMID:31626844 NCBI chr10:101,088,526...101,109,011
Ensembl chr10:101,088,526...101,109,011
JBrowse link
G Hmbs hydroxymethylbilane synthase increases expression ISO clothianidin results in increased expression of HMBS mRNA CTD PMID:31626844 NCBI chr 8:53,570,364...53,577,758
Ensembl chr 8:53,570,364...53,577,802
JBrowse link
G Hnf1b HNF1 homeobox B increases expression ISO clothianidin results in increased expression of HNF1B mRNA CTD PMID:31626844 NCBI chr10:69,233,377...69,287,360
Ensembl chr10:69,233,131...69,287,361
JBrowse link
G Hnf4a hepatocyte nuclear factor 4, alpha increases expression ISO clothianidin results in increased expression of HNF4A mRNA CTD PMID:31626844 NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:172,606,220...172,667,758
JBrowse link
G Hnrnpk heterogeneous nuclear ribonucleoprotein K decreases expression ISO clothianidin results in decreased expression of HNRNPK mRNA CTD PMID:31626844 NCBI chr17:6,269,302...6,280,429
Ensembl chr17:6,268,385...6,280,565
JBrowse link
G Ift70b intraflagellar transport 70B decreases expression ISO clothianidin results in decreased expression of IFT70B mRNA CTD PMID:31626844 NCBI chr 3:81,263,074...81,265,645 JBrowse link
G Il17re interleukin 17 receptor E decreases expression ISO clothianidin results in decreased expression of IL17RE mRNA CTD PMID:29044138 NCBI chr 4:148,160,384...148,173,830
Ensembl chr 4:148,159,475...148,173,827
JBrowse link
G Il18bp interleukin 18 binding protein decreases expression ISO clothianidin results in decreased expression of IL18BP mRNA CTD PMID:29044138 NCBI chr 1:165,784,916...165,787,990
Ensembl chr 1:165,784,069...165,786,955
JBrowse link
G Il2rg interleukin 2 receptor subunit gamma increases expression ISO clothianidin results in increased expression of IL2RG mRNA CTD PMID:31626844 NCBI chr  X:70,435,340...70,439,052
Ensembl chr  X:70,435,343...70,439,161
JBrowse link
G Immp1l inner mitochondrial membrane peptidase subunit 1 increases expression ISO clothianidin results in increased expression of IMMP1L mRNA CTD PMID:31626844 NCBI chr 3:112,840,015...112,904,297
Ensembl chr 3:112,840,113...112,904,296
JBrowse link
G Inhba inhibin subunit beta A increases expression ISO clothianidin results in increased expression of INHBA mRNA CTD PMID:33563863 NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
JBrowse link
G Insyn2b inhibitory synaptic factor family member 2B decreases expression ISO clothianidin results in decreased expression of INSYN2B mRNA CTD PMID:31626844 NCBI chr10:19,420,561...19,528,006
Ensembl chr10:19,507,084...19,511,298
JBrowse link
G Irx5 iroquois homeobox 5 decreases expression ISO clothianidin results in decreased expression of IRX5 mRNA CTD PMID:31626844 NCBI chr19:30,812,033...30,816,885
Ensembl chr19:30,797,202...30,815,029
JBrowse link
G Itsn1 intersectin 1 decreases expression ISO clothianidin results in decreased expression of ITSN1 mRNA CTD PMID:31626844 NCBI chr11:44,464,515...44,646,598
Ensembl chr11:44,513,186...44,646,598
JBrowse link
G Jak2 Janus kinase 2 decreases expression ISO clothianidin results in decreased expression of JAK2 mRNA CTD PMID:31626844 NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
JBrowse link
G Kat6b lysine acetyltransferase 6B decreases expression ISO clothianidin results in decreased expression of KAT6B mRNA CTD PMID:31626844 NCBI chr15:2,688,535...2,861,443
Ensembl chr15:2,688,811...2,844,343
JBrowse link
G Kcnc4 potassium voltage-gated channel subfamily C member 4 increases expression ISO clothianidin results in increased expression of KCNC4 mRNA CTD PMID:31626844 NCBI chr 2:197,747,095...197,788,467
Ensembl chr 2:197,759,010...197,788,433
JBrowse link
G Kcnd3 potassium voltage-gated channel subfamily D member 3 decreases expression ISO clothianidin results in decreased expression of KCND3 mRNA CTD PMID:31626844 NCBI chr 2:195,626,316...195,843,690
Ensembl chr 2:195,626,316...195,843,690
JBrowse link
G Kcnk1 potassium two pore domain channel subfamily K member 1 decreases expression ISO clothianidin results in decreased expression of KCNK1 mRNA CTD PMID:31626844 NCBI chr19:70,856,985...70,895,053
Ensembl chr19:70,856,985...70,895,051
JBrowse link
G Kcnma1 potassium calcium-activated channel subfamily M alpha 1 decreases expression ISO clothianidin results in decreased expression of KCNMA1 mRNA CTD PMID:31626844 PMID:35690182 NCBI chr15:351,065...1,057,117
Ensembl chr15:351,659...1,057,117
JBrowse link
G Kif7 kinesin family member 7 increases expression ISO clothianidin results in increased expression of KIF7 mRNA CTD PMID:31626844 NCBI chr 1:143,041,206...143,067,873
Ensembl chr 1:143,049,036...143,067,890
JBrowse link
G Kifc3 kinesin family member C3 increases expression ISO clothianidin results in increased expression of KIFC3 mRNA CTD PMID:31626844 NCBI chr19:9,831,159...9,926,405
Ensembl chr19:9,831,159...9,926,405
JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase increases expression ISO clothianidin results in increased expression of KIT mRNA CTD PMID:31626844 NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812
JBrowse link
G Klhdc9 kelch domain containing 9 decreases expression ISO clothianidin results in decreased expression of KLHDC9 mRNA CTD PMID:31626844 NCBI chr13:86,323,004...86,326,237
Ensembl chr13:86,323,004...86,325,653
JBrowse link
G Kpna6 karyopherin subunit alpha 6 increases expression ISO clothianidin results in increased expression of KPNA6 mRNA CTD PMID:31626844 NCBI chr 5:147,272,466...147,307,523
Ensembl chr 5:147,275,918...147,305,851
JBrowse link
G Krt28 keratin 28 increases expression ISO clothianidin results in increased expression of KRT28 mRNA CTD PMID:31626844 NCBI chr10:84,814,516...84,824,857
Ensembl chr10:84,814,516...84,824,857
JBrowse link
G Ksr1 kinase suppressor of ras 1 decreases expression ISO clothianidin results in decreased expression of KSR1 mRNA CTD PMID:31626844 NCBI chr10:64,459,786...64,596,083
Ensembl chr10:64,459,786...64,596,082
JBrowse link
G Ky kyphoscoliosis peptidase multiple interactions
decreases expression
EXP [enilconazole co-treated with clothianidin] results in decreased expression of KY mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of KY mRNA
clothianidin results in decreased expression of KY mRNA
CTD PMID:33426623 NCBI chr 8:111,965,862...112,005,206
Ensembl chr 8:111,965,862...112,005,206
JBrowse link
G L3mbtl1 L3MBTL histone methyl-lysine binding protein 1 decreases expression ISO clothianidin results in decreased expression of L3MBTL1 mRNA CTD PMID:31626844 NCBI chr 3:172,014,774...172,053,181
Ensembl chr 3:172,021,416...172,053,181
JBrowse link
G Lgals12 galectin 12 increases expression ISO clothianidin results in increased expression of LGALS12 mRNA CTD PMID:31626844 NCBI chr 1:214,261,216...214,272,825
Ensembl chr 1:214,261,216...214,271,910
JBrowse link
G Lgi4 leucine-rich repeat LGI family, member 4 increases expression ISO clothianidin results in increased expression of LGI4 mRNA CTD PMID:31626844 NCBI chr 1:95,422,461...95,433,296
Ensembl chr 1:95,414,058...95,433,289
JBrowse link
G Lif LIF, interleukin 6 family cytokine decreases expression ISO clothianidin results in decreased expression of LIF mRNA CTD PMID:35690182 NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053
JBrowse link
G Lim2 lens intrinsic membrane protein 2 increases expression ISO clothianidin results in increased expression of LIM2 mRNA CTD PMID:31626844 NCBI chr 1:102,974,188...102,980,358
Ensembl chr 1:102,974,188...102,980,358
JBrowse link
G Lonrf1 LON peptidase N-terminal domain and ring finger 1 increases expression ISO clothianidin results in increased expression of LONRF1 mRNA CTD PMID:31626844 NCBI chr16:62,687,931...62,718,525
Ensembl chr16:62,687,746...62,718,520
JBrowse link
G Lox lysyl oxidase increases expression ISO clothianidin results in increased expression of LOX mRNA CTD PMID:29044138 NCBI chr18:48,162,889...48,175,640
Ensembl chr18:48,165,688...48,239,810
JBrowse link
G Lpar1 lysophosphatidic acid receptor 1 decreases expression ISO clothianidin results in decreased expression of LPAR1 mRNA CTD PMID:31626844 NCBI chr 5:78,024,139...78,147,071
Ensembl chr 5:78,024,139...78,142,188
JBrowse link
G Lrig1 leucine-rich repeats and immunoglobulin-like domains 1 increases expression ISO clothianidin results in increased expression of LRIG1 mRNA CTD PMID:31626844 NCBI chr 4:128,687,723...128,788,219
Ensembl chr 4:128,687,723...128,788,219
JBrowse link
G Lrmda leucine rich melanocyte differentiation associated decreases expression ISO clothianidin results in decreased expression of LRMDA mRNA CTD PMID:35690182 NCBI chr15:1,275,139...2,334,153
Ensembl chr15:1,274,199...2,334,089
JBrowse link
G Lrrc74b leucine rich repeat containing 74B decreases expression ISO clothianidin results in decreased expression of LRRC74B mRNA CTD PMID:31626844 NCBI chr11:96,954,648...96,974,290
Ensembl chr11:96,954,449...96,974,288
JBrowse link
G Luzp2 leucine zipper protein 2 increases expression ISO clothianidin results in increased expression of LUZP2 mRNA CTD PMID:31626844 NCBI chr 1:114,733,026...115,119,374
Ensembl chr 1:114,733,455...115,119,630
JBrowse link
G Lysmd2 LysM domain containing 2 decreases expression ISO clothianidin results in decreased expression of LYSMD2 mRNA CTD PMID:31626844 NCBI chr 8:85,259,443...85,274,876
Ensembl chr 8:85,259,410...85,275,241
JBrowse link
G Mapk1 mitogen activated protein kinase 1 increases phosphorylation ISO clothianidin results in increased phosphorylation of MAPK1 protein CTD PMID:31626844 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases phosphorylation ISO clothianidin results in increased phosphorylation of MAPK3 protein CTD PMID:31626844 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
JBrowse link
G Mchr1 melanin-concentrating hormone receptor 1 increases expression ISO clothianidin results in increased expression of MCHR1 mRNA CTD PMID:31626844 NCBI chr 7:114,641,721...114,644,913
Ensembl chr 7:114,641,580...114,644,919
JBrowse link
G Megf11 multiple EGF-like-domains 11 multiple interactions
decreases expression
EXP [enilconazole co-treated with clothianidin] results in decreased expression of MEGF11 mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of MEGF11 mRNA
clothianidin results in decreased expression of MEGF11 mRNA
CTD PMID:33426623 NCBI chr 8:73,787,568...74,113,228
Ensembl chr 8:73,787,397...74,111,690
JBrowse link
G Meioc meiosis specific with coiled-coil domain increases expression ISO clothianidin results in increased expression of MEIOC mRNA CTD PMID:31626844 NCBI chr10:88,128,939...88,147,833
Ensembl chr10:88,128,990...88,147,829
JBrowse link
G Mettl16 methyltransferase 16, RNA N6-adenosine increases expression ISO clothianidin results in increased expression of METTL16 mRNA CTD PMID:31626844 NCBI chr10:60,139,317...60,185,438
Ensembl chr10:60,139,330...60,187,571
JBrowse link
G Mical1 microtubule associated monooxygenase, calponin and LIM domain containing 1 increases expression ISO clothianidin results in increased expression of MICAL1 mRNA CTD PMID:31626844 NCBI chr20:46,547,983...46,568,487
Ensembl chr20:46,556,536...46,568,487
JBrowse link
G Micall2 MICAL-like 2 decreases expression ISO clothianidin results in decreased expression of MICALL2 mRNA CTD PMID:29044138 NCBI chr12:20,013,037...20,041,795
Ensembl chr12:20,012,985...20,041,795
JBrowse link
G Mlana melan-A increases expression ISO clothianidin results in increased expression of MLANA mRNA CTD PMID:31626844 NCBI chr 1:236,883,075...236,897,693
Ensembl chr 1:236,883,075...236,896,880
JBrowse link
G Mme membrane metallo-endopeptidase multiple interactions
increases expression
EXP [enilconazole co-treated with clothianidin] results in increased expression of MME mRNA; [thiacloprid co-treated with clothianidin] results in increased expression of MME mRNA
clothianidin results in increased expression of MME mRNA
CTD PMID:33426623 NCBI chr 2:149,806,826...149,957,381
Ensembl chr 2:149,872,291...149,953,463
JBrowse link
G Mmp10 matrix metallopeptidase 10 increases expression ISO clothianidin results in increased expression of MMP10 mRNA CTD PMID:31626844 NCBI chr 8:12,974,707...12,982,613
Ensembl chr 8:12,974,707...12,982,613
JBrowse link
G Ms4a2 membrane spanning 4-domains A2 decreases expression ISO clothianidin results in decreased expression of MS4A2 mRNA CTD PMID:29044138 NCBI chr 1:217,864,855...217,873,934
Ensembl chr 1:217,865,159...217,873,108
JBrowse link
G Mss51 MSS51 mitochondrial translational activator decreases expression ISO clothianidin results in decreased expression of MSS51 mRNA CTD PMID:29044138 NCBI chr15:3,855,094...3,868,614
Ensembl chr15:3,855,478...3,868,611
JBrowse link
G Mtg1 mitochondrial ribosome-associated GTPase 1 decreases expression ISO clothianidin results in decreased expression of MTG1 mRNA CTD PMID:29044138 NCBI chr 1:204,361,176...204,373,917
Ensembl chr 1:204,361,147...204,373,924
JBrowse link
G Myl11 myosin light chain 11 decreases expression ISO clothianidin results in decreased expression of MYL11 mRNA CTD PMID:31626844 NCBI chr 1:191,257,432...191,263,046
Ensembl chr 1:191,256,196...191,263,045
JBrowse link
G Myl4 myosin, light chain 4 decreases expression ISO clothianidin results in decreased expression of MYL4 mRNA CTD PMID:31626844 NCBI chr10:89,949,733...89,985,308
Ensembl chr10:89,949,404...89,985,308
JBrowse link
G Myl6 myosin light chain 6 decreases expression ISO clothianidin results in decreased expression of MYL6 mRNA CTD PMID:31626844 NCBI chr 7:1,495,301...1,498,512
Ensembl chr 7:1,495,747...1,498,344
JBrowse link
G Myo3b myosin IIIB increases expression ISO clothianidin results in increased expression of MYO3B mRNA CTD PMID:31626844 NCBI chr 3:75,228,017...75,636,272
Ensembl chr 3:75,228,017...75,636,272
JBrowse link
G Myorg myogenesis regulating glycosidase increases expression ISO clothianidin results in increased expression of MYORG mRNA CTD PMID:29044138 NCBI chr 5:61,452,956...61,460,500
Ensembl chr 5:61,432,418...61,460,581
JBrowse link
G Myt1l myelin transcription factor 1-like increases expression ISO clothianidin results in increased expression of MYT1L mRNA CTD PMID:31626844 NCBI chr 6:51,892,858...52,291,830
Ensembl chr 6:52,155,754...52,291,828
JBrowse link
G N4bp2l1 NEDD4 binding protein 2-like 1 increases expression ISO clothianidin results in increased expression of N4BP2L1 mRNA CTD PMID:31626844 NCBI chr12:4,938,199...4,965,003
Ensembl chr12:4,927,142...4,963,045
JBrowse link
G Nadsyn1 NAD synthetase 1 decreases expression ISO clothianidin results in decreased expression of NADSYN1 mRNA CTD PMID:31626844 NCBI chr 1:208,410,914...208,439,242
Ensembl chr 1:208,410,914...208,439,207
JBrowse link
G Nasp nuclear autoantigenic sperm protein decreases expression ISO clothianidin results in decreased expression of NASP mRNA CTD PMID:31626844 NCBI chr 5:135,294,599...135,319,992
Ensembl chr 5:135,294,032...135,319,591
JBrowse link
G Ncf2 neutrophil cytosolic factor 2 increases expression ISO clothianidin results in increased expression of NCF2 mRNA CTD PMID:35690182 NCBI chr13:67,505,492...67,536,015
Ensembl chr13:67,505,375...67,536,149
JBrowse link
G Ndufa10 NADH:ubiquinone oxidoreductase subunit A10 increases expression ISO clothianidin results in increased expression of NDUFA10 mRNA CTD PMID:31626844 NCBI chr 9:100,454,498...100,490,023
Ensembl chr 9:100,437,379...100,489,264
JBrowse link
G Nectin4 nectin cell adhesion molecule 4 decreases expression ISO clothianidin results in decreased expression of NECTIN4 mRNA CTD PMID:35690182 NCBI chr13:86,335,027...86,354,152
Ensembl chr13:86,335,831...86,353,967
JBrowse link
G Neurod4 neuronal differentiation 4 decreases expression ISO clothianidin results in decreased expression of NEUROD4 mRNA CTD PMID:31626844 NCBI chr 7:7,740,852...7,828,052
Ensembl chr 7:7,740,852...7,752,824
JBrowse link
G Ngef neuronal guanine nucleotide exchange factor increases expression ISO clothianidin results in increased expression of NGEF mRNA CTD PMID:31626844 NCBI chr 9:95,594,823...95,692,381
Ensembl chr 9:95,594,823...95,692,251
JBrowse link
G Ngfr nerve growth factor receptor increases expression ISO clothianidin results in increased expression of NGFR mRNA CTD PMID:29044138 NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
JBrowse link
G Ninl ninein-like decreases expression ISO clothianidin results in decreased expression of NINL mRNA CTD PMID:35690182 NCBI chr 3:160,208,757...160,275,077
Ensembl chr 3:160,196,883...160,275,108
JBrowse link
G Nos2 nitric oxide synthase 2 increases expression ISO clothianidin results in increased expression of NOS2 mRNA CTD PMID:31626844 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 decreases expression
multiple interactions
ISO clothianidin results in decreased expression of NR0B2 mRNA
[clothianidin co-treated with enilconazole] results in decreased expression of NR0B2 mRNA
CTD PMID:32201337 NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475
JBrowse link
G Ntn4 netrin 4 decreases expression ISO clothianidin results in decreased expression of NTN4 mRNA CTD PMID:31626844 NCBI chr 7:30,073,637...30,187,407
Ensembl chr 7:30,073,333...30,188,309
JBrowse link
G Nts neurotensin decreases expression ISO clothianidin results in decreased expression of NTS mRNA CTD PMID:31626844 NCBI chr 7:39,451,484...39,460,888
Ensembl chr 7:39,451,073...39,460,961
JBrowse link
G Nxnl2 nucleoredoxin-like 2 increases expression ISO clothianidin results in increased expression of NXNL2 mRNA CTD PMID:31626844 NCBI chr17:14,182,849...14,187,595
Ensembl chr17:14,182,849...14,188,208
JBrowse link
G Nxph2 neurexophilin 2 increases expression ISO clothianidin results in increased expression of NXPH2 mRNA CTD PMID:31626844 NCBI chr 3:26,373,858...26,392,392
Ensembl chr 3:26,153,756...26,391,876
JBrowse link
G Ocrl OCRL, inositol polyphosphate-5-phosphatase decreases expression ISO clothianidin results in decreased expression of OCRL mRNA CTD PMID:31626844 NCBI chr  X:131,955,775...132,018,298
Ensembl chr  X:131,967,355...132,018,298
JBrowse link
G Olr59 olfactory receptor 59 increases expression ISO clothianidin results in increased expression of OR51E2 mRNA CTD PMID:31626844 NCBI chr 1:166,604,972...166,639,634
Ensembl chr 1:166,604,141...166,623,265
JBrowse link
G Otud6b OTU deubiquitinase 6B increases expression ISO clothianidin results in increased expression of OTUD6B mRNA CTD PMID:29044138 NCBI chr 5:32,979,190...33,011,781
Ensembl chr 5:32,979,147...33,011,568
JBrowse link
G Padi4 peptidyl arginine deiminase 4 increases expression ISO clothianidin results in increased expression of PADI4 mRNA CTD PMID:31626844 NCBI chr 5:158,324,417...158,357,466
Ensembl chr 5:158,324,417...158,360,422
JBrowse link
G Pak5 p21 (RAC1) activated kinase 5 decreases expression ISO clothianidin results in decreased expression of PAK5 mRNA CTD PMID:31626844 PMID:35690182 NCBI chr 3:143,848,404...144,156,674
Ensembl chr 3:143,849,223...144,156,640
JBrowse link
G Paqr8 progestin and adipoQ receptor family member 8 decreases expression ISO clothianidin results in decreased expression of PAQR8 mRNA CTD PMID:29044138 NCBI chr 9:30,808,921...30,858,599
Ensembl chr 9:30,808,923...30,861,043
JBrowse link
G Pbld1 phenazine biosynthesis-like protein domain containing 1 decreases expression ISO clothianidin results in decreased expression of PBLD mRNA CTD PMID:31626844 NCBI chr20:25,549,974...25,565,390
Ensembl chr20:25,549,974...25,565,226
JBrowse link
G Pcca propionyl-CoA carboxylase subunit alpha decreases expression ISO clothianidin results in decreased expression of PCCA mRNA CTD PMID:32201337 NCBI chr15:106,034,586...106,374,908
Ensembl chr15:106,034,610...106,374,908
JBrowse link
G Pcsk1 proprotein convertase subtilisin/kexin type 1 decreases expression ISO clothianidin results in decreased expression of PCSK1 mRNA CTD PMID:31626844 NCBI chr 2:6,130,045...6,176,974
Ensembl chr 2:6,129,592...6,176,974
JBrowse link
G Pde10a phosphodiesterase 10A decreases expression ISO clothianidin results in decreased expression of PDE10A mRNA CTD PMID:31626844 NCBI chr 1:54,313,343...54,765,668
Ensembl chr 1:54,317,732...54,764,051
JBrowse link
G Pde1c phosphodiesterase 1C increases expression ISO clothianidin results in increased expression of PDE1C mRNA CTD PMID:31626844 NCBI chr 4:86,629,074...87,108,147
Ensembl chr 4:86,626,282...87,193,259
JBrowse link
G Pde4dip phosphodiesterase 4D interacting protein increases expression ISO clothianidin results in increased expression of PDE4DIP mRNA CTD PMID:31626844 NCBI chr 2:187,982,002...188,178,937
Ensembl chr 2:187,981,878...188,178,869
JBrowse link
G Pdzd7 PDZ domain containing 7 decreases expression ISO clothianidin results in decreased expression of PDZD7 mRNA CTD PMID:29044138 NCBI chr 1:253,837,454...253,856,919
Ensembl chr 1:253,837,459...253,855,999
JBrowse link
G Peli2 pellino E3 ubiquitin protein ligase family member 2 decreases expression ISO clothianidin results in decreased expression of PELI2 mRNA CTD PMID:31626844 NCBI chr15:23,872,984...24,017,448
Ensembl chr15:23,872,984...24,014,817
JBrowse link
G Pgap6 post-GPI attachment to proteins 6 decreases expression ISO clothianidin results in decreased expression of PGAP6 mRNA CTD PMID:31626844 NCBI chr10:15,643,081...15,652,912
Ensembl chr10:15,643,106...15,652,912
JBrowse link
G Pgr progesterone receptor increases expression ISO clothianidin results in increased expression of PGR mRNA CTD PMID:33563863 NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
JBrowse link
G Pheta2 PH domain containing endocytic trafficking adaptor 2 increases expression ISO clothianidin results in increased expression of FAM109B mRNA CTD PMID:31626844 NCBI chr 7:115,735,499...115,741,988
Ensembl chr 7:115,734,649...115,742,461
JBrowse link
G Pik3c2b phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta decreases expression ISO clothianidin results in decreased expression of PIK3C2B mRNA CTD PMID:31626844 NCBI chr13:47,046,866...47,107,733
Ensembl chr13:47,047,127...47,107,725
JBrowse link
G Pip5k1c phosphatidylinositol-4-phosphate 5-kinase type 1 gamma decreases expression ISO clothianidin results in decreased expression of PIP5K1C mRNA CTD PMID:31626844 NCBI chr 7:9,048,135...9,076,751
Ensembl chr 7:9,048,146...9,076,716
JBrowse link
G Pip5kl1 phosphatidylinositol-4-phosphate 5-kinase-like 1 decreases expression ISO clothianidin results in decreased expression of PIP5KL1 mRNA CTD PMID:29044138 NCBI chr 3:36,258,141...36,266,902
Ensembl chr 3:36,258,102...36,266,888
JBrowse link
G Pla2g2a phospholipase A2 group IIA increases expression ISO clothianidin results in increased expression of PLA2G2A mRNA CTD PMID:31626844 NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:156,359,725...156,362,297
JBrowse link
G Plbd1 phospholipase B domain containing 1 decreases expression ISO clothianidin results in decreased expression of PLBD1 mRNA CTD PMID:31626844 NCBI chr 4:171,204,198...171,260,488
Ensembl chr 4:171,204,198...171,260,488
JBrowse link
G Plcd1 phospholipase C, delta 1 increases expression ISO clothianidin results in increased expression of PLCD1 mRNA CTD PMID:31626844 NCBI chr 8:127,672,955...127,695,939
Ensembl chr 8:127,672,980...127,695,939
JBrowse link
G Plcd3 phospholipase C, delta 3 decreases expression ISO clothianidin results in decreased expression of PLCD3 mRNA CTD PMID:31626844 NCBI chr10:88,526,802...88,548,116
Ensembl chr10:88,526,802...88,548,069
JBrowse link
G Plcl1 phospholipase C-like 1 decreases expression ISO clothianidin results in decreased expression of PLCL1 mRNA CTD PMID:31626844 NCBI chr 9:64,395,976...64,733,171
Ensembl chr 9:64,361,520...64,733,171
JBrowse link
G Pllp plasmolipin increases expression ISO clothianidin results in increased expression of PLLP mRNA CTD PMID:31626844 NCBI chr19:10,321,080...10,341,869
Ensembl chr19:10,321,080...10,342,226
JBrowse link
G Pnpla1 patatin-like phospholipase domain containing 1 increases expression ISO clothianidin results in increased expression of PNPLA1 mRNA CTD PMID:31626844 NCBI chr20:6,919,689...6,953,850
Ensembl chr20:6,919,115...6,955,143
JBrowse link
G Polr2m RNA polymerase II subunit M decreases expression ISO clothianidin results in decreased expression of POLR2M mRNA CTD PMID:31626844 NCBI chr 8:81,012,770...81,020,201
Ensembl chr 8:81,012,771...81,020,302
JBrowse link
G Ppp1r3c protein phosphatase 1, regulatory subunit 3C increases expression ISO clothianidin results in increased expression of PPP1R3C mRNA CTD PMID:29044138 NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:243,871,704...243,878,835
JBrowse link
G Ppp3cc protein phosphatase 3 catalytic subunit gamma increases expression ISO clothianidin results in increased expression of PPP3CC mRNA CTD PMID:31626844 NCBI chr15:51,699,586...51,771,763
Ensembl chr15:51,700,255...51,771,538
JBrowse link
G Prg3 proteoglycan 3, pro eosinophil major basic protein 2 increases expression ISO clothianidin results in increased expression of PRG3 mRNA CTD PMID:31626844 NCBI chr 3:90,478,627...90,484,760
Ensembl chr 3:90,479,154...90,484,759
JBrowse link
G Prkn parkin RBR E3 ubiquitin protein ligase decreases expression ISO clothianidin results in decreased expression of PARK2 mRNA CTD PMID:35690182 NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:51,210,330...52,430,304
JBrowse link
G Prlr prolactin receptor decreases expression ISO clothianidin results in decreased expression of PRLR mRNA CTD PMID:29044138 NCBI chr 2:60,861,391...61,051,883
Ensembl chr 2:60,861,658...61,051,882
JBrowse link
G Prnd prion like protein doppel increases expression ISO clothianidin results in increased expression of PRND mRNA CTD PMID:31626844 NCBI chr 3:139,666,383...139,671,647
Ensembl chr 3:139,666,068...139,671,890
JBrowse link
G Prodh2 proline dehydrogenase 2 increases expression ISO clothianidin results in increased expression of PRODH2 mRNA CTD PMID:31626844 NCBI chr 1:94,881,000...94,894,609
Ensembl chr 1:94,881,061...94,894,609
JBrowse link
G Prr5l proline rich 5 like increases expression ISO clothianidin results in increased expression of PRR5L mRNA CTD PMID:31626844 NCBI chr 3:108,458,107...108,628,552
Ensembl chr 3:108,458,633...108,537,763
JBrowse link
G Prxl2b peroxiredoxin like 2B decreases expression ISO clothianidin results in decreased expression of PRXL2B mRNA CTD PMID:31626844 NCBI chr 5:170,744,953...170,747,556
Ensembl chr 5:170,744,953...170,747,556
JBrowse link
G Psen1 presenilin 1 decreases expression ISO clothianidin results in decreased expression of PSEN1 mRNA CTD PMID:35264496 NCBI chr 6:109,054,160...109,106,191
Ensembl chr 6:109,060,352...109,106,189
JBrowse link
G Psmc6 proteasome 26S subunit, ATPase 6 decreases expression ISO clothianidin results in decreased expression of PSMC6 mRNA CTD PMID:31626844 NCBI chr15:21,022,314...21,043,785
Ensembl chr15:21,022,314...21,043,785
JBrowse link
G Ptgfr prostaglandin F receptor decreases expression ISO clothianidin results in decreased expression of PTGFR mRNA CTD PMID:31626844 NCBI chr 2:243,390,820...243,426,647
Ensembl chr 2:243,393,350...243,425,623
JBrowse link
G Ptpn3 protein tyrosine phosphatase, non-receptor type 3 increases expression ISO clothianidin results in increased expression of PTPN3 mRNA CTD PMID:29044138 NCBI chr 5:76,703,687...76,822,584
Ensembl chr 5:76,703,687...76,860,470
JBrowse link
G Ptprb protein tyrosine phosphatase, receptor type, B decreases expression ISO clothianidin results in decreased expression of PTPRB mRNA CTD PMID:31626844 NCBI chr 7:53,816,197...53,920,760
Ensembl chr 7:53,816,097...53,920,760
JBrowse link
G Ptpro protein tyrosine phosphatase, receptor type, O decreases expression ISO clothianidin results in decreased expression of PTPRO mRNA CTD PMID:29044138 NCBI chr 4:171,895,104...172,105,911
Ensembl chr 4:171,895,232...172,105,903
JBrowse link
G Qpct glutaminyl-peptide cyclotransferase increases expression ISO clothianidin results in increased expression of QPCT mRNA CTD PMID:31626844 NCBI chr 6:21,716,824...21,748,895
Ensembl chr 6:21,716,824...21,748,895
JBrowse link
G Rag1 recombination activating 1 decreases expression ISO clothianidin results in decreased expression of RAG1 mRNA CTD PMID:31626844 NCBI chr 3:108,372,087...108,383,184
Ensembl chr 3:108,371,978...108,383,261
JBrowse link
G Rapgefl1 Rap guanine nucleotide exchange factor like 1 decreases expression ISO clothianidin results in decreased expression of RAPGEFL1 mRNA CTD PMID:29044138 NCBI chr10:84,289,980...84,306,614
Ensembl chr10:84,289,980...84,306,614
JBrowse link
G Rbm26 RNA binding motif protein 26 decreases expression ISO clothianidin results in decreased expression of RBM26 mRNA CTD PMID:31626844 NCBI chr15:88,299,378...88,379,365
Ensembl chr15:88,301,436...88,378,686
JBrowse link
G Rbms1 RNA binding motif, single stranded interacting protein 1 decreases expression ISO clothianidin results in decreased expression of RBMS1 mRNA CTD PMID:31626844 NCBI chr 3:65,604,475...65,829,072
Ensembl chr 3:65,606,358...65,829,013
JBrowse link
G Reg3g regenerating family member 3 gamma increases expression ISO clothianidin results in increased expression of REG3G mRNA CTD PMID:31626844 NCBI chr 4:112,482,183...112,484,738
Ensembl chr 4:112,482,183...112,484,738
JBrowse link
G Rfesd Rieske (Fe-S) domain containing decreases expression ISO clothianidin results in decreased expression of RFESD mRNA CTD PMID:31626844 NCBI chr 2:7,220,389...7,254,394
Ensembl chr 2:7,237,947...7,247,628
JBrowse link
G Riiad1 regulatory subunit of type II PKA R-subunit domain containing 1 decreases expression ISO clothianidin results in decreased expression of RIIAD1 mRNA CTD PMID:31626844 NCBI chr 2:184,788,948...184,807,344
Ensembl chr 2:184,790,822...184,799,172
JBrowse link
G Rnd1 Rho family GTPase 1 increases expression ISO clothianidin results in increased expression of RND1 mRNA CTD PMID:29044138 NCBI chr 7:131,700,321...131,707,392
Ensembl chr 7:131,700,321...131,707,392
JBrowse link
G Rp1l1 RP1 like 1 increases expression ISO clothianidin results in increased expression of RP1L1 mRNA CTD PMID:31626844 NCBI chr15:42,435,803...42,447,165
Ensembl chr15:42,435,803...42,447,165
JBrowse link
G Rps29 ribosomal protein S29 increases expression ISO clothianidin results in increased expression of RPS29 mRNA CTD PMID:31626844 NCBI chr 6:93,371,293...93,372,731
Ensembl chr13:87,816,954...87,817,267
Ensembl chr 6:87,816,954...87,817,267
JBrowse link
G Rrad RRAD, Ras related glycolysis inhibitor and calcium channel regulator increases expression ISO clothianidin results in increased expression of RRAD mRNA CTD PMID:35690182 NCBI chr19:360,581...363,874
Ensembl chr19:360,973...363,871
JBrowse link
G RT1-Bb RT1 class II, locus Bb increases expression ISO clothianidin results in increased expression of HLA-DQB1 mRNA CTD PMID:31626844 NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,598,475...4,604,118
JBrowse link
G S100a5 S100 calcium binding protein A5 decreases expression ISO clothianidin results in decreased expression of S100A5 mRNA CTD PMID:31626844 NCBI chr 2:178,392,922...178,397,128
Ensembl chr 2:178,395,121...178,397,128
JBrowse link
G Sash3 SAM and SH3 domain containing 3 increases expression ISO clothianidin results in increased expression of SASH3 mRNA CTD PMID:31626844 NCBI chr  X:132,204,717...132,219,421
Ensembl chr  X:132,204,543...132,219,419
JBrowse link
G Scn7a sodium voltage-gated channel alpha subunit 7 decreases expression ISO clothianidin results in decreased expression of SCN7A mRNA CTD PMID:31626844 NCBI chr 3:71,743,873...71,846,454
Ensembl chr 3:71,743,873...71,846,284
JBrowse link
G Scnn1b sodium channel epithelial 1 subunit beta increases expression ISO clothianidin results in increased expression of SCNN1B mRNA CTD PMID:31626844 NCBI chr 1:185,861,326...185,915,717
Ensembl chr 1:185,854,733...185,916,049
JBrowse link
G Sema3f semaphorin 3F decreases expression ISO clothianidin results in decreased expression of SEMA3F mRNA CTD PMID:31626844 NCBI chr 8:117,236,269...117,265,206
Ensembl chr 8:117,236,269...117,265,206
JBrowse link
G Serp1 stress-associated endoplasmic reticulum protein 1 decreases expression ISO clothianidin results in decreased expression of SERP1 mRNA CTD PMID:31626844 NCBI chr 2:144,907,204...144,911,187
Ensembl chr 2:144,907,205...144,911,187
JBrowse link
G Serpina3n serpin family A member 3N decreases expression ISO clothianidin results in decreased expression of SERPINA3N mRNA CTD PMID:35264496 NCBI chr 6:129,088,392...129,095,950
Ensembl chr 6:129,088,398...129,097,415
JBrowse link
G Serpinc1 serpin family C member 1 decreases expression ISO clothianidin results in decreased expression of SERPINC1 mRNA CTD PMID:31626844 NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643
JBrowse link
G Serpine1 serpin family E member 1 decreases expression ISO clothianidin results in decreased expression of SERPINE1 mRNA CTD PMID:31626844 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
JBrowse link
G Sgcd sarcoglycan, delta increases expression ISO clothianidin results in increased expression of SGCD mRNA CTD PMID:31626844 NCBI chr10:31,847,713...32,829,554
Ensembl chr10:31,781,748...32,419,064
JBrowse link
G Sgk2 serum/glucocorticoid regulated kinase 2 decreases expression ISO clothianidin results in decreased expression of SGK2 mRNA CTD PMID:29044138 NCBI chr 3:172,063,625...172,089,000
Ensembl chr 3:172,063,776...172,089,011
JBrowse link
G Sh3tc1 SH3 domain and tetratricopeptide repeats 1 increases expression ISO clothianidin results in increased expression of SH3TC1 mRNA CTD PMID:29044138 NCBI chr14:79,230,322...79,274,622
Ensembl chr14:79,230,371...79,274,620
JBrowse link
G Sipa1l2 signal-induced proliferation-associated 1 like 2 increases expression ISO clothianidin results in increased expression of SIPA1L2 mRNA CTD PMID:29044138 NCBI chr19:70,287,134...70,437,810
Ensembl chr19:70,287,147...70,437,773
JBrowse link
G Slc14a1 solute carrier family 14 member 1 (Kidd blood group) decreases expression ISO clothianidin results in decreased expression of SLC14A1 mRNA CTD PMID:31626844 NCBI chr18:73,840,568...73,883,925
Ensembl chr18:73,840,569...73,870,489
JBrowse link
G Slc17a7 solute carrier family 17 member 7 decreases expression ISO clothianidin results in decreased expression of SLC17A7 mRNA CTD PMID:31626844 NCBI chr 1:104,786,172...104,798,049
Ensembl chr 1:104,785,955...104,798,049
JBrowse link
G Slc22a2 solute carrier family 22 member 2 decreases activity ISO clothianidin results in decreased activity of SLC22A2 protein CTD PMID:31364238 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
JBrowse link
G Slc22a6 solute carrier family 22 member 6 decreases activity ISO clothianidin results in decreased activity of SLC22A6 protein CTD PMID:31364238 NCBI chr 1:214,951,493...214,960,317
Ensembl chr 1:214,951,867...214,960,311
JBrowse link
G Slc22a8 solute carrier family 22 member 8 decreases activity ISO clothianidin results in decreased activity of SLC22A8 protein CTD PMID:31364238 NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588
JBrowse link
G Slc28a1 solute carrier family 28 member 1 increases expression ISO clothianidin results in increased expression of SLC28A1 mRNA CTD PMID:31626844 NCBI chr 1:144,490,453...144,532,025
Ensembl chr 1:144,490,623...144,531,544
JBrowse link
G Slc38a9 solute carrier family 38, member 9 decreases expression ISO clothianidin results in decreased expression of SLC38A9 mRNA CTD PMID:31626844 NCBI chr 2:46,024,731...46,102,419
Ensembl chr 2:46,024,947...46,105,983
JBrowse link
G Slc45a2 solute carrier family 45, member 2 decreases expression ISO clothianidin results in decreased expression of SLC45A2 mRNA CTD PMID:31626844 NCBI chr 2:61,690,828...61,723,437
Ensembl chr 2:61,690,828...61,723,437
JBrowse link
G Slc47a2 solute carrier family 47 member 2 decreases activity ISO clothianidin results in decreased activity of SLC47A2 protein CTD PMID:31364238 NCBI chr10:46,490,262...46,532,954
Ensembl chr10:46,489,831...46,533,425
JBrowse link
G Slc48a1 solute carrier family 48 member 1 increases expression ISO clothianidin results in increased expression of SLC48A1 mRNA CTD PMID:31626844 NCBI chr 7:130,794,233...130,802,119
Ensembl chr 7:130,794,245...130,803,022
JBrowse link
G Slc6a1 solute carrier family 6 member 1 decreases expression
multiple interactions
EXP clothianidin results in decreased expression of SLC6A1 mRNA
[enilconazole co-treated with clothianidin] results in decreased expression of SLC6A1 mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of SLC6A1 mRNA
CTD PMID:33426623 NCBI chr 4:149,004,447...149,037,840
Ensembl chr 4:149,004,635...149,037,839
JBrowse link
G Slco1c1 solute carrier organic anion transporter family, member 1c1 increases expression ISO clothianidin results in increased expression of SLCO1C1 mRNA CTD PMID:31626844 NCBI chr 4:176,197,736...176,244,401
Ensembl chr 4:176,197,741...176,244,395
JBrowse link
G Smpd3 sphingomyelin phosphodiesterase 3 decreases expression ISO clothianidin results in decreased expression of SMPD3 mRNA CTD PMID:35690182 NCBI chr19:51,072,209...51,155,639
Ensembl chr19:51,072,209...51,085,936
JBrowse link
G Sorbs1 sorbin and SH3 domain containing 1 increases expression ISO clothianidin results in increased expression of SORBS1 mRNA CTD PMID:31626844 NCBI chr 1:249,057,324...249,279,703
Ensembl chr 1:249,057,324...249,279,608
JBrowse link
G Spata3 spermatogenesis associated 3 increases expression ISO clothianidin results in increased expression of SPATA3 mRNA CTD PMID:31626844 NCBI chr 9:94,107,832...94,120,280
Ensembl chr 9:94,107,807...94,119,172
JBrowse link
G Spire2 spire-type actin nucleation factor 2 decreases expression ISO clothianidin results in decreased expression of SPIRE2 mRNA CTD PMID:29044138 NCBI chr19:68,281,878...68,320,427
Ensembl chr19:68,281,870...68,320,427
JBrowse link
G Srd5a2 steroid 5 alpha-reductase 2 increases expression ISO clothianidin results in increased expression of SRD5A2 mRNA CTD PMID:31626844 NCBI chr 6:27,178,089...27,217,588
Ensembl chr 6:27,178,079...27,217,588
JBrowse link
G Sspo SCO-spondin decreases expression ISO clothianidin results in decreased expression of SSPOP mRNA CTD PMID:29044138 NCBI chr 4:78,725,829...78,781,330
Ensembl chr 4:78,727,275...78,781,315
JBrowse link
G Stac2 SH3 and cysteine rich domain 2 increases expression ISO clothianidin results in increased expression of STAC2 mRNA CTD PMID:31626844 NCBI chr10:83,528,741...83,544,583
Ensembl chr10:83,528,741...83,544,583
JBrowse link
G Steap2 STEAP2 metalloreductase increases expression ISO clothianidin results in increased expression of STEAP2 mRNA CTD PMID:31626844 NCBI chr 4:29,302,487...29,323,006
Ensembl chr 4:29,303,381...29,330,620
JBrowse link
G Susd4 sushi domain containing 4 increases expression ISO clothianidin results in increased expression of SUSD4 mRNA CTD PMID:31626844 NCBI chr13:96,982,867...97,109,419
Ensembl chr13:96,986,788...97,109,401
JBrowse link
G Sycp2 synaptonemal complex protein 2 decreases expression ISO clothianidin results in decreased expression of SYCP2 mRNA CTD PMID:29044138 NCBI chr 3:185,814,033...185,876,516
Ensembl chr 3:185,814,035...185,876,492
JBrowse link
G Synpo synaptopodin decreases expression ISO clothianidin results in decreased expression of SYNPO mRNA CTD PMID:29044138 NCBI chr18:56,326,369...56,347,359
Ensembl chr18:56,319,571...56,353,306
JBrowse link
G Tacr1 tachykinin receptor 1 increases expression ISO clothianidin results in increased expression of TACR1 mRNA CTD PMID:31626844 NCBI chr 4:116,478,617...116,647,492
Ensembl chr 4:116,478,617...116,647,492
JBrowse link
G Tafa2 TAFA chemokine like family member 2 decreases expression ISO clothianidin results in decreased expression of TAFA2 mRNA CTD PMID:31626844 NCBI chr 7:60,827,985...61,303,873
Ensembl chr 7:60,891,958...61,303,869
JBrowse link
G Tafa5 TAFA chemokine like family member 5 increases expression ISO clothianidin results in increased expression of TAFA5 mRNA CTD PMID:31626844 NCBI chr 7:120,493,447...120,714,720
Ensembl chr 7:120,493,060...120,714,718
JBrowse link
G Tbx2 T-box transcription factor 2 increases expression ISO clothianidin results in increased expression of TBX2 mRNA CTD PMID:29044138 NCBI chr10:71,177,082...71,186,275
Ensembl chr10:71,177,082...71,186,275
JBrowse link
G Tcp10b t-complex protein 10b increases expression ISO clothianidin results in increased expression of TCP10L2 mRNA CTD PMID:31626844 NCBI chr 1:55,485,354...55,508,836
Ensembl chr 1:55,485,411...55,508,836
JBrowse link
G Tecpr1 tectonin beta-propeller repeat containing 1 decreases expression ISO clothianidin results in decreased expression of TECPR1 mRNA CTD PMID:31626844 NCBI chr12:15,504,456...15,534,541
Ensembl chr12:15,505,343...15,534,116
JBrowse link
G Tef TEF transcription factor, PAR bZIP family member increases expression ISO clothianidin results in increased expression of TEF mRNA CTD PMID:31626844 NCBI chr 7:115,197,180...115,221,930
Ensembl chr 7:115,193,282...115,221,928
JBrowse link
G Tgfbi transforming growth factor, beta induced increases expression ISO clothianidin results in increased expression of TGFBI mRNA CTD PMID:31626844 NCBI chr17:7,960,885...7,990,234
Ensembl chr17:7,960,516...7,990,471
JBrowse link
G Tgm5 transglutaminase 5 decreases expression ISO clothianidin results in decreased expression of TGM5 mRNA CTD PMID:29044138 NCBI chr 3:128,461,836...128,497,761
Ensembl chr 3:128,461,836...128,497,761
JBrowse link
G Thrsp thyroid hormone responsive decreases expression ISO clothianidin results in decreased expression of THRSP mRNA CTD PMID:35690182 NCBI chr 1:161,134,640...161,138,964
Ensembl chr 1:161,133,453...161,139,827
JBrowse link
G Ticam1 TIR domain containing adaptor molecule 1 increases expression ISO clothianidin results in increased expression of TICAM1 mRNA CTD PMID:35264496 NCBI chr 9:1,189,717...1,197,730
Ensembl chr 9:1,172,963...1,196,892
JBrowse link
G Tifa TRAF-interacting protein with forkhead-associated domain increases expression ISO clothianidin results in increased expression of TIFA mRNA CTD PMID:31626844 NCBI chr 2:218,927,724...218,942,111
Ensembl chr 2:218,909,915...218,956,224
JBrowse link
G Tlcd4 TLC domain containing 4 increases expression ISO clothianidin results in increased expression of TLCD4 mRNA CTD PMID:29044138 NCBI chr 2:211,969,612...212,044,883
Ensembl chr 2:211,974,471...212,026,081
JBrowse link
G Tlr2 toll-like receptor 2 increases expression ISO clothianidin results in increased expression of TLR2 mRNA CTD PMID:35264496 NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
JBrowse link
G Tlx3 T-cell leukemia, homeobox 3 decreases expression ISO clothianidin results in decreased expression of TLX3 mRNA CTD PMID:31626844 NCBI chr10:18,293,932...18,296,551
Ensembl chr10:18,293,932...18,296,773
JBrowse link
G Tmem273 transmembrane protein 273 increases expression ISO clothianidin results in increased expression of TMEM273 mRNA CTD PMID:31626844 NCBI chr16:8,055,930...8,088,280
Ensembl chr16:8,055,930...8,088,280
JBrowse link
G Tmem38a transmembrane protein 38a decreases expression ISO clothianidin results in decreased expression of TMEM38A mRNA CTD PMID:29044138 NCBI chr16:17,292,215...17,307,704
Ensembl chr16:17,292,215...17,333,132
JBrowse link
G Tmem71 transmembrane protein 71 decreases expression ISO clothianidin results in decreased expression of TMEM71 mRNA CTD PMID:31626844 NCBI chr 7:100,166,038...100,212,234
Ensembl chr 7:100,166,516...100,204,969
JBrowse link
G Tmt1a thiol methyltransferase 1A decreases expression ISO clothianidin results in decreased expression of TMT1A mRNA CTD PMID:29044138 NCBI chr 7:133,330,141...133,377,172
Ensembl chr 7:133,330,447...133,338,959
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO clothianidin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; clothianidin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] CTD PMID:29044138 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
G Tnfrsf11b TNF receptor superfamily member 11B decreases expression ISO clothianidin results in decreased expression of TNFRSF11B mRNA CTD PMID:31626844 NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
JBrowse link
G Tnxb tenascin XB decreases expression ISO clothianidin results in decreased expression of TNXB mRNA CTD PMID:29044138 Ensembl chr20:4,031,082...4,090,128 JBrowse link
G Tpm1 tropomyosin 1 increases expression ISO clothianidin results in increased expression of TPM1 mRNA CTD PMID:29044138 NCBI chr 8:76,516,654...76,543,661
Ensembl chr 8:76,511,871...76,543,468
JBrowse link
G Traf4 Tnf receptor associated factor 4 increases expression ISO clothianidin results in increased expression of TRAF4 mRNA CTD PMID:29044138 NCBI chr10:63,552,251...63,558,356
Ensembl chr10:63,552,253...63,558,356
JBrowse link
G Traf6 TNF receptor associated factor 6 decreases expression ISO clothianidin results in decreased expression of TRAF6 mRNA CTD PMID:29044138 NCBI chr 3:108,418,537...108,443,330
Ensembl chr 3:108,418,513...108,443,328
JBrowse link
G Trappc4 trafficking protein particle complex subunit 4 increases expression ISO clothianidin results in increased expression of TRAPPC4 mRNA CTD PMID:31626844 NCBI chr 8:53,626,382...53,630,042
Ensembl chr 8:53,625,474...53,630,241
JBrowse link
G Trim37 tripartite motif-containing 37 decreases expression ISO clothianidin results in decreased expression of TRIM37 mRNA CTD PMID:31626844 NCBI chr10:72,440,672...72,572,831
Ensembl chr10:72,440,644...72,572,828
JBrowse link
G Trmt44 tRNA methyltransferase 44 increases expression ISO clothianidin results in increased expression of TRMT44 mRNA CTD PMID:31626844 NCBI chr14:79,399,943...79,424,761
Ensembl chr14:79,406,647...79,424,761
JBrowse link
G Tssk6 testis-specific serine kinase 6 decreases expression ISO clothianidin results in decreased expression of TSSK6 mRNA CTD PMID:31626844 NCBI chr16:19,551,757...19,559,918
Ensembl chr16:19,548,473...19,567,061
JBrowse link
G Ttc28 tetratricopeptide repeat domain 28 decreases expression ISO clothianidin results in decreased expression of TTC28 mRNA CTD PMID:31626844 NCBI chr12:51,002,816...51,443,461
Ensembl chr12:51,005,089...51,443,531
JBrowse link
G Ttc33 tetratricopeptide repeat domain 33 decreases expression ISO clothianidin results in decreased expression of TTC33 mRNA CTD PMID:31626844 NCBI chr 2:56,007,377...56,054,312
Ensembl chr 2:56,007,316...56,054,326
JBrowse link
G Ttc8 tetratricopeptide repeat domain 8 decreases expression ISO clothianidin results in decreased expression of TTC8 mRNA CTD PMID:31626844 NCBI chr 6:123,927,657...124,025,354
Ensembl chr 6:123,927,907...123,982,117
JBrowse link
G Tubgcp3 tubulin gamma complex component 3 increases expression ISO clothianidin results in increased expression of TUBGCP3 mRNA CTD PMID:31626844 NCBI chr16:83,553,950...83,614,626
Ensembl chr16:83,553,959...83,614,623
JBrowse link
G Txndc2 thioredoxin domain containing 2 increases expression ISO clothianidin results in increased expression of TXNDC2 mRNA CTD PMID:31626844 NCBI chr 9:112,677,459...112,682,027
Ensembl chr 9:112,668,084...112,682,092
JBrowse link
G Ubap1l ubiquitin associated protein 1-like increases expression
decreases expression
ISO clothianidin results in increased expression of UBAP1L mRNA
clothianidin results in decreased expression of UBAP1L mRNA
CTD PMID:29044138 PMID:31626844 NCBI chr 8:74,772,794...74,792,753
Ensembl chr 8:74,781,395...74,792,716
JBrowse link
G Unc119b unc-119 lipid binding chaperone B increases expression ISO clothianidin results in increased expression of UNC119B mRNA CTD PMID:31626844 NCBI chr12:47,139,492...47,152,115
Ensembl chr12:47,139,545...47,152,112
JBrowse link
G Usp43 ubiquitin specific peptidase 43 decreases expression ISO clothianidin results in decreased expression of USP43 mRNA CTD PMID:31626844 NCBI chr10:53,047,368...53,110,099
Ensembl chr10:53,048,158...53,110,180
JBrowse link
G Utrn utrophin decreases expression ISO clothianidin results in decreased expression of UTRN mRNA CTD PMID:31626844 NCBI chr 1:8,541,061...9,044,487
Ensembl chr 1:8,542,798...9,044,487
JBrowse link
G Vamp8 vesicle-associated membrane protein 8 increases expression ISO clothianidin results in increased expression of VAMP8 mRNA CTD PMID:31626844 NCBI chr 4:106,000,570...106,011,081
Ensembl chr 4:106,000,570...106,011,073
JBrowse link
G Vegfd vascular endothelial growth factor D decreases expression ISO clothianidin results in decreased expression of VEGFD mRNA CTD PMID:31626844 NCBI chr  X:33,704,582...33,740,305
Ensembl chr  X:33,706,055...33,740,167
JBrowse link
G Vps8 VPS8 subunit of CORVET complex decreases expression ISO clothianidin results in decreased expression of VPS8 mRNA CTD PMID:31626844 NCBI chr11:92,906,702...93,140,844
Ensembl chr11:92,906,700...93,138,570
JBrowse link
G Washc4 WASH complex subunit 4 increases expression ISO clothianidin results in increased expression of WASHC4 mRNA CTD PMID:31626844 NCBI chr 7:22,075,546...22,127,847
Ensembl chr 7:22,050,098...22,127,828
JBrowse link
G Whrn whirlin increases expression ISO clothianidin results in increased expression of WHRN mRNA CTD PMID:31626844 NCBI chr 5:81,843,820...81,933,400
Ensembl chr 5:81,843,820...81,927,381
JBrowse link
G Wnt7b Wnt family member 7B decreases expression ISO clothianidin results in decreased expression of WNT7B mRNA CTD PMID:35690182 NCBI chr 7:118,514,684...118,559,316
Ensembl chr 7:118,514,684...118,559,316
JBrowse link
G Ypel2 yippee-like 2 increases expression ISO clothianidin results in increased expression of YPEL2 mRNA CTD PMID:31626844 NCBI chr10:72,243,591...72,301,124
Ensembl chr10:72,243,591...72,301,124
JBrowse link
G Ypel3 yippee-like 3 decreases expression ISO clothianidin results in decreased expression of YPEL3 mRNA CTD PMID:29044138 NCBI chr 1:190,814,920...190,818,248
Ensembl chr 1:190,814,512...190,818,251
JBrowse link
G Zbtb45 zinc finger and BTB domain containing 45 decreases expression ISO clothianidin results in decreased expression of ZBTB45 mRNA CTD PMID:31626844 NCBI chr 1:82,707,633...82,712,926
Ensembl chr 1:82,707,634...82,710,277
JBrowse link
G Zcchc13 zinc finger CCHC-type containing 13 decreases expression ISO clothianidin results in decreased expression of ZCCHC13 mRNA CTD PMID:31626844 NCBI chr  X:72,709,319...72,710,422
Ensembl chr  X:72,709,152...72,731,030
JBrowse link
G Zfp18 zinc finger protein 18 decreases expression ISO clothianidin results in decreased expression of ZNF18 mRNA CTD PMID:31626844 NCBI chr10:50,972,531...50,994,796
Ensembl chr10:50,972,572...50,995,329
JBrowse link
G Zfp219 zinc finger protein 219 decreases expression ISO clothianidin results in decreased expression of ZNF219 mRNA CTD PMID:29044138 NCBI chr15:27,169,335...27,183,555
Ensembl chr15:27,169,339...27,182,926
JBrowse link
G Zfp467 zinc finger protein 467 increases expression ISO clothianidin results in increased expression of ZNF467 mRNA CTD PMID:31626844 NCBI chr 4:78,716,473...78,725,829
Ensembl chr 4:78,716,666...78,723,135
JBrowse link
G Zfp470 zinc finger protein 470 increases expression ISO clothianidin results in increased expression of ZNF470 mRNA CTD PMID:31626844 NCBI chr 1:100,200,601...100,248,567 JBrowse link
G Zfp502 zinc finger protein 502 increases expression ISO clothianidin results in increased expression of ZNF502 mRNA CTD PMID:31626844 NCBI chr 1:30,712,974...30,737,956 JBrowse link
G Zfp521 zinc finger protein 521 decreases expression ISO clothianidin results in decreased expression of ZNF521 mRNA CTD PMID:31626844 NCBI chr18:5,050,297...5,343,188
Ensembl chr18:5,056,236...5,343,054
JBrowse link
G Zfp653 zinc finger protein 653 decreases expression ISO clothianidin results in decreased expression of ZNF653 mRNA CTD PMID:31626844 NCBI chr 8:28,862,618...28,881,439
Ensembl chr 8:28,862,618...28,881,070
JBrowse link
G Zfp865 zinc finger protein 865 increases expression ISO clothianidin results in increased expression of ZNF784 mRNA CTD PMID:31626844 NCBI chr 1:77,834,142...77,838,620
Ensembl chr 1:77,834,107...77,840,131
JBrowse link
G Zkscan7 zinc finger with KRAB and SCAN domains 7 increases expression ISO clothianidin results in increased expression of ZKSCAN7 mRNA CTD PMID:31626844 NCBI chr 8:131,379,514...131,397,065
Ensembl chr 8:131,378,013...131,397,065
JBrowse link
G Zswim4 zinc finger, SWIM-type containing 4 decreases expression ISO clothianidin results in decreased expression of ZSWIM4 mRNA CTD PMID:31626844 NCBI chr19:40,832,608...40,857,742
Ensembl chr19:40,832,635...40,857,742
JBrowse link
cobicistat term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Atf3 activating transcription factor 3 multiple interactions ISO [Rifampin co-treated with Cobicistat] results in increased expression of ATF3 mRNA CTD PMID:33629115 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions ISO [Rifampin co-treated with Cobicistat] results in increased expression of BAX mRNA CTD PMID:33629115 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
JBrowse link
G Cbr3 carbonyl reductase 3 multiple interactions ISO [Rifampin co-treated with Cobicistat] results in increased expression of CBR3 mRNA CTD PMID:33629115 NCBI chr11:46,478,295...46,486,555
Ensembl chr11:46,478,274...46,486,558
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions ISO [[Rifampin results in increased activity of NR1I2 protein] which results in increased activity of CYP3A4 protein] which results in increased metabolism of and results in increased activity of and results in increased susceptibility to Cobicistat CTD PMID:33629115 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions ISO [1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Cobicistat] results in increased expression of DDIT3 mRNA; [Rifampin co-treated with Cobicistat] results in increased expression of DDIT3 mRNA CTD PMID:33629115 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
JBrowse link
G Gpx2 glutathione peroxidase 2 multiple interactions ISO [Rifampin co-treated with Cobicistat] results in increased expression of GPX2 mRNA CTD PMID:33629115 NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions ISO [1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Cobicistat] results in increased expression of HSPA5 mRNA; [Rifampin co-treated with Cobicistat] results in increased expression of HSPA5 mRNA CTD PMID:33629115 NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
JBrowse link
G Ngfr nerve growth factor receptor multiple interactions ISO [Rifampin co-treated with Cobicistat] results in increased expression of TNFRSF10B mRNA CTD PMID:33629115 NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO [[Rifampin results in increased activity of NR1I2 protein] which results in increased activity of CYP3A4 protein] which results in increased metabolism of and results in increased activity of and results in increased susceptibility to Cobicistat CTD PMID:33629115 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 multiple interactions ISO [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased activity of NR1I3 protein] which results in increased susceptibility to Cobicistat CTD PMID:33629115 NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
JBrowse link
dabrafenib term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcc1 ATP binding cassette subfamily C member 1 increases expression ISO dabrafenib results in increased expression of ABCC1 mRNA CTD PMID:34780725 NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404
JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 increases expression ISO dabrafenib results in increased expression of ABCG2 mRNA CTD PMID:34780725 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
JBrowse link
G Braf B-Raf proto-oncogene, serine/threonine kinase multiple interactions
affects response to substance
increases response to substance
decreases activity
ISO [BRAF protein affects the susceptibility to dabrafenib] which affects the cleavage of SREBF1 protein; betulin affects the reaction [BRAF protein affects the susceptibility to [dabrafenib co-treated with trametinib]]; BRAF protein affects the susceptibility to [dabrafenib co-treated with trametinib]; CCND1 protein inhibits the reaction [BRAF protein mutant form results in increased susceptibility to dabrafenib]; fatostatin affects the reaction [BRAF protein affects the susceptibility to [dabrafenib co-treated with trametinib]]; MAPK1 protein modified form inhibits the reaction [BRAF protein mutant form results in increased susceptibility to dabrafenib]; MAPK3 protein modified form inhibits the reaction [BRAF protein mutant form results in increased susceptibility to dabrafenib]
dabrafenib results in decreased activity of BRAF protein; dabrafenib results in decreased activity of BRAF protein mutant form
CTD PMID:20823850 PMID:23237741 PMID:26978007 PMID:29950559 NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:69,342,813...69,476,931
JBrowse link
G Ccnd1 cyclin D1 multiple interactions ISO CCND1 protein inhibits the reaction [BRAF protein mutant form results in increased susceptibility to dabrafenib] CTD PMID:26978007 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 decreases activity ISO dabrafenib results in decreased activity of CYP1A2 protein CTD PMID:34780725 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 decreases activity ISO dabrafenib results in decreased activity of CYP2C19 protein CTD PMID:34780725 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
JBrowse link
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 decreases activity ISO dabrafenib results in decreased activity of CYP2C8 protein CTD PMID:34780725
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression
multiple interactions
decreases activity
ISO dabrafenib results in increased expression of CYP3A4 mRNA
dabrafenib inhibits the reaction [CYP3A4 protein results in decreased susceptibility to Docetaxel]
dabrafenib results in decreased activity of CYP3A4 protein
CTD PMID:34780725 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 decreases activity ISO dabrafenib results in decreased activity of CYP3A5 protein CTD PMID:34780725 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO dabrafenib inhibits the reaction [decabromobiphenyl ether results in increased phosphorylation of EGFR protein] CTD PMID:38641160 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions ISO dabrafenib inhibits the reaction [Polyphosphates results in increased expression of GPT protein] CTD PMID:27458080 NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO dabrafenib inhibits the reaction [Polyphosphates results in increased expression of ICAM1 mRNA]; dabrafenib inhibits the reaction [Polyphosphates results in increased expression of ICAM1 protein]; dabrafenib inhibits the reaction [TGFBI protein results in increased expression of ICAM1 protein] CTD PMID:27458080 PMID:29042256 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
JBrowse link
G Il6 interleukin 6 multiple interactions ISO dabrafenib inhibits the reaction [Polyphosphates results in increased secretion of IL6 protein] CTD PMID:27458080 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
JBrowse link
G Itgav integrin subunit alpha V multiple interactions ISO dabrafenib inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of [ITGAV protein binds to ITGB5 protein]] CTD PMID:29042256 NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:89,245,095...89,333,511
JBrowse link
G Itgb5 integrin subunit beta 5 multiple interactions ISO dabrafenib inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of [ITGAV protein binds to ITGB5 protein]] CTD PMID:29042256 NCBI chr11:80,333,588...80,449,373
Ensembl chr11:80,333,590...80,449,373
JBrowse link
G Kras KRAS proto-oncogene, GTPase affects response to substance
multiple interactions
ISO KRAS protein affects the susceptibility to dabrafenib
[KRAS protein affects the susceptibility to dabrafenib] which affects the expression of TNFRSF10B protein; [KRAS protein affects the susceptibility to dabrafenib] which affects the phosphorylation of MAPK1 protein; [KRAS protein affects the susceptibility to dabrafenib] which affects the phosphorylation of MAPK3 protein
CTD PMID:27222248 NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320
JBrowse link
G Map2k1 mitogen activated protein kinase kinase 1 decreases phosphorylation
multiple interactions
ISO dabrafenib results in decreased phosphorylation of MAP2K1 protein
decabromobiphenyl ether inhibits the reaction [dabrafenib results in decreased phosphorylation of MAP2K1 protein]
CTD PMID:38641160 NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184
JBrowse link
G Map2k2 mitogen activated protein kinase kinase 2 multiple interactions
decreases phosphorylation
ISO decabromobiphenyl ether inhibits the reaction [dabrafenib results in decreased phosphorylation of MAP2K2 protein] CTD PMID:38641160 NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:9,241,310...9,260,940
JBrowse link
G Mapk1 mitogen activated protein kinase 1 decreases phosphorylation
increases phosphorylation
multiple interactions
ISO dabrafenib results in decreased phosphorylation of MAPK1 protein
dabrafenib results in increased phosphorylation of MAPK1 protein
[KRAS protein affects the susceptibility to dabrafenib] which affects the phosphorylation of MAPK1 protein; dabrafenib inhibits the reaction [Polyphosphates results in increased phosphorylation of MAPK1 protein]; decabromobiphenyl ether inhibits the reaction [dabrafenib results in decreased phosphorylation of MAPK1 protein]; MAPK1 protein modified form inhibits the reaction [BRAF protein mutant form results in increased susceptibility to dabrafenib]; SRPIN340 inhibits the reaction [dabrafenib results in increased phosphorylation of MAPK1 protein]
CTD PMID:26978007 PMID:27222248 PMID:27458080 PMID:31962201 PMID:38641160 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases phosphorylation
decreases phosphorylation
ISO [KRAS protein affects the susceptibility to dabrafenib] which affects the phosphorylation of MAPK3 protein; dabrafenib inhibits the reaction [Polyphosphates results in increased phosphorylation of MAPK3 protein]; decabromobiphenyl ether inhibits the reaction [dabrafenib results in decreased phosphorylation of MAPK3 protein]; MAPK3 protein modified form inhibits the reaction [BRAF protein mutant form results in increased susceptibility to dabrafenib]; SRPIN340 inhibits the reaction [dabrafenib results in increased phosphorylation of MAPK3 protein] CTD PMID:26978007 PMID:27222248 PMID:27458080 PMID:31962201 PMID:38641160 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions ISO dabrafenib inhibits the reaction [lenvatinib results in increased cleavage of PARP1 protein] CTD PMID:38754640 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
JBrowse link
G Raf1 Raf-1 proto-oncogene, serine/threonine kinase multiple interactions ISO dabrafenib inhibits the reaction [decabromobiphenyl ether results in increased phosphorylation of RAF1 protein] CTD PMID:38641160 NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO dabrafenib inhibits the reaction [Polyphosphates results in increased activity of RELA protein] CTD PMID:27458080 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
JBrowse link
G Sele selectin E multiple interactions ISO dabrafenib inhibits the reaction [Polyphosphates results in increased expression of SELE mRNA]; dabrafenib inhibits the reaction [Polyphosphates results in increased expression of SELE protein]; dabrafenib inhibits the reaction [TGFBI protein results in increased expression of SELE protein] CTD PMID:27458080 PMID:29042256 NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903
JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 decreases cleavage
multiple interactions
ISO dabrafenib results in decreased cleavage of SREBF1 protein
[BRAF protein affects the susceptibility to dabrafenib] which affects the cleavage of SREBF1 protein
CTD PMID:29950559 NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
JBrowse link
G Srsf5 serine and arginine rich splicing factor 5 multiple interactions ISO [SRPIN340 co-treated with dabrafenib] results in decreased phosphorylation of SRSF5 protein CTD PMID:31962201 NCBI chr 6:106,333,998...106,341,467
Ensembl chr 6:106,336,756...106,341,931
JBrowse link
G Tgfbi transforming growth factor, beta induced multiple interactions ISO dabrafenib inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TGFBI mRNA]; dabrafenib inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TGFBI protein]; dabrafenib inhibits the reaction [TGFBI protein results in increased expression of ICAM1 protein]; dabrafenib inhibits the reaction [TGFBI protein results in increased expression of SELE protein]; dabrafenib inhibits the reaction [TGFBI protein results in increased expression of VCAM1 protein] CTD PMID:29042256 NCBI chr17:7,960,885...7,990,234
Ensembl chr17:7,960,516...7,990,471
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO dabrafenib inhibits the reaction [Polyphosphates results in increased expression of TNF protein] CTD PMID:27458080 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
G Tnfsf10 TNF superfamily member 10 multiple interactions ISO dabrafenib inhibits the reaction [lenvatinib results in increased expression of TNFSF10 protein] CTD PMID:38754640 NCBI chr 2:112,136,550...112,155,903 JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO dabrafenib inhibits the reaction [Polyphosphates results in increased expression of VCAM1 mRNA]; dabrafenib inhibits the reaction [Polyphosphates results in increased expression of VCAM1 protein]; dabrafenib inhibits the reaction [TGFBI protein results in increased expression of VCAM1 protein] CTD PMID:27458080 PMID:29042256 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
JBrowse link
dysidenin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Slc5a5 solute carrier family 5 member 5 multiple interactions ISO dysidenin inhibits the reaction [SLC5A5 protein results in increased uptake of perrhenate analog]; dysidenin inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide analog]; dysidenin inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Pertechnetate Tc 99m] CTD PMID:12488351 NCBI chr16:18,580,705...18,590,692
Ensembl chr16:18,580,705...18,590,691
JBrowse link
epothilone A term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Casp3 caspase 3 increases expression
multiple interactions
ISO epothilone A results in increased expression of CASP3 mRNA
[epothilone A co-treated with Metformin] results in increased expression of CASP3 mRNA; Sodium Salicylate promotes the reaction [[epothilone A co-treated with Metformin] results in increased expression of CASP3 mRNA]; triciribine promotes the reaction [[epothilone A co-treated with Metformin] results in increased expression of CASP3 mRNA]
CTD PMID:29117515 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G H2ax H2A.X variant histone multiple interactions
increases expression
ISO [epothilone A co-treated with Metformin] results in increased expression of H2AX mRNA
epothilone A results in increased expression of H2AX mRNA
CTD PMID:29117515 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions
increases expression
ISO [epothilone A co-treated with Metformin] results in increased expression of PARP1 mRNA; Sodium Salicylate inhibits the reaction [epothilone A results in increased expression of PARP1 mRNA]; triciribine inhibits the reaction [epothilone A results in increased expression of PARP1 mRNA]; triciribine promotes the reaction [[epothilone A co-treated with Metformin] results in increased expression of PARP1 mRNA] CTD PMID:29117515 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
JBrowse link
epothilone B term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Calca calcitonin-related polypeptide alpha decreases expression
multiple interactions
EXP epothilone B results in decreased expression of CALCA protein
epothilone B affects the reaction [[Capsaicin co-treated with NGF protein] results in increased secretion of CALCA protein]; epothilone B inhibits the reaction [Potassium results in increased secretion of CALCA protein]; epothilone B promotes the reaction [[Potassium co-treated with NGF protein] results in increased secretion of CALCA protein]
CTD PMID:26883566 NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
JBrowse link
G Ngf nerve growth factor multiple interactions EXP epothilone B affects the reaction [[Capsaicin co-treated with NGF protein] results in increased secretion of CALCA protein]; epothilone B promotes the reaction [[Potassium co-treated with NGF protein] results in increased secretion of CALCA protein] CTD PMID:26883566 NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
JBrowse link
famotidine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adcyap1 adenylate cyclase activating polypeptide 1 multiple interactions ISO Famotidine inhibits the reaction [ADCYAP1 protein affects the secretion of Acids] CTD PMID:20388963 NCBI chr 9:120,550,236...120,569,096
Ensembl chr 9:120,550,328...120,556,383
JBrowse link
G Agt angiotensinogen multiple interactions EXP Famotidine inhibits the reaction [Indomethacin results in increased expression of AGT protein] CTD PMID:27645307 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
JBrowse link
G Braf B-Raf proto-oncogene, serine/threonine kinase decreases activity ISO Famotidine results in decreased activity of BRAF protein CTD PMID:20823850 NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:69,342,813...69,476,931
JBrowse link
G Ca12 carbonic anhydrase 12 multiple interactions ISO Famotidine binds to and results in decreased activity of CA12 protein CTD PMID:30344913 NCBI chr 8:76,169,723...76,225,465
Ensembl chr 8:76,169,815...76,225,465
JBrowse link
G Ca6 carbonic anhydrase 6 multiple interactions ISO Famotidine binds to and results in decreased activity of CA6 protein CTD PMID:30344913 NCBI chr 5:165,941,028...165,959,566
Ensembl chr 5:165,941,029...165,959,566
JBrowse link
G Car2 carbonic anhydrase 2 multiple interactions ISO Famotidine binds to and results in decreased activity of CA2 protein CTD PMID:30344913 NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064
JBrowse link
G Car7 carbonic anhydrase 7 multiple interactions ISO Famotidine binds to and results in decreased activity of CA7 protein CTD PMID:30344913 NCBI chr19:435,520...444,927
Ensembl chr19:435,522...452,384
JBrowse link
G Cat catalase multiple interactions EXP
ISO
Famotidine inhibits the reaction [Indomethacin results in decreased activity of CAT protein]; Famotidine inhibits the reaction [Indomethacin results in increased activity of CAT protein]; Quercetin promotes the reaction [Famotidine inhibits the reaction [Indomethacin results in decreased activity of CAT protein]]
Famotidine inhibits the reaction [Indomethacin results in decreased expression of CAT protein]
CTD PMID:18726076 PMID:19034656 PMID:19497431 PMID:25926722 PMID:38447874 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
JBrowse link
G Cd80 Cd80 molecule multiple interactions ISO Famotidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of CD80 protein]] CTD PMID:12538815 NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540
JBrowse link
G Ctnnb1 catenin beta 1 multiple interactions
increases expression
ISO Famotidine inhibits the reaction [Dizocilpine Maleate results in decreased expression of CTNNB1 mRNA]
Famotidine results in increased expression of CTNNB1 mRNA
CTD PMID:31563592 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 increases expression EXP Famotidine results in increased expression of CXCL1 protein CTD PMID:12023551 NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811
JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 multiple interactions ISO Famotidine inhibits the reaction [CYP2C19 gene affects the susceptibility to Lansoprazole] CTD PMID:15963082 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions ISO [Famotidine co-treated with Sucralfate] results in increased expression of FGF2 mRNA CTD PMID:17717918 NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
JBrowse link
G Fgf21 fibroblast growth factor 21 increases expression ISO Famotidine results in increased expression of FGF21 protein CTD PMID:8774986 NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO Famotidine inhibits the reaction [[Dimaprit binds to and results in increased activity of HRH2 protein] which results in increased expression of FOS mRNA]; Famotidine inhibits the reaction [[Histamine binds to and results in increased activity of HRH2 protein] which results in increased expression of FOS mRNA] CTD PMID:9187264 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
JBrowse link
G Gabra1 gamma-aminobutyric acid type A receptor subunit alpha 1 multiple interactions EXP Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG1 protein]]; Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein]] CTD PMID:15363660 NCBI chr10:27,096,731...27,152,563
Ensembl chr10:27,096,740...27,152,442
JBrowse link
G Gabra3 gamma-aminobutyric acid type A receptor subunit alpha 3 multiple interactions EXP Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA3 protein binds to GABRB2 protein binds to GABRG1 protein]]; Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA3 protein binds to GABRB2 protein binds to GABRG2 protein]] CTD PMID:15363660 NCBI chr  X:155,301,979...155,543,870
Ensembl chr  X:155,303,928...155,543,863
JBrowse link
G Gabrb2 gamma-aminobutyric acid type A receptor subunit beta 2 multiple interactions EXP Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG1 protein]]; Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein]]; Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA3 protein binds to GABRB2 protein binds to GABRG1 protein]]; Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA3 protein binds to GABRB2 protein binds to GABRG2 protein]] CTD PMID:15363660 NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171
JBrowse link
G Gabrg1 gamma-aminobutyric acid type A receptor subunit gamma 1 multiple interactions EXP Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG1 protein]]; Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA3 protein binds to GABRB2 protein binds to GABRG1 protein]] CTD PMID:15363660 NCBI chr14:37,750,292...37,821,651
Ensembl chr14:37,750,292...37,989,945
JBrowse link
G Gabrg2 gamma-aminobutyric acid type A receptor subunit gamma 2 multiple interactions EXP Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Famotidine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA3 protein binds to GABRB2 protein binds to GABRG2 protein]] CTD PMID:15363660 NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523
JBrowse link
G Gast gastrin affects expression
increases expression
ISO
EXP
Famotidine affects the expression of GAST protein
Famotidine results in increased expression of GAST protein
CTD PMID:12503773 PMID:17652263 NCBI chr10:85,765,216...85,767,881
Ensembl chr10:85,765,216...85,767,880
JBrowse link
G Ghrl ghrelin and obestatin prepropeptide multiple interactions EXP Famotidine inhibits the reaction [GHRL protein results in increased secretion of Acids] CTD PMID:16838121 NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:148,421,315...148,425,969
JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions ISO Famotidine inhibits the reaction [Dizocilpine Maleate results in decreased phosphorylation of and results in increased activity of GSK3B protein]; Famotidine inhibits the reaction [Dizocilpine Maleate results in increased expression of GSK3B mRNA] CTD PMID:31563592 NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
JBrowse link
G Hrh2 histamine receptor H 2 multiple interactions
decreases activity
increases expression
ISO
EXP
[Famotidine binds to and results in decreased activity of HRH2 protein] which affects the susceptibility to Metformin; Famotidine binds to and results in decreased activity of HRH2 protein; Famotidine inhibits the reaction [[Dimaprit binds to and results in increased activity of HRH2 protein] which results in increased expression of FOS mRNA]; Famotidine inhibits the reaction [[Histamine binds to and results in increased activity of HRH2 protein] which results in increased expression of FOS mRNA]
Famotidine results in decreased activity of HRH2 protein
[Famotidine binds to and results in decreased activity of HRH2 protein] which affects the susceptibility to Histamine
Famotidine results in increased expression of HRH2 protein
CTD PMID:9187264 PMID:9681472 PMID:12832840 PMID:15961859 PMID:16632449 More... NCBI chr17:10,371,083...10,412,979
Ensembl chr17:10,371,083...10,391,041
JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A decreases expression
multiple interactions
EXP Famotidine results in decreased expression of HSPA1A protein
Zinc Compounds analog inhibits the reaction [Famotidine results in decreased expression of HSPA1A protein]; Zinc Sulfate inhibits the reaction [Famotidine results in decreased expression of HSPA1A protein]
CTD PMID:16945336 NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]] CTD PMID:11752121 PMID:12364868 PMID:12538815 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
JBrowse link
G Ifng interferon gamma multiple interactions ISO Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]]
Famotidine inhibits the reaction [Dimaprit inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein]]
CTD PMID:11752121 PMID:12364868 PMID:19277450 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
JBrowse link
G Il10 interleukin 10 multiple interactions ISO Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]] CTD PMID:11752121 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
JBrowse link
G Il12a interleukin 12A multiple interactions ISO Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]] CTD PMID:11752121 PMID:12364868 NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:155,275,625...155,282,997
JBrowse link
G Il12b interleukin 12B multiple interactions ISO Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]] CTD PMID:11752121 PMID:12364868 NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194
JBrowse link
G Il18 interleukin 18 multiple interactions ISO Famotidine inhibits the reaction [Cimetidine results in increased expression of IL18 protein]; Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of TNF protein]] CTD PMID:11752121 PMID:12364868 PMID:16723495 NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO
EXP
[Famotidine co-treated with Sucralfate] results in decreased expression of IL1B mRNA
Famotidine inhibits the reaction [Ethanol results in increased expression of IL1B protein]; Famotidine inhibits the reaction [Indomethacin results in increased expression of IL1B mRNA]
CTD PMID:17717918 PMID:27474069 PMID:27645307 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Il2 interleukin 2 multiple interactions ISO Famotidine inhibits the reaction [Dimaprit inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]] CTD PMID:19277450 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
JBrowse link
G Il4 interleukin 4 multiple interactions ISO Famotidine inhibits the reaction [Dimaprit inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL4 protein]] CTD PMID:19277450 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
JBrowse link
G Il6 interleukin 6 multiple interactions EXP Famotidine inhibits the reaction [Ethanol results in increased expression of IL6 protein]; Famotidine inhibits the reaction [Ethanol results in increased secretion of IL6 protein] CTD PMID:17603938 PMID:27474069 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO Famotidine inhibits the reaction [Histamine results in increased phosphorylation of MAPK1 protein] CTD PMID:17656145 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO Famotidine inhibits the reaction [Histamine results in increased phosphorylation of MAPK3 protein] CTD PMID:17656145 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
JBrowse link
G Mmp1 matrix metallopeptidase 1 multiple interactions ISO Famotidine inhibits the reaction [Histamine results in increased expression of MMP1 mRNA]; Famotidine inhibits the reaction [Histamine results in increased secretion of MMP1 protein] CTD PMID:17656145 NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions EXP Famotidine inhibits the reaction [Ethanol results in increased expression of and results in increased activity of MMP9 protein]; Famotidine inhibits the reaction [Ethanol results in increased expression of MMP9 mRNA]; Famotidine inhibits the reaction [Ethanol results in increased secretion of and results in increased activity of MMP9 protein]; Famotidine inhibits the reaction [Ethanol results in increased secretion of MMP9 protein] CTD PMID:17603938 PMID:22257724 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
JBrowse link
G Mpo myeloperoxidase multiple interactions
increases expression
ISO
EXP
Famotidine inhibits the reaction [Acids results in increased activity of MPO protein]
Famotidine inhibits the reaction [Ethanol results in increased activity of MPO protein]; Famotidine inhibits the reaction [Indomethacin results in increased activity of MPO protein]; Famotidine promotes the reaction [Chlorpheniramine results in decreased activity of MPO protein]; Quercetin promotes the reaction [Famotidine inhibits the reaction [Indomethacin results in increased activity of MPO protein]]
Famotidine results in increased expression of MPO protein
CTD PMID:12023551 PMID:16091555 PMID:16437673 PMID:17603938 PMID:18726076 More... NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor multiple interactions ISO Famotidine inhibits the reaction [Indomethacin results in increased expression of MYD88 protein] CTD PMID:38447874 NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230
JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions ISO Famotidine inhibits the reaction [Indomethacin results in increased expression of NFKB1 protein] CTD PMID:38447874 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
JBrowse link
G Nfkb2 nuclear factor kappa B subunit 2 multiple interactions ISO Famotidine inhibits the reaction [Indomethacin results in increased expression of NFKB2 mRNA] CTD PMID:38447874 NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637
JBrowse link
G Nppb natriuretic peptide B decreases expression EXP Famotidine results in decreased expression of NPPB protein CTD PMID:30310171 NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310
JBrowse link
G Ntf3 neurotrophin 3 multiple interactions EXP [Pyrilamine co-treated with Famotidine co-treated with ciproxifan] inhibits the reaction [Histamine results in increased expression of NTF3 protein]; [Pyrilamine co-treated with Famotidine] inhibits the reaction [Histamine results in increased expression of NTF3 protein]; Famotidine inhibits the reaction [Histamine results in increased expression of NTF3 protein] CTD PMID:21276809 NCBI chr 4:160,601,161...160,670,623
Ensembl chr 4:160,600,770...160,676,349
JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions EXP [Famotidine co-treated with Indomethacin] promotes the reaction [Acetic Acid results in increased expression of PCNA protein]; Famotidine promotes the reaction [Acetic Acid results in increased expression of PCNA protein] CTD PMID:18853145 PMID:19251492 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
JBrowse link
G Ppp3ca protein phosphatase 3 catalytic subunit alpha decreases expression EXP Famotidine results in decreased expression of PPP3CA protein CTD PMID:30310171 NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:227,839,062...228,113,554
JBrowse link
G Prdx3 peroxiredoxin 3 increases expression EXP Famotidine results in increased expression of PRDX3 protein CTD PMID:30310171 NCBI chr 1:269,987,691...270,000,111
Ensembl chr 1:269,987,685...270,000,300
JBrowse link
G Prl prolactin increases expression ISO Famotidine results in increased expression of PRL protein CTD PMID:8104296 NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217
JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 multiple interactions EXP Famotidine inhibits the reaction [Indomethacin results in increased expression of PTGS1 mRNA] CTD PMID:27645307 NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions EXP
ISO
Famotidine inhibits the reaction [Indomethacin results in increased expression of PTGS2 mRNA]
Famotidine inhibits the reaction [Indomethacin results in decreased expression of PTGS2 mRNA]
CTD PMID:27645307 PMID:38447874 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions EXP Famotidine inhibits the reaction [Ethanol results in increased expression of RELA protein] CTD PMID:27474069 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
JBrowse link
G RT1-A2 RT1 class Ia, locus A2 affects expression ISO Famotidine affects the expression of HLA-E mRNA CTD PMID:25811541 NCBI chr20:4,872,720...4,876,425 JBrowse link
G RT1-DMb RT1 class II, locus DMb affects expression ISO Famotidine affects the expression of HLA-DMB mRNA CTD PMID:25811541 NCBI chr20:4,695,009...4,702,560
Ensembl chr20:4,695,010...4,702,246
JBrowse link
G Serpine1 serpin family E member 1 multiple interactions EXP Heparin promotes the reaction [[Famotidine co-treated with Lipopolysaccharides] results in increased expression of SERPINE1 protein] CTD PMID:16401727 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
JBrowse link
G Slc19a3 solute carrier family 19 member 3 multiple interactions
increases uptake
ISO Famotidine inhibits the reaction [SLC19A3 protein results in increased uptake of Metformin]; Famotidine inhibits the reaction [SLC19A3 protein results in increased uptake of Thiamine]
SLC19A3 protein results in increased uptake of Famotidine
CTD PMID:26528626 NCBI chr 9:91,723,799...91,747,499
Ensembl chr 9:91,724,718...91,754,991
JBrowse link
G Slc22a1 solute carrier family 22 member 1 multiple interactions
increases uptake
affects transport
ISO
EXP
Famotidine inhibits the reaction [SLC22A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
SLC22A1 protein results in increased uptake of Famotidine
SLC22A1 protein affects the transport of Famotidine
CTD PMID:16006492 PMID:16141367 NCBI chr 1:50,624,339...50,651,437
Ensembl chr 1:50,624,377...50,651,436
JBrowse link
G Slc22a2 solute carrier family 22 member 2 increases uptake
multiple interactions
ISO
EXP
SLC22A2 protein results in increased uptake of Famotidine
Famotidine inhibits the reaction [SLC22A2 protein affects the transport of Tetraethylammonium]; Famotidine inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Famotidine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD PMID:15496291 PMID:16006492 PMID:16141367 PMID:21599003 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
JBrowse link
G Slc22a3 solute carrier family 22 member 3 multiple interactions
decreases activity
ISO Famotidine inhibits the reaction [SLC22A3 protein affects the transport of 1-Methyl-4-phenylpyridinium]; Famotidine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
Famotidine results in decreased activity of SLC22A3 protein
CTD PMID:16141367 NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:50,783,218...50,872,353
JBrowse link
G Slc22a8 solute carrier family 22 member 8 multiple interactions
increases uptake
ISO
EXP
estrone sulfate inhibits the reaction [SLC22A8 protein results in increased uptake of Famotidine]; Famotidine inhibits the reaction [SLC22A8 protein affects the transport of estrone sulfate]; Probenecid inhibits the reaction [SLC22A8 protein affects the transport of Famotidine]
Famotidine inhibits the reaction [SLC22A8 protein results in increased uptake of Cimetidine]; Penicillin G inhibits the reaction [SLC22A8 protein results in increased uptake of Famotidine]; Probenecid inhibits the reaction [SLC22A8 protein affects the transport of Famotidine]; Probenecid promotes the reaction [SLC22A8 protein results in increased uptake of Famotidine]
Famotidine inhibits the reaction [SLC22A8 protein results in increased uptake of p-Aminohippuric Acid]
CTD PMID:15100168 PMID:15319347 PMID:15496291 PMID:16006492 NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588
JBrowse link
G Slc47a1 solute carrier family 47 member 1 multiple interactions ISO Famotidine inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 NCBI chr10:46,533,580...46,590,128
Ensembl chr10:46,533,583...46,587,096
JBrowse link
G Slc47a2 solute carrier family 47 member 2 multiple interactions ISO Famotidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 NCBI chr10:46,490,262...46,532,954
Ensembl chr10:46,489,831...46,533,425
JBrowse link
G Tacr1 tachykinin receptor 1 multiple interactions ISO Famotidine inhibits the reaction [Acids affects the localization of TACR1 protein] CTD PMID:16091555 NCBI chr 4:116,478,617...116,647,492
Ensembl chr 4:116,478,617...116,647,492
JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO Famotidine inhibits the reaction [Indomethacin results in increased expression of TLR4 protein] CTD PMID:38447874 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases secretion
ISO
EXP
Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of TNF protein]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]]
Famotidine results in increased secretion of TNF protein
Famotidine inhibits the reaction [Dimaprit inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TNF protein]]
Famotidine inhibits the reaction [Ethanol results in increased expression of TNF protein]; Famotidine inhibits the reaction [Ethanol results in increased secretion of TNF protein]; Famotidine inhibits the reaction [Indomethacin results in increased expression of TNF mRNA]
CTD PMID:11752121 PMID:12538815 PMID:17603938 PMID:17698507 PMID:19277450 More... NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
febuxostat term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ager advanced glycosylation end product-specific receptor multiple interactions EXP Febuxostat inhibits the reaction [Paraquat results in decreased secretion of AGER protein modified form]; Febuxostat inhibits the reaction [Paraquat results in increased expression of AGER mRNA] CTD PMID:30726711 NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions EXP Febuxostat inhibits the reaction [Doxorubicin results in increased expression of BAX protein] CTD PMID:26036690 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions EXP Febuxostat inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:26036690 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Casp3 caspase 3 multiple interactions EXP Febuxostat inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein] CTD PMID:26036690 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression ISO Febuxostat results in increased expression of CCL2 mRNA CTD PMID:26641773 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
JBrowse link
G Ctnnb1 catenin beta 1 multiple interactions EXP Febuxostat inhibits the reaction [Paraquat results in increased expression of CTNNB1 protein] CTD PMID:30726711 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
JBrowse link
G Dusp10 dual specificity phosphatase 10 increases expression ISO Febuxostat results in increased expression of DUSP10 mRNA CTD PMID:35866629 NCBI chr13:98,145,317...98,183,304
Ensembl chr13:98,145,893...98,183,304
JBrowse link
G Dusp4 dual specificity phosphatase 4 increases expression ISO Febuxostat results in increased expression of DUSP4 mRNA CTD PMID:35866629 NCBI chr16:64,079,893...64,101,396
Ensembl chr16:64,079,893...64,093,700
JBrowse link
G Dusp5 dual specificity phosphatase 5 increases expression ISO Febuxostat results in increased expression of DUSP5 mRNA CTD PMID:35866629 NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417
JBrowse link
G Dusp8 dual specificity phosphatase 8 increases expression ISO Febuxostat results in increased expression of DUSP8 mRNA CTD PMID:35866629 NCBI chr 1:206,596,912...206,613,728
Ensembl chr 1:206,598,942...206,612,441
JBrowse link
G Gadd45g growth arrest and DNA-damage-inducible, gamma increases expression ISO Febuxostat results in increased expression of GADD45G mRNA CTD PMID:35866629 NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369
JBrowse link
G Got2 glutamic-oxaloacetic transaminase 2 multiple interactions ISO Febuxostat inhibits the reaction [[myelin oligodendrocyte glycoprotein (35-55) co-treated with Freund's Adjuvant] results in decreased expression of GOT2 mRNA]; Febuxostat inhibits the reaction [[myelin oligodendrocyte glycoprotein (35-55) co-treated with Freund's Adjuvant] results in decreased expression of GOT2 protein] CTD PMID:29107957 NCBI chr19:9,180,428...9,206,113
Ensembl chr19:9,180,431...9,206,111
JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions EXP Febuxostat inhibits the reaction [Estradiol results in increased expression of HIF1A mRNA] CTD PMID:32228192 NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions EXP Febuxostat inhibits the reaction [Paraquat results in increased expression of HMGB1 mRNA] CTD PMID:30726711 NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327
JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta multiple interactions EXP Febuxostat inhibits the reaction [Doxorubicin results in increased expression of IKBKB protein] CTD PMID:26036690 NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
JBrowse link
G Il1rap interleukin 1 receptor accessory protein increases expression ISO Febuxostat results in increased expression of IL1RAP mRNA CTD PMID:35866629 NCBI chr11:87,567,813...87,704,346
Ensembl chr11:87,575,116...87,704,342
JBrowse link
G Il6 interleukin 6 multiple interactions EXP Febuxostat inhibits the reaction [Estradiol results in increased expression of IL6 protein] CTD PMID:32228192 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases phosphorylation ISO Febuxostat results in increased phosphorylation of MAPK8 protein CTD PMID:35866629 NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions EXP Febuxostat inhibits the reaction [Paraquat results in increased expression of MMP9 protein] CTD PMID:30726711 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
JBrowse link
G Mras muscle RAS oncogene homolog increases expression ISO Febuxostat results in increased expression of MRAS mRNA CTD PMID:35866629 NCBI chr 8:108,823,374...108,886,104
Ensembl chr 8:108,823,374...108,875,911
JBrowse link
G Nppb natriuretic peptide B multiple interactions EXP Febuxostat inhibits the reaction [Doxorubicin results in increased expression of NPPB protein] CTD PMID:26036690 NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310
JBrowse link
G Nr4a1 nuclear receptor subfamily 4, group A, member 1 increases expression ISO Febuxostat results in increased expression of NR4A1 mRNA CTD PMID:35866629 NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:134,247,192...134,268,041
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions EXP Febuxostat inhibits the reaction [Paraquat results in increased expression of PTGS2 mRNA] CTD PMID:30726711 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions EXP Febuxostat inhibits the reaction [Doxorubicin results in increased expression of RELA protein] CTD PMID:26036690 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions EXP Febuxostat inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein] CTD PMID:26036690 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression
EXP
ISO
Febuxostat inhibits the reaction [Doxorubicin results in increased expression of TNF protein]
Febuxostat results in increased expression of TNF mRNA
CTD PMID:26036690 PMID:26641773 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions EXP Febuxostat inhibits the reaction [Estradiol results in increased expression of VEGFA protein]; Febuxostat inhibits the reaction [Paraquat results in increased expression of VEGFA protein] CTD PMID:30726711 PMID:32228192 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
JBrowse link
G Xdh xanthine dehydrogenase decreases activity ISO Febuxostat results in decreased activity of XDH protein CTD PMID:35866629 NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
JBrowse link
fluensulfone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp2f4 cytochrome P450, family 2, subfamily f, polypeptide 4 increases response to substance
increases metabolic processing
ISO CYP2F2 protein results in increased susceptibility to fluensulfone
CYP2F2 protein results in increased metabolism of fluensulfone
CTD PMID:27605420 NCBI chr 1:91,543,768...91,557,553
Ensembl chr 1:91,543,768...91,557,553
JBrowse link
GW 501516 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abca1 ATP binding cassette subfamily A member 1 increases expression ISO GW 501516 results in increased expression of ABCA1 mRNA; GW 501516 results in increased expression of ABCA1 protein CTD PMID:19201410 NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
JBrowse link
G Abhd3 abhydrolase domain containing 3, phospholipase multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of ABHD3 mRNA CTD PMID:16197558 NCBI chr18:1,996,010...2,051,311
Ensembl chr18:1,993,525...2,075,492
JBrowse link
G Acadm acyl-CoA dehydrogenase medium chain multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of ACADM mRNA CTD PMID:16197558 NCBI chr 2:245,518,693...245,542,864
Ensembl chr 2:245,518,693...245,542,864
JBrowse link
G Acadvl acyl-CoA dehydrogenase, very long chain multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of ACADVL mRNA CTD PMID:16197558 NCBI chr10:55,231,558...55,236,786
Ensembl chr10:55,231,440...55,236,750
JBrowse link
G Acox1 acyl-CoA oxidase 1 increases expression ISO GW 501516 results in increased expression of ACOX1 mRNA CTD PMID:16574099 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136
JBrowse link
G Angptl4 angiopoietin-like 4 multiple interactions
increases expression
ISO [GW 501516 binds to PPARD protein] which results in increased expression of ANGPTL4 mRNA
GW 501516 results in increased expression of ANGPTL4 mRNA
CTD PMID:16197558 PMID:34627044 NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681
JBrowse link
G Apoa1 apolipoprotein A1 multiple interactions ISO GW 501516 promotes the reaction [APOA1 protein results in increased secretion of Lipids] CTD PMID:19201410 NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729
JBrowse link
G App amyloid beta precursor protein multiple interactions ISO GW 501516 inhibits the reaction [APP gene mutant form results in decreased expression of GCH1 protein]; GW 501516 inhibits the reaction [APP gene mutant form results in decreased expression of SOD1 protein]; GW 501516 inhibits the reaction [APP gene mutant form results in decreased expression of SOD3 protein]; GW 501516 inhibits the reaction [APP gene mutant form results in decreased phosphorylation of NOS3 protein]; GW 501516 inhibits the reaction [APP gene mutant form results in decreased susceptibility to Acetylcholine]; GW 501516 inhibits the reaction [APP gene mutant form results in increased abundance of 7,8-dihydrobiopterin]; GW 501516 inhibits the reaction [APP gene mutant form results in increased chemical synthesis of Superoxides]; GW 501516 inhibits the reaction [APP gene mutant form results in increased expression of CYBB protein]; GW 501516 inhibits the reaction [APP gene mutant form results in increased oxidation of and results in decreased abundance of sapropterin] CTD PMID:22886847 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
JBrowse link
G Bcl6 BCL6, transcription repressor multiple interactions ISO BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of SELE mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]] CTD PMID:23737761 NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
decreases expression
ISO BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]
GW 501516 results in decreased expression of CCL2 mRNA
GW 501516 inhibits the reaction [Palmitates results in increased expression of CCL2 mRNA]; GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]
CTD PMID:16574099 PMID:21966476 PMID:23737761 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of CEBPA mRNA CTD PMID:16197558 NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A multiple interactions
increases expression
ISO [GW 501516 binds to PPARD protein] which results in increased expression of CPT1A mRNA
GW 501516 results in increased expression of CPT1A mRNA
CTD PMID:16197558 PMID:16574099 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
JBrowse link
G Cpt1b carnitine palmitoyltransferase 1B multiple interactions
increases expression
EXP RELA protein inhibits the reaction [GW 501516 results in increased expression of CPT1B mRNA] CTD PMID:18701451 NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:122,370,444...122,380,036
JBrowse link
G Cx3cr1 C-X3-C motif chemokine receptor 1 decreases expression ISO GW 501516 results in decreased expression of CX3CR1 mRNA CTD PMID:19850645 NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:128,654,833...128,685,983
JBrowse link
G Cybb cytochrome b-245 beta chain multiple interactions ISO GW 501516 inhibits the reaction [APP gene mutant form results in increased expression of CYBB protein] CTD PMID:22886847 NCBI chr  X:16,030,596...16,065,065
Ensembl chr  X:16,030,596...16,065,065
JBrowse link
G Cyp24a1 cytochrome P450, family 24, subfamily a, polypeptide 1 multiple interactions ISO GW 501516 inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA] CTD PMID:19667161 NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:179,694,647...179,709,083
JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of DDIT4 mRNA CTD PMID:16197558 NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037
JBrowse link
G Ech1 enoyl-CoA hydratase 1 multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of ECH1 mRNA CTD PMID:16197558 NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:93,241,734...93,248,440
JBrowse link
G Fabp1 fatty acid binding protein 1 increases expression
multiple interactions
ISO GW 501516 results in increased expression of FABP1 mRNA
[GW 501516 binds to PPARD protein] which results in increased expression of FABP1 mRNA
CTD PMID:16197558 PMID:16574099 NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113
JBrowse link
G Gch1 GTP cyclohydrolase 1 multiple interactions ISO GW 501516 inhibits the reaction [APP gene mutant form results in decreased expression of GCH1 protein] CTD PMID:22886847 NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412
JBrowse link
G Hadha hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of HADHA mRNA CTD PMID:16197558 NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:31,907,291...31,947,698
JBrowse link
G Hmgcs2 3-hydroxy-3-methylglutaryl-CoA synthase 2 multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of HMGCS2 mRNA CTD PMID:16197558 NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242
JBrowse link
G Hsdl2 hydroxysteroid dehydrogenase like 2 multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of HSDL2 mRNA CTD PMID:16197558 NCBI chr 5:79,238,881...79,274,051
Ensembl chr 5:79,212,525...79,274,798
JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; GW 501516 inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] CTD PMID:23737761 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
JBrowse link
G Il1b interleukin 1 beta multiple interactions
decreases expression
ISO BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]]; GW 501516 inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]
GW 501516 results in decreased expression of IL1B mRNA
CTD PMID:16574099 PMID:23737761 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Il6 interleukin 6 decreases expression ISO GW 501516 results in decreased expression of IL6 mRNA CTD PMID:16574099 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
JBrowse link
G Kiz kizuna centrosomal protein multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of KIZ mRNA CTD PMID:16197558 NCBI chr 3:154,730,873...154,838,410
Ensembl chr 3:154,730,634...154,838,410
JBrowse link
G Lipc lipase C, hepatic type multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of LIPC mRNA CTD PMID:16197558 NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:80,390,471...80,516,285
JBrowse link
G Mdm2 MDM2 proto-oncogene multiple interactions EXP MDM2 protein inhibits the reaction [GW 501516 results in increased activity of PPARB protein] CTD PMID:19103650 NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791
JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions ISO BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]; GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]; PPARD mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]] CTD PMID:23737761 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
JBrowse link
G Nedd9 neural precursor cell expressed, developmentally down-regulated 9 multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of NEDD9 mRNA CTD PMID:16197558 NCBI chr17:23,495,531...23,673,780
Ensembl chr17:23,495,492...23,675,668
JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases activity ISO GW 501516 results in increased activity of NFE2L2 protein CTD PMID:30114225 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 decreases expression ISO GW 501516 results in decreased expression of NFKB1 mRNA CTD PMID:16574099 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
JBrowse link
G Nos3 nitric oxide synthase 3 multiple interactions ISO GW 501516 inhibits the reaction [APP gene mutant form results in decreased phosphorylation of NOS3 protein] CTD PMID:22886847 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
JBrowse link
G Nppa natriuretic peptide A multiple interactions EXP [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] CTD PMID:18701451 NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493
JBrowse link
G Nppb natriuretic peptide B multiple interactions EXP [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] CTD PMID:18701451 NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310
JBrowse link
G Nr1h2 nuclear receptor subfamily 1, group H, member 2 increases expression ISO GW 501516 results in increased expression of NR1H2 mRNA CTD PMID:19201410 NCBI chr 1:104,178,483...104,183,863
Ensembl chr 1:104,178,234...104,183,863
JBrowse link
G Nr1h3 nuclear receptor subfamily 1, group H, member 3 increases expression
affects response to substance
multiple interactions
ISO GW 501516 results in increased expression of NR1H3 mRNA
NR1H3 protein affects the susceptibility to GW 501516
NR1H3 protein affects the reaction [GW 501516 results in increased expression of PPARA mRNA]
CTD PMID:19201410 NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:97,614,616...97,624,532
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions ISO GW 501516 promotes the reaction [Indomethacin results in increased cleavage of PARP1 protein] CTD PMID:21400612 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1 multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of PCK1 mRNA CTD PMID:16197558 NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561
JBrowse link
G Pdk4 pyruvate dehydrogenase kinase 4 increases expression ISO GW 501516 results in increased expression of PDK4 mRNA CTD PMID:34627044 NCBI chr 4:34,558,327...34,568,329
Ensembl chr 4:34,556,330...34,568,381
JBrowse link
G Pdzk1 PDZ domain containing 1 multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of PDZK1 mRNA CTD PMID:16197558 NCBI chr 2:187,064,995...187,096,348
Ensembl chr 2:187,065,013...187,096,806
JBrowse link
G Plin2 perilipin 2 multiple interactions
increases expression
ISO [GW 501516 binds to PPARD protein] which results in increased expression of PLIN2 mRNA; PPARD mutant form inhibits the reaction [GW 501516 results in increased expression of PLIN2 mRNA] CTD PMID:16197558 PMID:23737761 NCBI chr 5:106,202,634...106,258,748
Ensembl chr 5:106,202,634...106,258,878
JBrowse link
G Pltp phospholipid transfer protein multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of PLTP mRNA CTD PMID:16197558 NCBI chr 3:173,994,162...174,011,982
Ensembl chr 3:173,994,162...174,012,505
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions
affects response to substance
increases expression
affects binding
ISO [Calcitriol co-treated with GW 501516] results in increased expression of PPARA mRNA; NR1H3 protein affects the reaction [GW 501516 results in increased expression of PPARA mRNA]
PPARA protein affects the susceptibility to GW 501516
GW 501516 binds to PPARA protein
CTD PMID:19201410 PMID:19667161 PMID:23843199 PMID:25689681 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
JBrowse link
G Ppard peroxisome proliferator-activated receptor delta affects binding
increases expression
increases activity
multiple interactions
ISO
EXP
GW 501516 binds to PPARB protein; GW 501516 binds to PPARD protein
GW 501516 results in increased expression of PPARD mRNA
GW 501516 results in increased activity of PPARD protein
[GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased activity of RELA protein]; [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]; MDM2 protein inhibits the reaction [GW 501516 results in increased activity of PPARB protein]
[Calcitriol co-treated with GW 501516] results in increased expression of PPARD mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of ABHD3 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of ACADM mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of ACADVL mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of ANGPTL4 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of CEBPA mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of CPT1A mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of DDIT4 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of ECH1 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of FABP1 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of HADHA mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of HMGCS2 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of HSDL2 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of KIZ mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of LIPC mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of NEDD9 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of PCK1 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of PDZK1 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of PLIN2 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of PLTP mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of RNU7-65P mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of SERPINE1 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of SLC22A7 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of SLC30A10 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of SULT2A1 mRNA; [GW 501516 binds to PPARD protein] which results in increased expression of TRIB2 mRNA; GW 501516 binds to and results in increased activity of PPARD protein; GW 501516 promotes the reaction [PPARD protein results in increased expression of SIRT1 mRNA]; PPARD mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]; PPARD mutant form inhibits the reaction [GW 501516 results in increased expression of PLIN2 mRNA]
4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide inhibits the reaction [GW 501516 results in increased expression of PPARD mRNA]; [GW 501516 co-treated with PPARD protein] results in increased expression of PPARGC1A mRNA; GW 501516 binds to and results in increased activity of PPARD protein
CTD PMID:16197558 PMID:17275789 PMID:18292206 PMID:18701451 PMID:19103650 More... NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,352,183...6,365,707
JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma increases expression
increases activity
ISO GW 501516 results in increased expression of PPARG mRNA
GW 501516 results in increased activity of PPARG protein
CTD PMID:16386710 PMID:19201410 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
JBrowse link
G Ppargc1a PPARG coactivator 1 alpha multiple interactions
increases expression
ISO [GW 501516 co-treated with PPARD protein] results in increased expression of PPARGC1A mRNA
GW 501516 results in increased expression of PPARGC1A mRNA
CTD PMID:17275789 PMID:23056435 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression
ISO cannabidiolic acid inhibits the reaction [GW 501516 results in increased expression of PTGS2 mRNA] CTD PMID:32238697 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions EXP [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased activity of RELA protein]; RELA protein inhibits the reaction [GW 501516 results in increased expression of CPT1B mRNA] CTD PMID:18701451 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
JBrowse link
G Sele selectin E multiple interactions ISO BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of SELE mRNA]]; GW 501516 inhibits the reaction [TNF protein results in increased expression of SELE mRNA] CTD PMID:23737761 NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903
JBrowse link
G Serpine1 serpin family E member 1 multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of SERPINE1 mRNA CTD PMID:16197558 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
JBrowse link
G Sirt1 sirtuin 1 multiple interactions ISO GW 501516 promotes the reaction [PPARD protein results in increased expression of SIRT1 mRNA] CTD PMID:20160399 NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
JBrowse link
G Slc22a7 solute carrier family 22 member 7 multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of SLC22A7 mRNA CTD PMID:16197558 NCBI chr 9:22,044,672...22,052,051
Ensembl chr 9:22,045,435...22,051,681
JBrowse link
G Slc30a10 solute carrier family 30, member 10 multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of SLC30A10 mRNA CTD PMID:16197558 NCBI chr13:99,529,664...99,584,442
Ensembl chr13:99,529,790...99,544,213
JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions ISO GW 501516 inhibits the reaction [APP gene mutant form results in decreased expression of SOD1 protein] CTD PMID:22886847 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
JBrowse link
G Sod3 superoxide dismutase 3 multiple interactions ISO GW 501516 inhibits the reaction [APP gene mutant form results in decreased expression of SOD3 protein] CTD PMID:22886847 NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
JBrowse link
G Stat5b signal transducer and activator of transcription 5B decreases activity ISO GW 501516 results in decreased activity of STAT5B protein CTD PMID:30114225 NCBI chr10:86,205,148...86,276,178
Ensembl chr10:86,207,293...86,275,990
JBrowse link
G Sult2a1 sulfotransferase family 2A member 1 multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of SULT2A1 mRNA CTD PMID:16197558 NCBI chr 1:84,582,011...84,639,001 JBrowse link
G Tgfb1 transforming growth factor, beta 1 decreases expression ISO GW 501516 results in decreased expression of TGFB1 mRNA CTD PMID:16574099 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
JBrowse link
G Tnf tumor necrosis factor multiple interactions
decreases expression
ISO BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of SELE mRNA]]; BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]]; GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; GW 501516 inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; GW 501516 inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]; GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]; GW 501516 inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; GW 501516 inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; PPARD mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]
GW 501516 results in decreased expression of TNF mRNA
CTD PMID:16574099 PMID:21966476 PMID:23737761 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
G Trib2 tribbles pseudokinase 2 multiple interactions ISO [GW 501516 binds to PPARD protein] which results in increased expression of TRIB2 mRNA CTD PMID:16197558 NCBI chr 6:44,274,762...44,299,139
Ensembl chr 6:44,274,762...44,299,094
JBrowse link
G Ucp2 uncoupling protein 2 increases expression EXP GW 501516 results in increased expression of UCP2 mRNA CTD PMID:16239165 NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]]; GW 501516 inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA] CTD PMID:23737761 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
JBrowse link
G Vdr vitamin D receptor increases expression
multiple interactions
ISO GW 501516 results in increased expression of VDR mRNA
[Calcitriol co-treated with GW 501516] results in increased expression of VDR mRNA
CTD PMID:19667161 NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757
JBrowse link
LCL161 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions ISO LCL161 binds to and affects the activity of ABCB1 protein; LCL161 inhibits the reaction [ABCB1 protein results in increased export of Fluorescent Dyes]; LCL161 inhibits the reaction [ABCB1 protein results in increased export of mitotracker green FM] CTD PMID:32497533 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
JBrowse link
G Birc2 baculoviral IAP repeat-containing 2 decreases expression
decreases expression
ISO LCL161 results in decreased expression of BIRC2 protein
LCL161 decreases expression of BIRC2 protein in hepatocellular carcinoma cells
CTD
RGD
PMID:32497533 PMID:24976294 RGD:153305953 NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 decreases expression ISO LCL161 decreases expression of BIRC3 protein in hepatocellular carcinoma cells RGD PMID:24976294 RGD:153305953 NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 decreases expression ISO LCL161 results in decreased expression of BIRC5 protein CTD PMID:32497533 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
JBrowse link
G Xiap X-linked inhibitor of apoptosis decreases expression ISO LCL161 decreases expression of XIAP protein in hepatocellular carcinoma cells RGD PMID:24976294 RGD:153305953 NCBI chr  X:125,756,107...125,803,979
Ensembl chr  X:125,737,971...125,803,978
JBrowse link
masitinib term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 increases metabolic processing ISO CYP2C8 protein results in increased metabolism of masitinib CTD PMID:36048877
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases metabolic processing ISO CYP3A4 protein results in increased metabolism of masitinib CTD PMID:36048877 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
JBrowse link
G Fgfr3 fibroblast growth factor receptor 3 decreases activity ISO masitinib results in decreased activity of FGFR3 protein CTD PMID:19789626 NCBI chr14:81,211,800...81,227,215
Ensembl chr14:81,211,800...81,227,209
JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase multiple interactions ISO masitinib results in decreased phosphorylation of and results in decreased activity of KIT protein
masitinib binds to and results in decreased phosphorylation of and results in decreased activity of KIT protein
CTD PMID:19789626 NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812
JBrowse link
G Lyn LYN proto-oncogene, Src family tyrosine kinase decreases activity ISO masitinib results in decreased activity of LYN protein CTD PMID:19789626 NCBI chr 5:21,437,127...21,553,097
Ensembl chr 5:21,437,084...21,554,461
JBrowse link
G Pdgfra platelet derived growth factor receptor alpha decreases activity ISO masitinib results in decreased activity of PDGFRA protein CTD PMID:19789626 NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,360,028...33,408,516
JBrowse link
G Pdgfrb platelet derived growth factor receptor beta decreases activity ISO masitinib results in decreased activity of PDGFRB protein CTD PMID:19789626 NCBI chr18:56,770,348...56,809,228
Ensembl chr18:56,770,348...56,809,233
JBrowse link
G Tgfb1 transforming growth factor, beta 1 increases secretion
multiple interactions
ISO masitinib results in increased secretion of TGFB1 protein
[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with masitinib co-treated with Cromolyn Sodium] results in increased secretion of TGFB1 protein; [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with masitinib] results in increased secretion of TGFB1 protein; [masitinib co-treated with Cromolyn Sodium] results in increased secretion of TGFB1 protein
CTD PMID:35007524 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
JBrowse link
G Tnf tumor necrosis factor decreases secretion ISO masitinib results in decreased secretion of TNF protein CTD PMID:19789626 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
meloxicam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions ISO Meloxicam inhibits the reaction [Doxorubicin results in increased activity of ABCB1 protein]; Meloxicam inhibits the reaction [Doxorubicin results in increased expression of ABCB1 protein] CTD PMID:15501994 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 affects binding ISO ABCC4 protein binds to meloxicam CTD PMID:17939016 NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
JBrowse link
G Abl1 ABL proto-oncogene 1, non-receptor tyrosine kinase multiple interactions ISO [Meloxicam co-treated with Cilostazol] results in decreased expression of ABL1 protein CTD PMID:35920412 NCBI chr 3:35,377,587...35,480,843
Ensembl chr 3:35,377,391...35,480,846
JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO [Meloxicam co-treated with Cilostazol] results in decreased phosphorylation of AKT1 protein CTD PMID:35920412 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
JBrowse link
G App amyloid beta precursor protein multiple interactions ISO meloxicam inhibits the reaction [Aluminum results in increased expression of APP protein] CTD PMID:16928369 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
multiple interactions
ISO meloxicam results in increased expression of BAX protein
[Cilostazol co-treated with Meloxicam] results in increased expression of BAX mRNA
CTD PMID:19709125 PMID:35920412 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
JBrowse link
G Bdkrb1 bradykinin receptor B1 multiple interactions EXP meloxicam inhibits the reaction [KNG1 protein binds to and results in increased activity of BDKRB1 protein] CTD PMID:11159707 NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973
JBrowse link
G Casp3 caspase 3 multiple interactions
increases activity
ISO
EXP
[Meloxicam co-treated with Cilostazol] results in increased activity of CASP3 protein
Meloxicam results in increased activity of CASP3 protein
Meloxicam inhibits the reaction [Diquat results in increased expression of CASP3 protein modified form]
[Rutin co-treated with Meloxicam] affects the reaction [Formaldehyde affects the expression of CASP3 protein]; Meloxicam affects the reaction [Formaldehyde affects the expression of CASP3 protein]; Meloxicam inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]
CTD PMID:19709125 PMID:24799355 PMID:29315975 PMID:29484840 PMID:35920412 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Casp9 caspase 9 multiple interactions
increases activity
EXP
ISO
Meloxicam inhibits the reaction [Diquat results in increased expression of CASP9 protein modified form]
Meloxicam results in increased activity of CASP9 protein
[Meloxicam co-treated with Cilostazol] results in increased activity of CASP9 protein
CTD PMID:29484840 PMID:35920412 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cat catalase decreases expression
multiple interactions
EXP
ISO
Meloxicam results in decreased expression of CAT protein
Meloxicam affects the expression of and affects the activity of CAT protein
meloxicam inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]
CTD PMID:24799355 PMID:25034942 PMID:38036073 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
JBrowse link
G Chat choline O-acetyltransferase multiple interactions ISO meloxicam inhibits the reaction [Aluminum results in decreased expression of CHAT protein] CTD PMID:16928369 NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,663,665...7,723,416
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO [CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Meloxicam] which results in increased chemical synthesis of Pyruvaldehyde; CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Meloxicam CTD PMID:33253783 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
JBrowse link
G Ereg epiregulin multiple interactions ISO [meloxicam results in decreased activity of PTGS2 protein] inhibits the reaction [trans-10,cis-12-conjugated linoleic acid results in increased expression of EREG mRNA] CTD PMID:22583689 NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,311,485...17,325,260
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions ISO meloxicam inhibits the reaction [Paraquat results in decreased expression of GCLC protein] CTD PMID:20851755 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions ISO Meloxicam affects the expression of and affects the activity of GPX1 protein CTD PMID:38036073 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO Meloxicam inhibits the reaction [HMGB1 protein results in increased expression of PTGS2 protein]; Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK1 protein]; Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK3 protein]; Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of NFKBIA protein] CTD PMID:34755645 NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327
JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [Rutin co-treated with Meloxicam] affects the reaction [Formaldehyde affects the expression of IL1B protein]; Meloxicam affects the reaction [Formaldehyde affects the expression of IL1B protein] CTD PMID:29315975 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Il6 interleukin 6 multiple interactions ISO meloxicam inhibits the reaction [Doxorubicin results in increased expression of IL6 protein] CTD PMID:24799355 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
JBrowse link
G Kng1 kininogen 1 multiple interactions EXP Meloxicam inhibits the reaction [KNG1 protein binds to and results in increased activity of BDKRB1 protein] CTD PMID:11159707 NCBI chr11:91,317,354...91,340,148
Ensembl chr11:91,317,355...91,340,148
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK1 protein] CTD PMID:34755645 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK3 protein] CTD PMID:34755645 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions ISO [Meloxicam co-treated with Cilostazol] results in decreased expression of MYC protein CTD PMID:35920412 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions ISO meloxicam inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein] CTD PMID:20851755 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of NFKBIA protein] CTD PMID:34755645 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
JBrowse link
G Park7 Parkinsonism associated deglycase multiple interactions ISO meloxicam inhibits the reaction [Paraquat promotes the reaction [Quinones binds to PARK7 protein]] CTD PMID:20851755 NCBI chr 5:166,636,551...166,659,825
Ensembl chr 5:166,636,552...166,659,825
JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression ISO meloxicam results in decreased expression of PCNA protein CTD PMID:19709125 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
JBrowse link
G Prkaa1 protein kinase AMP-activated catalytic subunit alpha 1 multiple interactions ISO [Meloxicam co-treated with Cilostazol] results in increased expression of and results in increased phosphorylation of PRKAA1 protein CTD PMID:35920412 NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:55,967,351...56,003,450
JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Meloxicam results in decreased activity of PTGS1 protein CTD PMID:25034942 NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression
decreases activity
multiple interactions
ISO
EXP
meloxicam results in increased expression of PTGS2 protein
meloxicam results in decreased activity of PTGS2 protein
Meloxicam inhibits the reaction [Diquat results in increased expression of PTGS2 protein]; Meloxicam inhibits the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone]
[meloxicam results in decreased activity of PTGS2 protein] inhibits the reaction [trans-10,cis-12-conjugated linoleic acid results in increased chemical synthesis of Dinoprost]; [meloxicam results in decreased activity of PTGS2 protein] inhibits the reaction [trans-10,cis-12-conjugated linoleic acid results in increased expression of EREG mRNA]; meloxicam inhibits the reaction [Aluminum results in increased expression of PTGS2 mRNA]; meloxicam inhibits the reaction [Aluminum results in increased expression of PTGS2 protein]
[Meloxicam results in decreased activity of PTGS2 protein] which results in decreased abundance of Dinoprostone; [Meloxicam results in decreased activity of PTGS2 protein] which results in decreased susceptibility to Chlorpyrifos; Meloxicam inhibits the reaction [HMGB1 protein results in increased expression of PTGS2 protein]
CTD PMID:10791687 PMID:11159707 PMID:12417326 PMID:16928369 PMID:17164136 More... NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
JBrowse link
G Scn5a sodium voltage-gated channel alpha subunit 5 decreases activity ISO Meloxicam results in decreased activity of SCN5A protein CTD PMID:33617802 NCBI chr 8:128,098,613...128,196,515
Ensembl chr 8:128,098,613...128,196,470
JBrowse link
G Sell selectin L affects expression ISO meloxicam affects the expression of SELL protein CTD PMID:12147693 NCBI chr13:78,950,100...78,969,604
Ensembl chr13:78,950,015...78,969,600
JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions ISO Meloxicam affects the expression of and affects the activity of SOD1 protein CTD PMID:38036073 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions ISO Meloxicam affects the expression of and affects the activity of SOD2 protein CTD PMID:38036073 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
JBrowse link
G Sord sorbitol dehydrogenase multiple interactions ISO [Rutin co-treated with Meloxicam] inhibits the reaction [Formaldehyde affects the activity of SORD protein]; Meloxicam inhibits the reaction [Formaldehyde affects the activity of SORD protein] CTD PMID:29315975 NCBI chr 3:129,638,282...129,669,727
Ensembl chr 3:129,638,302...129,686,100
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO meloxicam inhibits the reaction [Doxorubicin results in increased expression of TNF protein] CTD PMID:24799355 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
mirabegron term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions EXP mirabegron inhibits the reaction [Acetic Acid results in decreased secretion of ADIPOQ protein] CTD PMID:37414241 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions EXP mirabegron inhibits the reaction [Acetic Acid results in increased phosphorylation of AKT1 protein] CTD PMID:37414241 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
JBrowse link
G Casp3 caspase 3 multiple interactions EXP mirabegron inhibits the reaction [Acetic Acid results in increased cleavage of CASP3 protein] CTD PMID:37414241 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Cat catalase multiple interactions EXP mirabegron inhibits the reaction [Acetic Acid results in decreased activity of CAT protein] CTD PMID:37414241 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
JBrowse link
G Gstm1 glutathione S-transferase mu 1 multiple interactions EXP mirabegron inhibits the reaction [Acetic Acid results in decreased expression of GSTM1 protein] CTD PMID:37414241 NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
JBrowse link
G Mpo myeloperoxidase multiple interactions EXP mirabegron inhibits the reaction [Acetic Acid results in increased expression of MPO protein] CTD PMID:37414241 NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions EXP mirabegron inhibits the reaction [Acetic Acid results in increased phosphorylation of RELA protein] CTD PMID:37414241 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions EXP mirabegron inhibits the reaction [Acetic Acid results in increased expression of TLR4 protein] CTD PMID:37414241 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
JBrowse link
myxothiazol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cd36 CD36 molecule multiple interactions ISO myxothiazol inhibits the reaction [[Oxygen deficiency results in increased abundance of Reactive Oxygen Species] which results in increased expression of CD36 mRNA] CTD PMID:19640849 NCBI chr 4:18,209,088...18,302,142 JBrowse link
G Epas1 endothelial PAS domain protein 1 multiple interactions EXP myxothiazol inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein] CTD PMID:18353899 NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:13,544,389...13,624,729
JBrowse link
G Il6 interleukin 6 multiple interactions ISO myxothiazol inhibits the reaction [Sodium Chloride inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]] CTD PMID:23867654 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
JBrowse link
G Nfat5 nuclear factor of activated T-cells 5 multiple interactions ISO myxothiazol inhibits the reaction [Sodium Chloride results in increased activity of NFAT5 protein] CTD PMID:16303854 NCBI chr19:52,108,982...52,196,418
Ensembl chr19:52,109,483...52,196,418
JBrowse link
G P2rx2 purinergic receptor P2X 2 multiple interactions EXP myxothiazol promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX2 protein] CTD PMID:19793987 NCBI chr12:51,999,107...52,002,627
Ensembl chr12:51,999,372...52,002,627
JBrowse link
G Prkce protein kinase C, epsilon multiple interactions ISO myxothiazol inhibits the reaction [Oxygen deficiency results in increased activity of PRKCE protein] CTD PMID:17087917 NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:13,718,050...14,204,288
JBrowse link
G Slc5a3 solute carrier family 5 member 3 multiple interactions ISO myxothiazol inhibits the reaction [Sodium Chloride results in increased expression of SLC5A3 mRNA] CTD PMID:23867654 NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157
JBrowse link
G Slc6a12 solute carrier family 6 member 12 multiple interactions ISO myxothiazol inhibits the reaction [Sodium Chloride results in increased expression of SLC6A12 mRNA] CTD PMID:16303854 NCBI chr 4:156,257,518...156,275,870
Ensembl chr 4:156,254,208...156,275,879
JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions ISO myxothiazol inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA] CTD PMID:11264281 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO myxothiazol inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA] CTD PMID:11264281 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
G Ucp2 uncoupling protein 2 increases expression ISO myxothiazol results in increased expression of UCP2 protein CTD PMID:18082129 NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743
JBrowse link
G Ulk1 unc-51 like autophagy activating kinase 1 increases expression ISO myxothiazol results in increased expression of ULK1 protein CTD PMID:27629431 NCBI chr12:51,511,492...51,537,746
Ensembl chr12:51,511,492...51,537,746
JBrowse link
N-succinylsulfathiazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ddit4 DNA-damage-inducible transcript 4 multiple interactions
increases expression
ISO [Folic Acid deficiency co-treated with succinylsulfathiazole] results in decreased expression of DDIT4 protein
succinylsulfathiazole results in increased expression of DDIT4 protein
CTD PMID:33957263 NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037
JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 decreases phosphorylation ISO succinylsulfathiazole results in decreased phosphorylation of EIF4EBP1 protein CTD PMID:33957263 NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874
JBrowse link
G Mtor mechanistic target of rapamycin kinase decreases phosphorylation ISO succinylsulfathiazole results in decreased phosphorylation of MTOR protein CTD PMID:33957263 NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
JBrowse link
G Pdpk1 3-phosphoinositide dependent protein kinase-1 multiple interactions
decreases expression
ISO Folic Acid deficiency inhibits the reaction [succinylsulfathiazole results in decreased expression of PDPK1 protein] CTD PMID:33957263 NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,610,063...13,679,181
JBrowse link
nizatidine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Calca calcitonin-related polypeptide alpha increases expression ISO Nizatidine results in increased expression of CALCA protein CTD PMID:12495560 NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
JBrowse link
G Tac1 tachykinin, precursor 1 increases expression ISO Nizatidine results in increased expression of TAC1 protein CTD PMID:12495560 NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:36,645,571...36,653,546
JBrowse link
ritonavir term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP binding cassette subfamily B member 11 decreases activity
multiple interactions
ISO Ritonavir results in decreased activity of ABCB11 protein
Ritonavir inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
CTD PMID:20829430 PMID:22646477 PMID:23956101 PMID:24014644 PMID:28437613 More... NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581
JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions ISO hyperforin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; hypericin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; kaempferol inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir]; Quercetin inhibits the reaction [ABCB1 protein results in increased secretion of Ritonavir] CTD PMID:15266218 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 decreases expression
decreases activity
ISO Ritonavir results in decreased expression of ABCB4
Ritonavir results in decreased activity of ABCB4 protein
CTD PMID:26626330 PMID:28437613 NCBI chr 4:26,106,895...26,164,440 JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 decreases activity ISO Ritonavir results in decreased activity of ABCC3 protein CTD PMID:39023798 NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 decreases activity ISO Ritonavir results in decreased activity of ABCC4 protein CTD PMID:39023798 NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 affects expression EXP Ritonavir affects the expression of ACSS2 mRNA CTD PMID:17719200 NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing decreases expression
multiple interactions
ISO Ritonavir results in decreased expression of ADIPOQ mRNA; Ritonavir results in decreased expression of ADIPOQ protein
rosiglitazone inhibits the reaction [Ritonavir results in decreased secretion of ADIPOQ protein]
diphenyleneiodonium inhibits the reaction [Ritonavir results in decreased expression of ADIPOQ protein]
CTD PMID:15865214 PMID:17668557 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation ISO Ritonavir results in increased phosphorylation of AKT1 protein CTD PMID:36198369 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
JBrowse link
G Alb albumin affects binding ISO Ritonavir binds to ALB protein CTD PMID:15814459 PMID:16336266 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
JBrowse link
G Bak1 BCL2-antagonist/killer 1 increases expression ISO Ritonavir results in increased expression of BAK1 protein CTD PMID:19386116 NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974
JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression ISO Ritonavir results in decreased expression of BCL2 protein CTD PMID:19386116 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Bcl2l1 Bcl2-like 1 decreases expression ISO Ritonavir results in decreased expression of BCL2L1 mRNA CTD PMID:16174765 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 decreases expression ISO Ritonavir results in decreased expression of BIRC5 mRNA; Ritonavir results in decreased expression of BIRC5 protein CTD PMID:16174765 PMID:21270666 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
JBrowse link
G Casp1 caspase 1 decreases expression ISO Ritonavir results in decreased expression of CASP1 protein CTD PMID:10551732 NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
JBrowse link
G Casp3 caspase 3 decreases activity ISO Ritonavir results in decreased activity of CASP3 protein CTD PMID:10551732 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases expression
increases secretion
decreases expression
ISO diphenyleneiodonium inhibits the reaction [Ritonavir results in increased expression of CCL2 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased secretion of CCL2 protein]
Ritonavir results in decreased expression of CCL2
CTD PMID:17668557 PMID:20884875 PMID:26626330 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
JBrowse link
G Ccl20 C-C motif chemokine ligand 20 decreases expression ISO Ritonavir results in decreased expression of CCL20 CTD PMID:26626330 NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 decreases expression
increases expression
ISO Ritonavir results in decreased expression of CCL3
Ritonavir results in increased expression of CCL3 protein
CTD PMID:17668557 PMID:26626330 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
JBrowse link
G Ccl4 C-C motif chemokine ligand 4 decreases expression ISO Ritonavir results in decreased expression of CCL4 CTD PMID:26626330 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722
JBrowse link
G Ccna2 cyclin A2 decreases expression ISO Ritonavir results in decreased expression of CCNA2 mRNA CTD PMID:19386116 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
JBrowse link
G Ccnb1 cyclin B1 decreases expression ISO Ritonavir results in decreased expression of CCNB1 mRNA CTD PMID:19386116 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
JBrowse link
G Ccnd1 cyclin D1 decreases expression ISO Ritonavir results in decreased expression of CCND1 protein CTD PMID:16551874 PMID:21270666 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
JBrowse link
G Ccnd2 cyclin D2 decreases expression ISO Ritonavir results in decreased expression of CCND2 mRNA CTD PMID:16174765 PMID:19386116 NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301
Ensembl chr 4:161,653,048...161,680,301
JBrowse link
G Ccne2 cyclin E2 decreases expression ISO Ritonavir results in decreased expression of CCNE2 mRNA CTD PMID:19386116 NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:29,082,703...29,094,882
JBrowse link
G Cdk2 cyclin dependent kinase 2 decreases expression ISO Ritonavir results in decreased expression of CDK2 mRNA; Ritonavir results in decreased expression of CDK2 protein CTD PMID:16551874 PMID:19386116 NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
JBrowse link
G Cdk4 cyclin-dependent kinase 4 decreases expression ISO Ritonavir results in decreased expression of CDK4 mRNA; Ritonavir results in decreased expression of CDK4 protein CTD PMID:16551874 PMID:19386116 NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
JBrowse link
G Cdk5 cyclin-dependent kinase 5 decreases expression ISO Ritonavir results in decreased expression of CDK5 mRNA CTD PMID:19386116 NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777
JBrowse link
G Cdk6 cyclin-dependent kinase 6 decreases expression ISO Ritonavir results in decreased expression of CDK6 mRNA; Ritonavir results in decreased expression of CDK6 protein CTD PMID:16551874 PMID:19386116 NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
multiple interactions
ISO Ritonavir results in increased expression of CDKN1A mRNA; Ritonavir results in increased expression of CDKN1A protein
manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Ritonavir results in increased expression of CDKN1A protein]
CTD PMID:19386116 PMID:20884875 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B increases expression ISO Ritonavir results in increased expression of CDKN1B mRNA CTD PMID:19386116 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
JBrowse link
G Cdkn2b cyclin-dependent kinase inhibitor 2B increases expression ISO Ritonavir results in increased expression of CDKN2B mRNA CTD PMID:19386116 NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha multiple interactions ISO Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CEBPA protein] CTD PMID:11101056 NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
JBrowse link
G Ciita class II, major histocompatibility complex, transactivator increases expression ISO Ritonavir results in increased expression of CIITA CTD PMID:26626330 NCBI chr10:5,646,854...5,694,393
Ensembl chr10:5,647,085...5,694,342
JBrowse link
G Crot carnitine O-octanoyltransferase decreases expression EXP Ritonavir results in decreased expression of CROT mRNA CTD PMID:17719200 NCBI chr 4:26,031,729...26,088,057
Ensembl chr 4:26,052,516...26,088,064
JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 decreases expression ISO Ritonavir results in decreased expression of CXCL1 CTD PMID:26626330 NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 decreases expression ISO Ritonavir results in decreased expression of CXCL10 CTD PMID:26626330 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 decreases expression ISO Ritonavir results in decreased expression of CXCL12 CTD PMID:26626330 NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 decreases expression ISO Ritonavir results in decreased expression of CXCL2 CTD PMID:26626330 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression ISO Ritonavir results in decreased expression of CXCL1 CTD PMID:26626330 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
JBrowse link
G Cxcl6 C-X-C motif chemokine ligand 6 decreases expression ISO Ritonavir results in decreased expression of CXCL6 CTD PMID:26626330 NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,594,959...17,596,417
JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 affects expression EXP Ritonavir affects the expression of CYB5R3 mRNA CTD PMID:17719200 NCBI chr 7:116,186,729...116,204,290
Ensembl chr 7:116,186,729...116,204,306
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression
decreases activity
ISO Ritonavir results in increased expression of CYP1A1 mRNA
Ritonavir results in decreased activity of CYP1A1 protein
CTD PMID:11918509 PMID:33814510 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases expression
decreases expression
ISO
EXP
Ritonavir results in increased expression of CYP1A2 mRNA
Ritonavir results in decreased expression of CYP1A2 mRNA
CTD PMID:11918509 PMID:17719200 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 decreases activity ISO Ritonavir results in decreased activity of CYP1B1 protein CTD PMID:33814510 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases activity
increases expression
ISO Ritonavir results in increased activity of CYP2B6 protein
Ritonavir results in increased expression of CYP2B6 protein
CTD PMID:14977870 PMID:26626330 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 increases expression ISO Ritonavir results in increased expression of CYP2C19 mRNA CTD PMID:11918509 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
JBrowse link
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 decreases activity ISO Ritonavir results in decreased activity of CYP2C8 protein CTD PMID:15601807
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 affects metabolic processing ISO CYP2D6 protein affects the metabolism of Ritonavir CTD PMID:15286053 NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression
decreases activity
affects binding
affects metabolic processing
ISO Ritonavir results in increased expression of CYP3A4 mRNA
Ritonavir results in decreased activity of CYP3A4 protein
CYP3A4 protein binds to Ritonavir analog
CYP3A4 protein affects the metabolism of Ritonavir
CTD PMID:15286053 PMID:15523003 PMID:15860655 PMID:16837568 PMID:26626330 More... NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 increases expression EXP Ritonavir results in increased expression of CYP3A23-3A1 mRNA CTD PMID:17719200 NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813
JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 decreases activity ISO Ritonavir results in decreased activity of CYP3A5 protein CTD PMID:15523003 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
JBrowse link
G Cyp4a3 cytochrome P450, family 4, subfamily a, polypeptide 3 decreases expression EXP Ritonavir results in decreased expression of CYP4A3 mRNA CTD PMID:17719200 NCBI chr 5:134,334,396...134,352,268
Ensembl chr 5:134,334,701...134,352,236
JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 affects expression
decreases expression
EXP Ritonavir affects the expression of CYP4B1 mRNA
Ritonavir results in decreased expression of CYP4B1 mRNA
CTD PMID:17719200 NCBI chr 5:134,375,807...134,413,635
Ensembl chr 5:134,375,807...134,393,116
JBrowse link
G Cyp51 cytochrome P450, family 51 increases expression EXP Ritonavir results in increased expression of CYP51 mRNA CTD PMID:17719200 NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450
JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 decreases expression ISO
EXP
Ritonavir results in decreased expression of CYP7A1 mRNA CTD PMID:17719200 PMID:26626330 NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
JBrowse link
G Cyp8b1 cytochrome P450 family 8 subfamily B member 1 decreases expression ISO
EXP
Ritonavir results in decreased expression of CYP8B1
Ritonavir results in decreased expression of CYP8B1 mRNA
CTD PMID:17719200 PMID:26626330 NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689
JBrowse link
G Dhcr7 7-dehydrocholesterol reductase affects expression EXP Ritonavir affects the expression of DHCR7 mRNA CTD PMID:17719200 NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382
JBrowse link
G E2f1 E2F transcription factor 1 decreases expression ISO Ritonavir results in decreased expression of E2F1 mRNA; Ritonavir results in decreased expression of E2F1 protein CTD PMID:19386116 NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563
JBrowse link
G E2f2 E2F transcription factor 2 decreases expression ISO Ritonavir results in decreased expression of E2F2 mRNA CTD PMID:19386116 NCBI chr 5:153,682,789...153,706,087
Ensembl chr 5:153,682,789...153,706,087
JBrowse link
G E2f3 E2F transcription factor 3 decreases expression ISO Ritonavir results in decreased expression of E2F3 mRNA CTD PMID:19386116 NCBI chr17:34,810,355...34,887,725
Ensembl chr17:34,809,998...34,887,725
JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase affects expression EXP Ritonavir affects the expression of EHHADH mRNA CTD PMID:17719200 NCBI chr11:92,746,409...92,779,647
Ensembl chr11:92,746,420...92,779,662
JBrowse link
G Esr1 estrogen receptor 1 decreases expression ISO Ritonavir results in decreased expression of ESR1 protein CTD PMID:16551874 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
JBrowse link
G Faslg Fas ligand decreases expression ISO Ritonavir results in decreased expression of FASLG protein CTD PMID:10551732 NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
JBrowse link
G Fasn fatty acid synthase affects expression EXP Ritonavir affects the expression of FASN mRNA CTD PMID:17719200 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
JBrowse link
G Fgf19 fibroblast growth factor 19 increases expression ISO Ritonavir results in increased expression of FGF19 mRNA CTD PMID:26626330 NCBI chr 1:209,485,813...209,490,267
Ensembl chr 1:209,485,813...209,490,267
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression ISO Ritonavir results in increased expression of FOS protein CTD PMID:15504750 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
JBrowse link
G Glb1 galactosidase, beta 1 multiple interactions
increases activity
ISO Acetylcysteine inhibits the reaction [Ritonavir results in increased activity of GLB1 protein]; FTI 277 inhibits the reaction [Ritonavir results in increased activity of GLB1 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Ritonavir results in increased activity of GLB1 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased activity of GLB1 protein] CTD PMID:20884875 NCBI chr 8:122,963,718...123,036,326
Ensembl chr 8:122,963,718...123,036,326
JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 multiple interactions ISO Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of GPD1 protein] CTD PMID:11101056 NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:132,721,915...132,730,368
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
increases expression
ISO 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Bilirubin inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; HMOX1 protein inhibits the reaction [Ritonavir results in increased expression of ICAM1 protein]; NFE2L2 protein mutant form inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]; Ritonavir promotes the reaction [Atazanavir Sulfate results in increased expression of HMOX1 mRNA]; Ritonavir promotes the reaction [HMOX1 protein results in increased chemical synthesis of Bilirubin]; Ritonavir promotes the reaction [Lopinavir results in increased expression of HMOX1 mRNA]; Rotenone inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [Ritonavir results in increased expression of HMOX1 protein]; tricarbonyldichlororuthenium (II) dimer promotes the reaction [Ritonavir results in increased expression of HMOX1 protein]
Ritonavir results in increased expression of HMOX1 mRNA; Ritonavir results in increased expression of HMOX1 protein
CTD PMID:15504750 PMID:26968795 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
JBrowse link
G Hsp90aa1 heat shock protein 90 alpha family class A member 1 affects response to substance ISO HSP90AA1 protein affects the susceptibility to Ritonavir CTD PMID:16551874 NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499
JBrowse link
G Hsph1 heat shock protein family H (Hsp110) member 1 increases expression ISO Ritonavir results in increased expression of HSPH1 protein CTD PMID:26626330 NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891
JBrowse link
G Icam1 intercellular adhesion molecule 1 increases expression
multiple interactions
ISO Ritonavir results in increased expression of ICAM1 protein
HMOX1 protein inhibits the reaction [Ritonavir results in increased expression of ICAM1 protein]
CTD PMID:26968795 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
JBrowse link
G Ifng interferon gamma multiple interactions ISO Ritonavir inhibits the reaction [IFNG protein results in increased secretion of TNF protein] CTD PMID:10551732 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression
increases secretion
ISO diphenyleneiodonium inhibits the reaction [Ritonavir results in increased expression of IL6 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased secretion of IL6 protein]; Ritonavir inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]
rosiglitazone inhibits the reaction [Ritonavir results in increased expression of IL6 mRNA]
Ritonavir results in increased expression of IL6 mRNA; Ritonavir results in increased expression of IL6 protein
CTD PMID:15388451 PMID:15865214 PMID:17668557 PMID:20884875 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
JBrowse link
G Il7 interleukin 7 decreases expression ISO Ritonavir results in decreased expression of IL7 CTD PMID:26626330 NCBI chr 2:96,142,523...96,186,282
Ensembl chr 2:96,142,092...96,187,389
JBrowse link
G Ins1 insulin 1 multiple interactions ISO Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CEBPA protein]; Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein]; Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of GPD1 protein]; Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SREBF1 protein] CTD PMID:11101056 NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression ISO Ritonavir results in increased expression of JUN protein CTD PMID:15504750 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
JBrowse link
G Lep leptin multiple interactions
decreases expression
ISO diphenyleneiodonium inhibits the reaction [Ritonavir results in decreased expression of LEP protein] CTD PMID:17668557 NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
JBrowse link
G Lif LIF, interleukin 6 family cytokine decreases expression ISO Ritonavir results in decreased expression of LIF CTD PMID:26626330 NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053
JBrowse link
G Lmna lamin A/C increases expression
increases farnesylation
ISO Ritonavir results in increased expression of LMNA protein
Ritonavir results in increased farnesylation of LMNA protein alternative form
CTD PMID:18230615 PMID:20884875 NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:176,237,564...176,288,072
JBrowse link
G Lpl lipoprotein lipase affects expression ISO Ritonavir affects the expression of LPL mRNA CTD PMID:11741158 NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor decreases expression ISO Ritonavir results in decreased expression of MYC mRNA CTD PMID:16174765 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases expression
multiple interactions
ISO Ritonavir results in increased expression of NFE2L2 protein
NFE2L2 protein mutant form inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA]
CTD PMID:26968795 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 decreases activity ISO Ritonavir results in decreased activity of NFKB1 protein CTD PMID:16174765 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
JBrowse link
G Nfkbia NFKB inhibitor alpha decreases phosphorylation ISO Ritonavir results in decreased phosphorylation of NFKBIA protein CTD PMID:16174765 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
JBrowse link
G Nlrc5 NLR family, CARD domain containing 5 decreases expression ISO Ritonavir results in decreased expression of NLRC5 CTD PMID:26626330 NCBI chr19:10,483,601...10,587,223
Ensembl chr19:10,483,755...10,555,786
JBrowse link
G Nos3 nitric oxide synthase 3 multiple interactions
decreases expression
ISO Masoprocol inhibits the reaction [Ritonavir results in decreased expression of NOS3 mRNA] CTD PMID:22037733 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
JBrowse link
G Notch4 notch receptor 4 decreases expression
multiple interactions
EXP Ritonavir results in decreased expression of NOTCH4 protein
[Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of NOTCH4 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]
CTD PMID:20722969 NCBI chr20:4,164,969...4,189,072
Ensembl chr20:4,161,730...4,189,072
JBrowse link
G Nr1h3 nuclear receptor subfamily 1, group H, member 3 increases expression ISO Ritonavir increases expression of NR1H3 mRNA in macrophages RGD PMID:18849545 RGD:401842387 NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:97,614,616...97,624,532
JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 increases expression ISO Ritonavir results in increased expression of NR1H4 mRNA CTD PMID:26626330 NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:25,733,471...25,829,389
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions
increases activity
ISO
EXP
Ritonavir binds to and results in increased activity of NR1I2 protein
Ritonavir results in increased activity of NR1I2 protein
CTD PMID:14977870 PMID:15849716 PMID:27732639 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage ISO Ritonavir results in increased cleavage of PARP1 protein CTD PMID:19386116 PMID:21270666 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
JBrowse link
G Pon1 paraoxonase 1 decreases activity EXP Ritonavir results in decreased activity of PON1 protein CTD PMID:27378623 NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions
increases expression
ISO Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein]
Ritonavir results in increased expression of PPARG mRNA
CTD PMID:11101056 PMID:17879945 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
JBrowse link
G Prkca protein kinase C, alpha multiple interactions
increases activity
increases expression
ISO Ritonavir binds to and affects the localization of PRKCA protein
Ritonavir results in increased activity of PRKCA protein
Ritonavir results in increased expression of PRKCA protein
CTD PMID:22020176 NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572
JBrowse link
G Psma1 proteasome 20S subunit alpha 1 affects expression EXP Ritonavir affects the expression of PSMA1 mRNA CTD PMID:17719200 NCBI chr 1:177,876,838...177,887,857
Ensembl chr 1:177,875,353...177,887,949
JBrowse link
G Psmb3 proteasome 20S subunit beta 3 affects expression EXP Ritonavir affects the expression of PSMB3 mRNA CTD PMID:17719200 NCBI chr10:83,193,787...83,200,883
Ensembl chr10:83,193,787...83,200,883
JBrowse link
G Psmb5 proteasome 20S subunit beta 5 increases expression EXP Ritonavir results in increased expression of PSMB5 mRNA CTD PMID:20213465 NCBI chr15:32,042,784...32,047,379
Ensembl chr15:32,042,787...32,047,379
JBrowse link
G Rb1 RB transcriptional corepressor 1 decreases phosphorylation
increases expression
ISO Ritonavir results in decreased phosphorylation of RB1 protein
Ritonavir results in increased expression of RB1 mRNA
CTD PMID:16551874 PMID:19386116 PMID:21270666 NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857
JBrowse link
G Rbl1 RB transcriptional corepressor like 1 increases expression ISO Ritonavir results in increased expression of RBL1 mRNA CTD PMID:19386116 NCBI chr 3:166,226,187...166,289,862
Ensembl chr 3:166,226,198...166,289,376
JBrowse link
G Rbl2 RB transcriptional corepressor like 2 decreases expression ISO Ritonavir results in decreased expression of RBL2 mRNA CTD PMID:19386116 NCBI chr19:32,049,690...32,096,467
Ensembl chr19:32,049,691...32,096,411
JBrowse link
G Rel REL proto-oncogene, NF-kB subunit decreases activity ISO Ritonavir results in decreased activity of REL protein CTD PMID:16174765 NCBI chr14:101,891,238...101,922,324
Ensembl chr14:101,891,243...101,921,938
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit decreases activity ISO Ritonavir results in decreased activity of RELA protein CTD PMID:16174765 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
JBrowse link
G Scarb1 scavenger receptor class B, member 1 multiple interactions
increases expression
ISO Estradiol inhibits the reaction [Ritonavir results in increased expression of SCARB1 protein]
Ritonavir results in increased expression of SCARB1 mRNA
CTD PMID:17879945 NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980
JBrowse link
G Scp2 sterol carrier protein 2 decreases expression ISO Ritonavir results in decreased expression of SCP2 CTD PMID:26626330 NCBI chr 5:128,035,714...128,110,015
Ensembl chr 5:128,008,125...128,110,043
JBrowse link
G Slc10a1 solute carrier family 10 member 1 decreases expression ISO Ritonavir results in decreased expression of SLC10A1 CTD PMID:26626330 NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944
JBrowse link
G Slc51a solute carrier family 51 member A decreases expression ISO Ritonavir results in decreased expression of SLC51A CTD PMID:26626330 NCBI chr11:81,804,141...81,818,539
Ensembl chr11:81,803,972...81,818,539
JBrowse link
G Slco1b2 solute carrier organic anion transporter family member 1B2 decreases activity ISO Ritonavir results in decreased activity of SLCO1B3 protein CTD PMID:39023798 NCBI chr 4:176,282,577...176,355,557
Ensembl chr 4:176,282,584...176,351,083
JBrowse link
G Slco4c1 solute carrier organic anion transporter family, member 4C1 multiple interactions ISO Ritonavir inhibits the reaction [SLCO4C1 protein affects the transport of traumatic acid] CTD PMID:39041788 NCBI chr 9:104,624,802...104,676,462
Ensembl chr 9:104,624,802...104,676,462
JBrowse link
G Src SRC proto-oncogene, non-receptor tyrosine kinase decreases phosphorylation ISO Ritonavir results in decreased phosphorylation of SRC protein CTD PMID:21270666 NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 multiple interactions ISO Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SREBF1 protein] CTD PMID:11101056 NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
JBrowse link
G Stat3 signal transducer and activator of transcription 3 decreases phosphorylation ISO Ritonavir results in decreased phosphorylation of STAT3 protein CTD PMID:21270666 NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
JBrowse link
G Tjp1 tight junction protein 1 decreases expression
multiple interactions
EXP Ritonavir results in decreased expression of TJP1 protein
[Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of TJP1 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of TJP1 protein]
CTD PMID:20722969 NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158
JBrowse link
G Tnf tumor necrosis factor decreases secretion
multiple interactions
increases expression
ISO Ritonavir results in decreased secretion of TNF protein
rosiglitazone inhibits the reaction [Ritonavir results in increased expression of TNF mRNA]
Ritonavir inhibits the reaction [IFNG protein results in increased secretion of TNF protein]; Ritonavir inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
Ritonavir results in increased expression of TNF mRNA; Ritonavir results in increased expression of TNF protein
CTD PMID:10551732 PMID:15388451 PMID:15865214 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases expression
ISO FTI 277 inhibits the reaction [Ritonavir results in increased expression of TP53 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Ritonavir results in increased expression of TP53 protein]; Pravastatin inhibits the reaction [Ritonavir results in increased expression of TP53 protein] CTD PMID:19386116 PMID:20884875 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 affects expression ISO Ritonavir affects the expression of UGT1A1 mRNA CTD PMID:15849716 NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264
JBrowse link
G Zmpste24 zinc metallopeptidase STE24 decreases activity ISO Ritonavir results in decreased activity of ZMPSTE24 protein CTD PMID:18230615 NCBI chr 5:139,912,395...139,945,532
Ensembl chr 5:139,913,671...139,945,532
JBrowse link
thiabendazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G 1700012B07Rikl RIKEN cDNA 1700012B07 gene like multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of 1700012B07RIKL gene CTD PMID:33854195 NCBI chr10:95,271,034...95,304,337
Ensembl chr10:95,268,422...95,304,315
JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A decreases expression ISO Thiabendazole results in decreased expression of ABCB1 mRNA CTD PMID:39207506 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 increases expression ISO Thiabendazole results in increased expression of ABCC2 mRNA CTD PMID:39207506 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
JBrowse link
G Acot2 acyl-CoA thioesterase 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ACOT2 gene CTD PMID:33854195 NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:109,342,646...109,350,502
JBrowse link
G Acot4 acyl-CoA thioesterase 4 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACOT4 mRNA CTD PMID:33854195 NCBI chr 6:109,399,032...109,405,138
Ensembl chr 6:109,399,578...109,405,138
JBrowse link
G Acy1 aminoacylase 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACY1 mRNA CTD PMID:33854195 NCBI chr 8:115,951,068...115,956,471
Ensembl chr 8:115,951,068...115,956,405
JBrowse link
G Adam15 ADAM metallopeptidase domain 15 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAM15 gene CTD PMID:33854195 NCBI chr 2:177,052,363...177,062,879
Ensembl chr 2:177,052,363...177,062,849
JBrowse link
G Adamtsl3 ADAMTS-like 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene CTD PMID:33854195 NCBI chr 1:145,698,004...146,006,195
Ensembl chr 1:145,698,004...146,006,195
JBrowse link
G Adcy6 adenylate cyclase 6 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ADCY6 mRNA CTD PMID:33854195 NCBI chr 7:131,621,860...131,642,923
Ensembl chr 7:131,621,860...131,642,770
JBrowse link
G Adrm1 ADRM1 26S proteasome ubiquitin receptor multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ADRM1 mRNA CTD PMID:33854195 NCBI chr 3:187,643,043...187,647,805
Ensembl chr 3:187,642,654...187,648,483
JBrowse link
G Afp alpha-fetoprotein multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of AFP mRNA CTD PMID:33854195 NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649
JBrowse link
G Agt angiotensinogen multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of AGT mRNA CTD PMID:33854195 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
JBrowse link
G Aig1 androgen-induced 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of AIG1 gene CTD PMID:33854195 NCBI chr 1:9,866,546...10,089,454
Ensembl chr 1:9,866,548...10,089,155
JBrowse link
G Akap8 A-kinase anchoring protein 8 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of AKAP8 mRNA CTD PMID:33854195 NCBI chr 7:11,966,769...11,983,056
Ensembl chr 7:11,966,772...11,982,900
JBrowse link
G Akap8l A-kinase anchoring protein 8 like multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of AKAP8L mRNA CTD PMID:33854195 NCBI chr 7:11,983,215...12,012,843
Ensembl chr 7:11,982,721...12,012,811
JBrowse link
G Alb albumin decreases expression EXP Thiabendazole results in decreased expression of ALB mRNA CTD PMID:18539377 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
JBrowse link
G Aldh9a1 aldehyde dehydrogenase 9 family, member A1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALDH9A1 mRNA CTD PMID:33854195 NCBI chr13:82,038,679...82,055,478
Ensembl chr13:82,038,533...82,055,481
JBrowse link
G Alg2 ALG2, alpha-1,3/1,6-mannosyltransferase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALG2 mRNA CTD PMID:33854195 NCBI chr 5:66,564,328...66,568,887
Ensembl chr 5:66,564,330...66,568,887
JBrowse link
G Angptl4 angiopoietin-like 4 multiple interactions
increases expression
EXP
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANGPTL4 mRNA
Thiabendazole results in increased expression of ANGPTL4 mRNA
CTD PMID:33854195 PMID:39207506 NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681
JBrowse link
G Anks3 ankyrin repeat and sterile alpha motif domain containing 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ANKS3 mRNA CTD PMID:33854195 NCBI chr10:11,121,504...11,142,261
Ensembl chr10:11,121,553...11,142,491
JBrowse link
G Anxa11 annexin A11 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANXA11 mRNA CTD PMID:33854195 NCBI chr16:1,419,627...1,464,590
Ensembl chr16:1,418,351...1,464,839
JBrowse link
G Aplf aprataxin and PNKP like factor multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of APLF mRNA CTD PMID:33854195 NCBI chr 4:121,627,800...121,679,980
Ensembl chr 4:121,627,800...121,679,961
JBrowse link
G Apof apolipoprotein F multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of APOF mRNA CTD PMID:33854195 NCBI chr 7:1,285,222...1,286,659
Ensembl chr 7:1,285,222...1,286,659
JBrowse link
G Arf2 ADP-ribosylation factor 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ARF2 mRNA CTD PMID:33854195 NCBI chr10:89,367,843...89,389,644
Ensembl chr10:89,368,044...89,389,651
JBrowse link
G Arpc1a actin related protein 2/3 complex, subunit 1A multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ARPC1A gene CTD PMID:33854195 NCBI chr12:14,616,245...14,639,052
Ensembl chr12:14,616,248...14,639,052
JBrowse link
G Asb7 ankyrin repeat and SOCS box-containing 7 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA CTD PMID:33854195 NCBI chr 1:129,621,462...129,677,788
Ensembl chr 1:129,635,330...129,677,505
JBrowse link
G Ass1 argininosuccinate synthase 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ASS1 mRNA CTD PMID:33854195 NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627
JBrowse link
G Atosa atos homolog A multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ATOSA mRNA CTD PMID:33854195 NCBI chr 8:84,575,360...84,653,103
Ensembl chr 8:84,575,370...84,653,091
JBrowse link
G Atp5mc1 ATP synthase membrane subunit c locus 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP5MC1 mRNA CTD PMID:33854195 NCBI chr10:81,520,762...81,523,735
Ensembl chr10:81,520,765...81,523,363
JBrowse link
G Atp6v0d1 ATPase H+ transporting V0 subunit D1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP6V0D1 mRNA CTD PMID:33854195 NCBI chr19:50,313,268...50,357,248
Ensembl chr19:50,313,273...50,357,395
JBrowse link
G Bag3 BAG cochaperone 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BAG3 mRNA CTD PMID:33854195 NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280
JBrowse link
G Banp Btg3 associated nuclear protein multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BANP mRNA CTD PMID:33854195 NCBI chr19:66,916,417...66,994,286
Ensembl chr19:66,916,267...66,991,317
JBrowse link
G Bcl9 BCL9, transcription coactivator multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of BCL9 mRNA CTD PMID:33854195 NCBI chr 2:187,449,425...187,475,241
Ensembl chr 2:187,449,425...187,475,241
JBrowse link
G Bhmt betaine-homocysteine S-methyltransferase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BHMT mRNA CTD PMID:33854195 NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:26,594,854...26,614,715
JBrowse link
G C1qc complement C1q C chain multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C1QC mRNA CTD PMID:33854195 NCBI chr 5:154,410,845...154,414,208
Ensembl chr 5:154,410,848...154,414,468
JBrowse link
G C8h11orf54 similar to human chromosome 11 open reading frame 54 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C8H11ORF54 mRNA CTD PMID:33854195 NCBI chr 8:20,405,240...20,427,811
Ensembl chr 8:20,405,241...20,427,811
JBrowse link
G Camk2g calcium/calmodulin-dependent protein kinase II gamma multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CAMK2G mRNA CTD PMID:33854195 NCBI chr15:3,553,238...3,612,310
Ensembl chr15:3,553,294...3,612,310
JBrowse link
G Cap1 cyclase associated actin cytoskeleton regulatory protein 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CAP1 mRNA CTD PMID:33854195 NCBI chr 5:140,427,265...140,507,678
Ensembl chr 5:140,427,269...140,453,470
JBrowse link
G Caps2 calcyphosine 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CAPS2 mRNA CTD PMID:33854195 NCBI chr 7:49,467,320...49,525,465
Ensembl chr 7:49,464,885...49,525,465
JBrowse link
G Casp3 caspase 3 increases activity EXP Thiabendazole results in increased activity of CASP3 protein CTD PMID:26748015 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Casp8 caspase 8 increases activity EXP Thiabendazole results in increased activity of CASP8 protein CTD PMID:26748015 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
JBrowse link
G Casp9 caspase 9 increases activity EXP Thiabendazole results in increased activity of CASP9 protein CTD PMID:26748015 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cbs cystathionine beta synthase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CBS mRNA CTD PMID:33854195 NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066
JBrowse link
G Ccdc125 coiled-coil domain containing 125 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCDC125 mRNA CTD PMID:33854195 NCBI chr 2:33,542,916...33,568,501
Ensembl chr 2:33,543,300...33,568,288
JBrowse link
G Ccnd1 cyclin D1 increases expression ISO Thiabendazole results in increased expression of CCND1 mRNA CTD PMID:39207506 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
JBrowse link
G Ccnl1 cyclin L1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCNL1 mRNA CTD PMID:33854195 NCBI chr 2:152,495,169...152,508,855
Ensembl chr 2:152,495,172...152,507,468
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
multiple interactions
ISO
EXP
Thiabendazole results in increased expression of CDKN1A mRNA
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CDKN1A mRNA
CTD PMID:33854195 PMID:39207506 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
JBrowse link
G Cebpd CCAAT/enhancer binding protein delta multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CEBPD mRNA CTD PMID:33854195 NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824
JBrowse link
G Cep85 centrosomal protein 85 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CEP85 mRNA CTD PMID:33854195 NCBI chr 5:151,640,316...151,687,891
Ensembl chr 5:151,639,282...151,687,860
JBrowse link
G Cerk ceramide kinase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA CTD PMID:33854195 NCBI chr 7:119,105,674...119,149,885
Ensembl chr 7:119,105,674...119,148,570
JBrowse link
G Cfb complement factor B multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CFB mRNA CTD PMID:33854195 NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,955,776...3,981,740
JBrowse link
G Cfl1 cofilin 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CFL1 mRNA CTD PMID:33854195 NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353
JBrowse link
G Chchd10 coiled-coil-helix-coiled-coil-helix domain containing 10 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CHCHD10 mRNA CTD PMID:33854195 NCBI chr20:12,725,274...12,730,295
Ensembl chr20:12,725,277...12,745,677
JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CHEK2 mRNA CTD PMID:33854195 NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667
JBrowse link
G Chmp5 charged multivesicular body protein 5 affects expression EXP Thiabendazole affects the expression of CHMP5 mRNA CTD PMID:18539377 NCBI chr 5:60,877,369...60,894,512
Ensembl chr 5:60,877,341...60,894,511
JBrowse link
G Cirbp cold inducible RNA binding protein multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CIRBP mRNA CTD PMID:33854195 NCBI chr 7:10,184,515...10,189,623 JBrowse link
G Clcf1 cardiotrophin-like cytokine factor 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CLCF1 mRNA CTD PMID:33854195 NCBI chr 1:210,937,763...210,947,064
Ensembl chr 1:210,937,255...210,947,064
JBrowse link
G Clec2g C-type lectin domain family 2, member G multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CLEC2G mRNA CTD PMID:33854195 NCBI chr 4:164,303,865...164,313,737
Ensembl chr 4:164,300,076...164,314,591
JBrowse link
G Clu clusterin multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CLU mRNA CTD PMID:33854195 NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
JBrowse link
G Cndp2 carnosine dipeptidase 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA CTD PMID:33854195 NCBI chr18:80,314,799...80,331,900
Ensembl chr18:80,314,801...80,331,900
JBrowse link
G Cp ceruloplasmin decreases expression ISO Thiabendazole results in decreased expression of CP mRNA CTD PMID:39207506 NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087
JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CPT2 mRNA CTD PMID:33854195 NCBI chr 5:127,893,450...127,911,347
Ensembl chr 5:127,893,207...127,910,818
JBrowse link
G Cry1 cryptochrome circadian regulator 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CRY1 mRNA CTD PMID:33854195 NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:20,417,107...20,481,822
JBrowse link
G Cryab crystallin, alpha B decreases expression ISO Thiabendazole results in decreased expression of CRYAB mRNA CTD PMID:39207506 NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528
JBrowse link
G Cspp1 centrosome and spindle pole associated protein 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSPP1 mRNA CTD PMID:33854195 NCBI chr 5:13,860,072...13,975,299
Ensembl chr 5:13,860,072...13,975,321
JBrowse link
G Csrnp1 cysteine and serine rich nuclear protein 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSRNP1 mRNA CTD PMID:33854195 NCBI chr 8:128,582,364...128,594,163
Ensembl chr 8:128,582,365...128,588,469
JBrowse link
G Cth cystathionine gamma-lyase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of CTH gene CTD PMID:33854195 NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066
JBrowse link
G Ctnnal1 catenin alpha-like 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CTNNAL1 mRNA CTD PMID:33854195 NCBI chr 5:76,309,546...76,375,869
Ensembl chr 5:76,309,546...76,364,637
JBrowse link
G Cux2 cut-like homeobox 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA CTD PMID:33854195 NCBI chr12:40,168,402...40,368,303
Ensembl chr12:40,149,292...40,366,528
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
increases activity
EXP
ISO
herbimycin inhibits the reaction [Thiabendazole results in increased activity of CYP1A1 protein]; herbimycin inhibits the reaction [Thiabendazole results in increased expression of CYP1A1 mRNA]; herbimycin inhibits the reaction [Thiabendazole results in increased expression of CYP1A1 protein]
Thiabendazole results in increased expression of CYP1A1 mRNA; Thiabendazole results in increased expression of CYP1A1 protein
CTD PMID:8900397 PMID:10103034 PMID:11226373 PMID:14987951 PMID:15110098 More... NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
increases expression
affects metabolic processing
decreases activity
ISO
EXP
beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole]
Thiabendazole results in increased expression of CYP1A2 mRNA; Thiabendazole results in increased expression of CYP1A2 protein
Thiabendazole results in decreased activity of CYP1A2 protein
CTD PMID:10936227 PMID:11124226 PMID:12920490 PMID:15110098 PMID:16261361 More... NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases expression EXP Thiabendazole results in increased expression of CYP2B1 mRNA; Thiabendazole results in increased expression of CYP2B1 protein CTD PMID:15110098 NCBI chr 1:90,646,098...90,669,762 JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 increases expression EXP Thiabendazole results in increased expression of CYP2B2 mRNA; Thiabendazole results in increased expression of CYP2B2 protein CTD PMID:15110098 NCBI chr 1:90,722,243...90,736,272 JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases expression ISO Thiabendazole results in increased expression of CYP2B6 mRNA CTD PMID:18570159 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2c22 cytochrome P450, family 2, subfamily c, polypeptide 22 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP2C22 mRNA CTD PMID:33854195 NCBI chr 1:248,941,143...248,980,767
Ensembl chr 1:248,904,062...248,971,182
JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 increases expression ISO Thiabendazole results in increased expression of CYP2C19 mRNA CTD PMID:39207506 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 decreases expression ISO Thiabendazole results in decreased expression of CYP2E1 mRNA CTD PMID:39207506 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression ISO Thiabendazole results in increased expression of CYP3A4 mRNA CTD PMID:18570159 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
JBrowse link
G Cyp4a1 cytochrome P450, family 4, subfamily a, polypeptide 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA CTD PMID:33854195 NCBI chr 5:134,360,096...134,374,233
Ensembl chr 5:134,360,111...134,374,231
JBrowse link
G Cyp4f1 cytochrome P450, family 4, subfamily f, polypeptide 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4F1 mRNA CTD PMID:33854195 NCBI chr 7:12,661,357...12,672,952
Ensembl chr 7:12,661,359...12,672,612
JBrowse link
G Cytip cytohesin 1 interacting protein multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CYTIP mRNA CTD PMID:33854195 NCBI chr 3:63,106,895...63,183,769
Ensembl chr 3:63,107,607...63,134,832
JBrowse link
G Dbp D-box binding PAR bZIP transcription factor multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DBP mRNA CTD PMID:33854195 NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205
JBrowse link
G Dclre1c DNA cross-link repair 1C multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DCLRE1C mRNA CTD PMID:33854195 NCBI chr17:79,684,988...79,718,399
Ensembl chr17:79,678,698...79,718,734
JBrowse link
G Ddx20 DEAD-box helicase 20 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DDX20 mRNA CTD PMID:33854195 NCBI chr 2:195,847,105...195,859,989
Ensembl chr 2:195,847,105...195,855,461
JBrowse link
G Ddx5 DEAD-box helicase 5 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DDX5 mRNA CTD PMID:33854195 NCBI chr10:92,224,393...92,231,928
Ensembl chr10:92,224,395...92,231,300
JBrowse link
G Defb1 defensin beta 1 decreases expression ISO Thiabendazole results in decreased expression of DEFB1 mRNA CTD PMID:39207506 NCBI chr16:77,001,326...77,016,068
Ensembl chr16:77,001,326...77,016,068
JBrowse link
G Dffb DNA fragmentation factor subunit beta multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DFFB mRNA CTD PMID:33854195 NCBI chr 5:169,804,873...169,817,157
Ensembl chr 5:169,804,889...169,817,225
JBrowse link
G Dlg2 discs large MAGUK scaffold protein 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DLG2 gene CTD PMID:33854195 NCBI chr 1:153,864,545...155,916,238
Ensembl chr 1:153,865,299...155,916,215
JBrowse link
G Dll1 delta like canonical Notch ligand 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DLL1 mRNA CTD PMID:33854195 NCBI chr 1:64,985,161...64,993,274
Ensembl chr 1:64,985,161...64,993,276
JBrowse link
G Dmrt3 doublesex and mab-3 related transcription factor 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DMRT3 gene CTD PMID:33854195 NCBI chr 1:232,670,642...232,690,557
Ensembl chr 1:232,675,059...232,688,833
JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA CTD PMID:33854195 NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416
JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB9 mRNA CTD PMID:33854195 NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:66,997,842...67,009,344
JBrowse link
G Dpp4 dipeptidylpeptidase 4 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DPP4 mRNA CTD PMID:33854195 NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:67,370,804...67,452,422
JBrowse link
G Dusp1 dual specificity phosphatase 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DUSP1 mRNA CTD PMID:33854195 NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644
JBrowse link
G Dusp5 dual specificity phosphatase 5 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DUSP5 gene CTD PMID:33854195 NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417
JBrowse link
G Dusp6 dual specificity phosphatase 6 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DUSP6 mRNA CTD PMID:33854195 NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833
JBrowse link
G Dzip1l DAZ interacting zinc finger protein 1-like multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DZIP1L gene CTD PMID:33854195 NCBI chr 8:109,067,466...109,108,390
Ensembl chr 8:109,067,775...109,108,393
JBrowse link
G Emilin1 elastin microfibril interfacer 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of EMILIN1 mRNA CTD PMID:33854195 NCBI chr 6:31,175,919...31,183,657
Ensembl chr 6:31,175,919...31,183,657
JBrowse link
G Enpp3 ectonucleotide pyrophosphatase/phosphodiesterase 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ENPP3 mRNA CTD PMID:33854195 NCBI chr 1:22,382,717...22,454,324
Ensembl chr 1:22,382,964...22,454,314
JBrowse link
G Epb41l3 erythrocyte membrane protein band 4.1-like 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of EPB41L3 gene CTD PMID:33854195 NCBI chr 9:116,502,864...116,707,274
Ensembl chr 9:116,462,807...116,707,274
JBrowse link
G Epm2aip1 EPM2A interacting protein 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of EPM2AIP1 mRNA CTD PMID:33854195 NCBI chr 8:120,112,265...120,119,613
Ensembl chr 8:120,112,084...120,121,458
JBrowse link
G Erf Ets2 repressor factor multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ERF mRNA CTD PMID:33854195 NCBI chr 1:89,957,760...89,966,213
Ensembl chr 1:89,957,760...89,966,213
JBrowse link
G Esd esterase D multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ESD mRNA CTD PMID:33854195 NCBI chr15:56,453,082...56,472,582
Ensembl chr15:56,453,044...56,473,508
JBrowse link
G Fam135a family with sequence similarity 135, member A multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA CTD PMID:33854195 NCBI chr 9:33,916,449...33,997,140
Ensembl chr 9:33,916,449...33,997,051
JBrowse link
G Fam177a1 family with sequence similarity 177, member A1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM177A1 gene CTD PMID:33854195 NCBI chr 6:78,367,780...78,382,703
Ensembl chr 6:78,367,780...78,392,836
JBrowse link
G Fam204a family with sequence similarity 204, member A multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA CTD PMID:33854195 NCBI chr 1:269,323,473...269,352,772
Ensembl chr 1:269,323,473...269,352,772
JBrowse link
G Fam53a family with sequence similarity 53, member A multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM53A gene CTD PMID:33854195 NCBI chr14:81,308,127...81,348,930
Ensembl chr14:81,319,375...81,348,923
JBrowse link
G Ficd FIC domain protein adenylyltransferase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of FICD mRNA CTD PMID:33854195 NCBI chr12:48,549,737...48,554,626
Ensembl chr12:48,549,737...48,554,626
JBrowse link
G Fkbp4 FKBP prolyl isomerase 4 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of FKBP4 mRNA CTD PMID:33854195 NCBI chr 4:163,389,464...163,397,918
Ensembl chr 4:163,389,464...163,397,918
JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene CTD PMID:33854195 NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118
JBrowse link
G Fmn1 formin 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FMN1 mRNA CTD PMID:33854195 NCBI chr 3:120,555,445...120,939,978
Ensembl chr 3:120,555,431...120,933,124
JBrowse link
G Fmo2 flavin containing dimethylaniline monoxygenase 2 decreases expression ISO Thiabendazole results in decreased expression of FMO2 mRNA CTD PMID:39207506 NCBI chr13:77,755,131...77,777,597
Ensembl chr13:77,757,629...77,777,534
JBrowse link
G Frmd4b FERM domain containing 4B multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FRMD4B mRNA CTD PMID:33854195 NCBI chr 4:131,452,361...131,778,734
Ensembl chr 4:131,452,365...131,640,287
JBrowse link
G Fzd6 frizzled class receptor 6 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FZD6 mRNA CTD PMID:33854195 NCBI chr 7:71,939,916...71,971,685
Ensembl chr 7:71,939,973...71,971,680
JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression EXP Thiabendazole results in increased expression of GADD45A mRNA CTD PMID:18539377 NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
JBrowse link
G Gadd45g growth arrest and DNA-damage-inducible, gamma multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GADD45G mRNA CTD PMID:33854195 NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369
JBrowse link
G Gatd3a glutamine amidotransferase class 1 domain containing 3A multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GATD3A mRNA CTD PMID:33854195 NCBI chr20:10,514,459...10,522,556
Ensembl chr20:10,514,443...10,522,555
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit increases activity
multiple interactions
ISO Thiabendazole results in increased activity of GCLC protein
[Thiabendazole co-treated with Buthionine Sulfoximine] results in increased activity of GCLC protein
CTD PMID:11019651 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
JBrowse link
G Gdf15 growth differentiation factor 15 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GDF15 mRNA CTD PMID:33854195 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
JBrowse link
G Ghr growth hormone receptor increases expression ISO Thiabendazole results in increased expression of GHR mRNA CTD PMID:39207506 NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:54,270,206...54,532,331
JBrowse link
G Gin1 gypsy retrotransposon integrase 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GIN1 mRNA CTD PMID:33854195 NCBI chr 9:105,740,914...105,762,357
Ensembl chr 9:105,742,094...105,762,357
JBrowse link
G Git2 GIT ArfGAP 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GIT2 mRNA CTD PMID:33854195 NCBI chr12:47,490,350...47,531,232
Ensembl chr12:47,490,369...47,533,250
JBrowse link
G Glb1 galactosidase, beta 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GLB1 mRNA CTD PMID:33854195 NCBI chr 8:122,963,718...123,036,326
Ensembl chr 8:122,963,718...123,036,326
JBrowse link
G Gnpda2 glucosamine-6-phosphate deaminase 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA CTD PMID:33854195 NCBI chr14:38,874,611...38,892,688
Ensembl chr14:38,874,647...38,892,683
JBrowse link
G Gprasp3 G protein-coupled receptor associated sorting protein family member 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GPRASP3 mRNA CTD PMID:33854195 NCBI chr  X:103,639,366...103,644,561
Ensembl chr  X:103,609,243...103,650,463
JBrowse link
G Gramd1a GRAM domain containing 1A multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GRAMD1A mRNA CTD PMID:33854195 NCBI chr 1:95,494,378...95,520,730
Ensembl chr 1:95,494,378...95,520,716
JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of GRIA1 gene CTD PMID:33854195 NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309
JBrowse link
G Grina glutamate ionotropic receptor NMDA type subunit associated protein 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GRINA mRNA CTD PMID:33854195 NCBI chr 7:109,842,870...109,846,048
Ensembl chr 7:109,843,196...109,846,042
JBrowse link
G Gsdma gasdermin A multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of GSDMA gene CTD PMID:33854195 NCBI chr10:84,110,590...84,135,804
Ensembl chr10:84,123,314...84,135,804
JBrowse link
G Gstk1 glutathione S-transferase kappa 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GSTK1 mRNA CTD PMID:33854195 NCBI chr 4:72,085,532...72,089,934
Ensembl chr 4:72,085,531...72,089,927
JBrowse link
G Gstp1 glutathione S-transferase pi 1 increases expression EXP Thiabendazole results in increased expression of GSTP1 mRNA CTD PMID:15110098 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
JBrowse link
G Gstt1 glutathione S-transferase theta 1 increases expression EXP Thiabendazole results in increased expression of GSTT1 mRNA CTD PMID:15110098 NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019
JBrowse link
G Hapstr2 HUWE1 associated protein modifying stress responses 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of HAPSTR2 gene CTD PMID:33854195 NCBI chr  X:143,958,364...143,960,399
Ensembl chr  X:143,958,032...143,960,240
JBrowse link
G Hars1 histidyl-tRNA synthetase 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HARS1 mRNA CTD PMID:33854195 NCBI chr18:28,655,669...28,672,712
Ensembl chr18:28,655,671...28,672,712
JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 decreases expression ISO Thiabendazole results in decreased expression of HAVCR1 mRNA CTD PMID:39207506 NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268
JBrowse link
G Hebp1 heme binding protein 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA CTD PMID:33854195 NCBI chr 4:169,705,665...169,735,199
Ensembl chr 4:169,705,668...169,735,199
JBrowse link
G Hes1 hes family bHLH transcription factor 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of HES1 mRNA CTD PMID:33854195 NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061
JBrowse link
G Hmox1 heme oxygenase 1 increases expression ISO Thiabendazole results in increased expression of HMOX1 mRNA CTD PMID:39207506 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
JBrowse link
G Hs3st3b1 heparan sulfate-glucosamine 3-sulfotransferase 3B1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HS3ST3B1 mRNA CTD PMID:33854195 NCBI chr10:49,060,693...49,093,185
Ensembl chr10:49,060,693...49,093,185
JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSD11B2 mRNA CTD PMID:33854195 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812
JBrowse link
G Hsd17b10 hydroxysteroid (17-beta) dehydrogenase 10 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSD17B10 mRNA CTD PMID:33854195 NCBI chr  X:24,568,551...24,571,012
Ensembl chr  X:24,568,551...24,574,681
JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of HSD17B2 mRNA CTD PMID:33854195 NCBI chr19:62,662,320...62,733,944
Ensembl chr19:62,662,098...62,733,943
JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPA1B mRNA CTD PMID:33854195 NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979
JBrowse link
G Hspbp1 HSPA (Hsp70) binding protein 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPBP1 mRNA CTD PMID:33854195 NCBI chr 1:78,194,067...78,217,836
Ensembl chr 1:78,189,305...78,217,835
JBrowse link
G Ier3 immediate early response 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IER3 mRNA CTD PMID:33854195 NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377
JBrowse link
G Ifna12l interferon alpha 12 like multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of IFNA12L gene CTD PMID:33854195 NCBI chr 5:108,592,149...108,593,214
Ensembl chr 5:108,541,882...108,571,940
JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 multiple interactions
increases expression
EXP
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA
Thiabendazole results in increased expression of IGFBP1 mRNA
CTD PMID:33854195 PMID:39207506 NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344
JBrowse link
G Igkv2-112l2 immunoglobulin kappa variable 2-112 like 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of IGKV2-112L2 gene CTD PMID:33854195 NCBI chr 4:103,444,658...103,445,307
Ensembl chr 4:103,766,891...103,767,229
JBrowse link
G Inpp5f inositol polyphosphate-5-phosphatase F multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA CTD PMID:33854195 NCBI chr 1:192,620,891...192,700,681
Ensembl chr 1:192,620,891...192,700,681
JBrowse link
G Iqcb1 IQ motif containing B1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IQCB1 mRNA CTD PMID:33854195 NCBI chr11:77,410,986...77,465,540
Ensembl chr11:77,410,314...77,465,478
JBrowse link
G Irf2bp2 interferon regulatory factor 2 binding protein 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IRF2BP2 mRNA CTD PMID:33854195 NCBI chr19:71,456,689...71,462,368
Ensembl chr19:71,456,689...71,462,368
JBrowse link
G Itprip inositol 1,4,5-trisphosphate receptor interacting protein multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ITPRIP mRNA CTD PMID:33854195 NCBI chr 1:256,704,087...256,727,661
Ensembl chr 1:256,699,832...256,727,644
JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of JUNB mRNA CTD PMID:33854195 NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218
JBrowse link
G Katnip katanin interacting protein multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KATNIP gene CTD PMID:33854195 NCBI chr 1:189,700,838...189,867,402
Ensembl chr 1:189,700,775...189,867,402
JBrowse link
G Khdc4 KH domain containing 4, pre-mRNA splicing factor multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of KHDC4 mRNA CTD PMID:33854195 NCBI chr 2:176,446,895...176,475,405
Ensembl chr 2:176,446,910...176,475,392
JBrowse link
G Klf10 KLF transcription factor 10 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of KLF10 mRNA CTD PMID:33854195 NCBI chr 7:71,352,612...71,358,680
Ensembl chr 7:71,350,573...71,358,948
JBrowse link
G Klf2 KLF transcription factor 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of KLF2 mRNA CTD PMID:33854195 NCBI chr16:17,555,136...17,557,768
Ensembl chr16:17,555,136...17,557,768
JBrowse link
G Klhl10 kelch-like family member 10 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KLHL10 gene CTD PMID:33854195 NCBI chr10:85,876,804...85,893,081
Ensembl chr10:85,876,783...85,893,081
JBrowse link
G Lgalsl galectin-like multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LGALSL mRNA CTD PMID:33854195 NCBI chr14:99,198,340...99,205,846
Ensembl chr14:99,198,339...99,206,487
JBrowse link
G Lhx2 LIM homeobox 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of LHX2 gene CTD PMID:33854195 NCBI chr 3:42,523,345...42,553,646
Ensembl chr 3:42,535,744...42,553,645
JBrowse link
G Litaf lipopolysaccharide-induced TNF factor multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LITAF mRNA CTD PMID:33854195 NCBI chr10:5,163,258...5,199,930
Ensembl chr10:5,163,242...5,199,930
JBrowse link
G Lnx2 ligand of numb-protein X 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LNX2 mRNA CTD PMID:33854195 NCBI chr12:13,119,139...13,184,401
Ensembl chr12:13,119,139...13,184,401
JBrowse link
G Loxl3 lysyl oxidase-like 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LOXL3 gene CTD PMID:33854195 NCBI chr 4:117,098,358...117,114,673
Ensembl chr 4:117,099,635...117,115,046
JBrowse link
G Lpcat1 lysophosphatidylcholine acyltransferase 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LPCAT1 gene CTD PMID:33854195 NCBI chr 1:31,594,621...31,644,946
Ensembl chr 1:31,594,622...31,644,946
JBrowse link
G Lpgat1 lysophosphatidylglycerol acyltransferase 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LPGAT1 gene CTD PMID:33854195 NCBI chr13:105,825,630...105,896,366
Ensembl chr13:105,820,468...105,896,364
JBrowse link
G Lpin3 lipin 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of LPIN3 mRNA CTD PMID:33854195 NCBI chr 3:169,953,479...169,978,034
Ensembl chr 3:169,960,522...169,978,031
JBrowse link
G Lta4h leukotriene A4 hydrolase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LTA4H mRNA CTD PMID:33854195 NCBI chr 7:29,856,846...29,888,642
Ensembl chr 7:29,856,802...29,888,641
JBrowse link
G Lurap1l leucine rich adaptor protein 1-like multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LURAP1L gene CTD PMID:33854195 NCBI chr 5:100,402,921...100,455,479
Ensembl chr 5:100,407,483...100,455,478
JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta increases expression ISO Thiabendazole results in increased expression of MAP1LC3B protein CTD PMID:39207506 NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358
Ensembl chr16:66,574,407...66,584,358
JBrowse link
G Mapkapk2 MAPK activated protein kinase 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MAPKAPK2 mRNA CTD PMID:33854195 NCBI chr13:45,066,027...45,112,326
Ensembl chr13:45,066,031...45,112,326
JBrowse link
G Marf1 meiosis regulator and mRNA stability factor 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MARF1 mRNA CTD PMID:33854195 NCBI chr10:1,395,271...1,439,974
Ensembl chr10:1,395,282...1,439,974
JBrowse link
G Med12l mediator complex subunit 12L multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MED12L mRNA CTD PMID:33854195 NCBI chr 2:145,403,318...145,726,317
Ensembl chr 2:145,404,375...145,723,516
JBrowse link
G Mettl14 methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA CTD PMID:33854195 NCBI chr 2:214,215,165...214,231,412
Ensembl chr 2:214,215,165...214,231,412
JBrowse link
G Mfap5 microfibril associated protein 5 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of MFAP5 gene CTD PMID:33854195 NCBI chr 4:157,399,919...157,422,448
Ensembl chr 4:157,395,597...157,422,448
JBrowse link
G Mif macrophage migration inhibitory factor multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIF mRNA CTD PMID:33854195 NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121
Ensembl chr20:134,041,774...134,042,121
JBrowse link
G Mir122 microRNA 122 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR122 mRNA CTD PMID:34626815 NCBI chr18:61,028,817...61,028,901 JBrowse link
G Mir130a microRNA 130a multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR130A mRNA CTD PMID:34626815 NCBI chr 3:90,229,228...90,229,315 JBrowse link
G Mir146a microRNA 146a multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MIR146A mRNA CTD PMID:34626815 NCBI chr10:28,349,996...28,350,090 JBrowse link
G Mir193 microRNA 193 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR193 mRNA CTD PMID:34626815 NCBI chr10:65,170,317...65,170,402 JBrowse link
G Mir22 microRNA 22 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR22 mRNA CTD PMID:34626815 NCBI chr10:60,805,331...60,805,425
Ensembl chr10:60,805,331...60,805,425
JBrowse link
G Mir32 microRNA 32 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR32 mRNA CTD PMID:34626815 NCBI chr 5:76,391,285...76,391,354 JBrowse link
G Mir33 microRNA 33 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR33 mRNA CTD PMID:34626815 NCBI chr 7:115,593,952...115,594,020
Ensembl chr 7:115,593,952...115,594,020
JBrowse link
G Mir486 microRNA 486 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MIR486 mRNA CTD PMID:34626815
G Mlycd malonyl-CoA decarboxylase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MLYCD mRNA CTD PMID:33854195 NCBI chr19:64,356,582...64,372,447
Ensembl chr19:64,356,223...64,372,446
JBrowse link
G Mocs2 molybdenum cofactor synthesis 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MOCS2 mRNA CTD PMID:33854195 NCBI chr 2:48,237,655...48,249,394
Ensembl chr 2:48,237,655...48,249,394
JBrowse link
G Morc3 MORC family CW-type zinc finger 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MORC3 mRNA CTD PMID:33854195 NCBI chr11:46,621,575...46,664,315
Ensembl chr11:46,621,548...46,664,309
JBrowse link
G Mpo myeloperoxidase increases metabolic processing ISO MPO protein results in increased metabolism of Thiabendazole metabolite CTD PMID:21513789 NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
JBrowse link
G Mrgbp MRG domain binding protein multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MRGBP mRNA CTD PMID:33854195 NCBI chr 3:188,074,695...188,078,162
Ensembl chr 3:188,074,709...188,078,153
JBrowse link
G Mrnip MRN complex interacting protein multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MRNIP mRNA CTD PMID:33854195 NCBI chr10:35,002,440...35,026,555 JBrowse link
G Mrpl44 mitochondrial ribosomal protein L44 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPL44 mRNA CTD PMID:33854195 NCBI chr 9:88,555,050...88,560,101
Ensembl chr 9:88,555,019...88,561,215
JBrowse link
G Mrps18b mitochondrial ribosomal protein S18B multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPS18B mRNA CTD PMID:33854195 NCBI chr20:2,842,978...2,849,065
Ensembl chr20:2,842,528...2,849,065
JBrowse link
G Mtarc1 mitochondrial amidoxime reducing component 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MTARC1 mRNA CTD PMID:33854195 NCBI chr13:98,854,235...98,894,208
Ensembl chr13:98,871,289...98,894,252
JBrowse link
G Myo10 myosin X multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MYO10 mRNA CTD PMID:33854195 NCBI chr 2:77,831,532...78,036,137
Ensembl chr 2:77,831,532...78,036,137
JBrowse link
G N4bp2l2 NEDD4 binding protein 2-like 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of N4BP2L2 mRNA CTD PMID:33854195 NCBI chr12:4,972,967...5,038,027
Ensembl chr12:4,972,990...5,033,405
JBrowse link
G Nae1 NEDD8 activating enzyme E1 subunit 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NAE1 mRNA CTD PMID:33854195 NCBI chr19:452,462...478,591
Ensembl chr19:452,432...478,831
JBrowse link
G Ndufb11 NADH:ubiquinone oxidoreductase subunit B11 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of NDUFB11 gene CTD PMID:33854195 NCBI chr  X:4,126,317...4,128,575
Ensembl chr  X:4,126,245...4,128,566
JBrowse link
G Nfe2 nuclear factor, erythroid 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NFE2 mRNA CTD PMID:33854195 NCBI chr 7:136,261,234...136,273,850
Ensembl chr 7:136,261,236...136,268,585
JBrowse link
G Nfil3 nuclear factor, interleukin 3 regulated multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of NFIL3 mRNA CTD PMID:33854195 NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,432,198...12,450,826
JBrowse link
G Nppb natriuretic peptide B increases expression EXP Thiabendazole results in increased expression of NPPB mRNA CTD PMID:18539377 NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310
JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR0B2 mRNA CTD PMID:33854195 NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475
JBrowse link
G Nr1d1 nuclear receptor subfamily 1, group D, member 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR1D1 mRNA CTD PMID:33854195 NCBI chr10:84,224,599...84,231,812
Ensembl chr10:84,224,540...84,231,812
JBrowse link
G Nr1d2 nuclear receptor subfamily 1, group D, member 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR1D2 mRNA CTD PMID:33854195 NCBI chr15:9,955,034...9,981,329
Ensembl chr15:9,954,906...9,981,330
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity ISO Thiabendazole results in increased activity of NR1I2 protein CTD PMID:25455453 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
JBrowse link
G Nucks1 nuclear casein kinase and cyclin-dependent kinase substrate 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of NUCKS1 mRNA CTD PMID:33854195 NCBI chr13:45,897,275...45,926,491
Ensembl chr13:45,897,248...45,923,101
JBrowse link
G Odc1 ornithine decarboxylase 1 increases expression ISO Thiabendazole results in increased expression of ODC1 mRNA CTD PMID:39207506 NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146
JBrowse link
G Olr943 olfactory receptor 943 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of OLR943 gene CTD PMID:33854195 NCBI chr 7:4,038,349...4,039,287
Ensembl chr 7:4,038,349...4,039,287
JBrowse link
G Oplah 5-oxoprolinase (ATP-hydrolysing) multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of OPLAH mRNA CTD PMID:33854195 NCBI chr 7:109,892,136...109,932,403
Ensembl chr 7:109,891,405...109,915,979
JBrowse link
G Orai3 ORAI calcium release-activated calcium modulator 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ORAI3 gene CTD PMID:33854195 NCBI chr 1:191,811,671...191,816,530
Ensembl chr 1:191,811,424...191,816,530
JBrowse link
G Oxct1 3-oxoacid CoA transferase 1 affects expression EXP Thiabendazole affects the expression of OXCT1 mRNA CTD PMID:18539377 NCBI chr 2:54,963,964...55,112,303
Ensembl chr 2:54,963,784...55,112,298
JBrowse link
G Pabir1 PP2A Aalpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PABIR1 gene CTD PMID:33854195 NCBI chr 1:231,541,411...231,542,717
Ensembl chr 1:231,537,357...231,612,411
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage ISO Thiabendazole results in increased cleavage of PARP1 protein CTD PMID:39207506 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
JBrowse link
G Parpbp PARP1 binding protein multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of PARPBP gene CTD PMID:33854195 NCBI chr 7:24,398,897...24,468,330
Ensembl chr 7:24,398,897...24,464,744
JBrowse link
G Pdlim1 PDZ and LIM domain 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PDLIM1 mRNA CTD PMID:33854195 NCBI chr 1:248,991,818...249,040,409
Ensembl chr 1:248,991,818...249,047,379
JBrowse link
G Pdp1 pyruvate dehydrogenase phosphatase catalytic subunit 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PDP1 mRNA CTD PMID:33854195 NCBI chr 5:30,245,699...30,252,494
Ensembl chr 5:30,242,704...30,253,960
JBrowse link
G Pdzd2 PDZ domain containing 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PDZD2 gene CTD PMID:33854195 NCBI chr 2:63,111,650...63,497,520
Ensembl chr 2:63,111,650...63,497,478
JBrowse link
G Per1 period circadian regulator 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PER1 mRNA CTD PMID:33854195 NCBI chr10:54,299,002...54,313,804
Ensembl chr10:54,302,641...54,314,211
JBrowse link
G Per3 period circadian regulator 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PER3 mRNA CTD PMID:33854195 NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:166,743,050...166,777,999
JBrowse link
G Pfkfb1 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 increases expression EXP Thiabendazole results in increased expression of PFKFB1 mRNA CTD PMID:18539377 NCBI chr  X:22,936,038...22,989,691
Ensembl chr  X:22,937,494...22,989,704
JBrowse link
G Pgk1 phosphoglycerate kinase 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PGK1 mRNA CTD PMID:33854195 NCBI chr  X:75,336,988...75,352,962
Ensembl chr  X:75,336,687...75,352,959
JBrowse link
G Pias3 protein inhibitor of activated STAT, 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PIAS3 mRNA CTD PMID:33854195 NCBI chr 2:186,921,384...186,930,292
Ensembl chr 2:186,921,428...186,936,714
JBrowse link
G Pip4p1 phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PIP4P1 mRNA CTD PMID:33854195 NCBI chr15:26,620,399...26,624,369
Ensembl chr15:26,620,401...26,624,246
JBrowse link
G Pirb paired Ig-like receptor B multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of LILRB3 mRNA CTD PMID:33854195 NCBI chr 1:74,414,556...74,433,015
Ensembl chr 1:74,331,291...74,422,116
JBrowse link
G Plekhg5 pleckstrin homology and RhoGEF domain containing G5 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLEKHG5 mRNA CTD PMID:33854195 NCBI chr 5:167,860,730...167,904,229
Ensembl chr 5:167,860,794...167,904,229
JBrowse link
G Plk2 polo-like kinase 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLK2 mRNA CTD PMID:33854195 NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296
JBrowse link
G Plpp4 phospholipid phosphatase 4 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PLPP4 gene CTD PMID:33854195 NCBI chr 1:193,260,181...193,389,659
Ensembl chr 1:193,260,434...193,389,675
JBrowse link
G Pmvk phosphomevalonate kinase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PMVK mRNA CTD PMID:33854195 NCBI chr 2:177,174,344...177,184,076
Ensembl chr 2:177,174,335...177,184,080
JBrowse link
G Pnkd PNKD metallo-beta-lactamase domain containing multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PNKD mRNA CTD PMID:33854195 NCBI chr 9:83,317,757...83,386,263
Ensembl chr 9:83,317,738...83,386,262
JBrowse link
G Pnrc1 proline-rich nuclear receptor coactivator 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PNRC1 mRNA CTD PMID:33854195 NCBI chr 5:52,443,400...52,489,303
Ensembl chr 5:52,443,400...52,446,491
JBrowse link
G Por cytochrome p450 oxidoreductase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of POR gene CTD PMID:33854195 NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809
JBrowse link
G Ppard peroxisome proliferator-activated receptor delta multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PPARD mRNA CTD PMID:33854195 NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,352,183...6,365,707
JBrowse link
G Prdm15 PR/SET domain 15 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PRDM15 mRNA CTD PMID:33854195 NCBI chr11:50,633,973...50,691,624
Ensembl chr11:50,633,973...50,691,823
JBrowse link
G Prelid2 PRELI domain containing 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PRELID2 mRNA CTD PMID:33854195 NCBI chr18:34,120,989...34,212,699
Ensembl chr18:34,125,373...34,212,167
JBrowse link
G Prelp proline and arginine rich end leucine rich repeat protein multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PRELP mRNA CTD PMID:33854195 NCBI chr13:47,920,480...47,943,547
Ensembl chr13:47,922,590...47,932,324
JBrowse link
G Prkcb protein kinase C, beta increases expression EXP Thiabendazole results in increased expression of PRKCB mRNA CTD PMID:18539377 NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:186,263,447...186,594,740
JBrowse link
G Proser2 proline and serine rich 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PROSER2 mRNA CTD PMID:33854195 NCBI chr17:77,061,371...77,096,788
Ensembl chr17:77,077,727...77,095,194
JBrowse link
G Prpf39 pre-mRNA processing factor 39 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PRPF39 mRNA CTD PMID:33854195 NCBI chr 6:88,825,227...88,851,342
Ensembl chr 6:88,825,243...88,851,341
JBrowse link
G Prss3b protease, serine, 3B multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PRSS3B gene CTD PMID:33854195 NCBI chr 4:70,838,484...70,842,192
Ensembl chr 4:70,838,471...70,845,283
JBrowse link
G Psmc2 proteasome 26S subunit, ATPase 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC2 mRNA CTD PMID:33854195 NCBI chr 4:14,148,080...14,162,390
Ensembl chr 4:14,148,090...14,162,390
JBrowse link
G Psmc4 proteasome 26S subunit, ATPase 4 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC4 mRNA CTD PMID:33854195 NCBI chr 1:92,476,690...92,485,268
Ensembl chr 1:92,476,690...92,485,060
JBrowse link
G Psmc5 proteasome 26S subunit, ATPase 5 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC5 mRNA CTD PMID:33854195 NCBI chr10:91,687,553...91,693,487
Ensembl chr10:91,686,295...91,695,921
JBrowse link
G Ptpa protein phosphatase 2 phosphatase activator multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PTPA mRNA CTD PMID:33854195 NCBI chr 3:34,087,637...34,118,100
Ensembl chr 3:34,087,575...34,162,772
JBrowse link
G Pus10 pseudouridine synthase 10 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PUS10 mRNA CTD PMID:33854195 NCBI chr14:101,822,525...101,885,187
Ensembl chr14:101,822,458...101,885,190
JBrowse link
G Rabep1 rabaptin, RAB GTPase binding effector protein 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RABEP1 mRNA CTD PMID:33854195 NCBI chr10:56,064,742...56,168,778
Ensembl chr10:56,064,753...56,166,177
JBrowse link
G Rabl2 RAB, member of RAS oncogene family like 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RABL2 mRNA CTD PMID:33854195 NCBI chr 7:122,531,787...122,540,500
Ensembl chr 7:122,531,792...122,540,395
JBrowse link
G Ramac RNA guanine-7 methyltransferase activating subunit multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RAMAC gene CTD PMID:33854195 NCBI chr 1:145,117,752...145,123,640
Ensembl chr 1:145,117,736...145,124,256
JBrowse link
G Rangap1 RAN GTPase activating protein 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RANGAP1 mRNA CTD PMID:33854195 NCBI chr 7:115,104,820...115,130,564
Ensembl chr 7:115,104,823...115,130,564
JBrowse link
G Rars1 arginyl-tRNA synthetase 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RARS1 mRNA CTD PMID:33854195 NCBI chr10:20,774,804...20,799,251
Ensembl chr10:20,774,805...20,799,251
JBrowse link
G Rbm14 RNA binding motif protein 14 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RBM14 mRNA CTD PMID:33854195 NCBI chr 1:211,476,298...211,535,077
Ensembl chr 1:211,523,972...211,535,065
JBrowse link
G Rbm3 RNA binding motif protein 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RBM3 mRNA CTD PMID:33854195 NCBI chr  X:17,020,863...17,024,341
Ensembl chr  X:17,020,864...17,024,841
JBrowse link
G Rbpms RNA binding protein, mRNA processing factor multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RBPMS gene CTD PMID:33854195 NCBI chr16:64,942,159...65,098,504
Ensembl chr16:64,942,530...65,098,503
JBrowse link
G Resf1 retroelement silencing factor 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RESF1 mRNA CTD PMID:33854195 NCBI chr 4:184,057,165...184,093,374
Ensembl chr 4:184,057,010...184,098,429
JBrowse link
G Rev1 REV1, DNA directed polymerase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of REV1 mRNA CTD PMID:33854195 NCBI chr 9:47,773,907...47,847,554
Ensembl chr 9:47,773,907...47,847,332
JBrowse link
G Rfx7 regulatory factor X, 7 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RFX7 mRNA CTD PMID:33854195 NCBI chr 8:82,134,747...82,219,898
Ensembl chr 8:82,134,747...82,219,898
JBrowse link
G Rgcc regulator of cell cycle multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RGCC gene CTD PMID:33854195 NCBI chr15:61,071,574...61,084,408
Ensembl chr15:61,071,574...61,084,408
JBrowse link
G Rgs16 regulator of G-protein signaling 16 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RGS16 mRNA CTD PMID:33854195 NCBI chr13:68,421,480...68,443,312
Ensembl chr13:68,438,120...68,443,313
JBrowse link
G Rhobtb3 Rho-related BTB domain containing 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RHOBTB3 mRNA CTD PMID:33854195 NCBI chr 2:7,094,972...7,201,507
Ensembl chr 2:7,095,253...7,150,906
JBrowse link
G Rnase10 ribonuclease A family member 10 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of RNASE10 gene CTD PMID:33854195 NCBI chr15:26,700,219...26,702,681
Ensembl chr15:26,688,102...26,706,105
JBrowse link
G Rnd3 Rho family GTPase 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RND3 gene; [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RND3 mRNA CTD PMID:33854195 NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:55,980,355...55,998,536
JBrowse link
G Rorc RAR-related orphan receptor C multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RORC mRNA CTD PMID:33854195 NCBI chr 2:184,698,779...184,723,942
Ensembl chr 2:184,698,818...184,724,566
JBrowse link
G Rxylt1 ribitol xylosyltransferase 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of RXYLT1 gene CTD PMID:33854195 NCBI chr 7:59,656,274...59,668,140
Ensembl chr 7:59,656,276...59,668,050
JBrowse link
G Sall4 spalt-like transcription factor 4 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SALL4 gene CTD PMID:33854195 NCBI chr 3:177,891,705...177,909,743
Ensembl chr 3:177,891,705...177,909,743
JBrowse link
G Sardh sarcosine dehydrogenase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SARDH mRNA CTD PMID:33854195 NCBI chr 3:30,908,621...30,973,409
Ensembl chr 3:30,908,621...30,972,137
JBrowse link
G Scnn1a sodium channel epithelial 1 subunit alpha multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SCNN1A mRNA CTD PMID:33854195 NCBI chr 4:159,809,187...159,832,409
Ensembl chr 4:159,809,170...159,832,405
JBrowse link
G Sdr42e1 short chain dehydrogenase/reductase family 42E, member 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SDR42E1 mRNA CTD PMID:33854195 NCBI chr19:62,624,130...62,636,652
Ensembl chr19:62,624,150...62,636,756
JBrowse link
G Serpina1 serpin family A member 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SERPINA1 mRNA CTD PMID:33854195 NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:128,619,382...128,660,703
JBrowse link
G Sesn2 sestrin 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SESN2 mRNA CTD PMID:33854195 NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255
JBrowse link
G Setd6 SET domain containing 6, protein lysine methyltransferase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SETD6 mRNA CTD PMID:33854195 NCBI chr19:9,349,011...9,356,515
Ensembl chr19:9,353,520...9,356,515
JBrowse link
G Sfrp2 secreted frizzled-related protein 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SFRP2 gene CTD PMID:33854195 NCBI chr 2:171,387,536...171,395,081
Ensembl chr 2:171,387,385...171,395,079
JBrowse link
G Sh3bp2 SH3-domain binding protein 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SH3BP2 mRNA CTD PMID:33854195 NCBI chr14:80,400,685...80,437,887
Ensembl chr14:80,400,685...80,437,906
JBrowse link
G Sigirr single Ig and TIR domain containing multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SIGIRR mRNA CTD PMID:33854195 NCBI chr 1:205,625,742...205,637,883
Ensembl chr 1:205,627,708...205,637,802
JBrowse link
G Sik2 salt-inducible kinase 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SIK2 mRNA CTD PMID:33854195 NCBI chr 8:60,121,913...60,221,707
Ensembl chr 8:60,121,913...60,221,818
JBrowse link
G Slc12a6 solute carrier family 12, member 6 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC12A6 mRNA CTD PMID:33854195 NCBI chr 3:119,525,521...119,624,655
Ensembl chr 3:119,526,295...119,624,653
JBrowse link
G Slc20a1 solute carrier family 20 member 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC20A1 mRNA CTD PMID:33854195 NCBI chr 3:136,880,360...136,894,255
Ensembl chr 3:136,880,290...136,894,249
JBrowse link
G Slc25a39 solute carrier family 25, member 39 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC25A39 mRNA CTD PMID:33854195 NCBI chr10:87,862,630...87,867,626
Ensembl chr10:87,862,631...87,866,973
JBrowse link
G Slc26a6 solute carrier family 26 member 6 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC26A6 mRNA CTD PMID:33854195 NCBI chr 8:118,438,110...118,448,271
Ensembl chr 8:118,438,180...118,448,270
JBrowse link
G Slc37a2 solute carrier family 37 member 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC37A2 mRNA CTD PMID:33854195 NCBI chr 8:45,134,596...45,160,551
Ensembl chr 8:45,134,596...45,277,989
JBrowse link
G Slk STE20-like kinase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SLK gene CTD PMID:33854195 NCBI chr 1:256,415,013...256,470,942
Ensembl chr 1:256,415,013...256,467,829
JBrowse link
G Smad7 SMAD family member 7 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SMAD7 mRNA CTD PMID:33854195 NCBI chr18:71,263,508...71,291,849
Ensembl chr18:71,263,508...71,291,849
JBrowse link
G Smpx small muscle protein, X-linked multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SMPX gene CTD PMID:33854195 NCBI chr  X:41,049,354...41,107,323
Ensembl chr  X:41,049,356...41,107,137
JBrowse link
G Snrnp200 small nuclear ribonucleoprotein U5 subunit 200 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SNRNP200 mRNA CTD PMID:33854195 NCBI chr 3:134,882,173...134,911,512
Ensembl chr 3:134,882,173...134,911,500
JBrowse link
G Snx4 sorting nexin 4 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SNX4 mRNA CTD PMID:33854195 NCBI chr11:80,965,965...81,023,234
Ensembl chr11:80,965,967...81,028,448
JBrowse link
G Socs3 suppressor of cytokine signaling 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SOCS3 mRNA CTD PMID:33854195 NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,690,976...103,704,825
JBrowse link
G Sod3 superoxide dismutase 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SOD3 mRNA CTD PMID:33854195 NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
JBrowse link
G Sohlh1 spermatogenesis and oogenesis specific basic helix-loop-helix 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SOHLH1 gene CTD PMID:33854195 NCBI chr 3:29,061,267...29,065,588
Ensembl chr 3:29,061,267...29,065,588
JBrowse link
G Spag1 sperm associated antigen 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SPAG1 mRNA CTD PMID:33854195 NCBI chr 7:69,246,301...69,306,483
Ensembl chr 7:69,246,582...69,306,482
JBrowse link
G Srd5a2 steroid 5 alpha-reductase 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SRD5A2 gene CTD PMID:33854195 NCBI chr 6:27,178,089...27,217,588
Ensembl chr 6:27,178,079...27,217,588
JBrowse link
G Srrm2 serine/arginine repetitive matrix 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRRM2 mRNA CTD PMID:33854195 NCBI chr10:13,320,059...13,353,337
Ensembl chr10:13,320,059...13,353,337
JBrowse link
G Srsf5 serine and arginine rich splicing factor 5 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRSF5 mRNA CTD PMID:33854195 NCBI chr 6:106,333,998...106,341,467
Ensembl chr 6:106,336,756...106,341,931
JBrowse link
G Stard9 StAR-related lipid transfer domain containing 9 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of STARD9 mRNA CTD PMID:33854195 NCBI chr 3:128,034,866...128,150,493
Ensembl chr 3:128,034,908...128,127,402
JBrowse link
G Susd2 sushi domain containing 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SUSD2 mRNA CTD PMID:33854195 NCBI chr20:13,016,960...13,024,264
Ensembl chr20:13,016,907...13,024,264
JBrowse link
G Sympk symplekin scaffold protein multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SYMPK mRNA CTD PMID:33854195 NCBI chr 1:87,800,416...87,828,727
Ensembl chr 1:87,799,853...87,828,727
JBrowse link
G Taf9b TATA-box binding protein associated factor 9b affects expression EXP Thiabendazole affects the expression of TAF9B mRNA CTD PMID:18539377 NCBI chr  X:75,354,823...75,366,166
Ensembl chr  X:75,354,825...75,366,414
JBrowse link
G Tat tyrosine aminotransferase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TAT mRNA CTD PMID:33854195 NCBI chr19:54,856,604...54,867,168
Ensembl chr19:54,856,563...54,867,482
JBrowse link
G Tdp2 tyrosyl-DNA phosphodiesterase 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TDP2 mRNA CTD PMID:33854195 NCBI chr17:40,656,969...40,668,362
Ensembl chr17:40,656,971...40,668,288
JBrowse link
G Tead2 TEA domain transcription factor 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TEAD2 mRNA CTD PMID:33854195 NCBI chr 1:104,838,795...104,855,635
Ensembl chr 1:104,838,623...104,855,630
JBrowse link
G Tecr trans-2,3-enoyl-CoA reductase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TECR mRNA CTD PMID:33854195 NCBI chr19:41,431,422...41,472,880
Ensembl chr19:41,446,071...41,474,432
JBrowse link
G Tgds TDP-glucose 4,6-dehydratase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TGDS mRNA CTD PMID:33854195 NCBI chr15:101,581,765...101,602,779
Ensembl chr15:101,582,227...101,602,718
JBrowse link
G Tgfbi transforming growth factor, beta induced multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TGFBI mRNA CTD PMID:33854195 NCBI chr17:7,960,885...7,990,234
Ensembl chr17:7,960,516...7,990,471
JBrowse link
G Tjap1 tight junction associated protein 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TJAP1 mRNA CTD PMID:33854195 NCBI chr 9:22,198,984...22,223,201
Ensembl chr 9:22,199,676...22,223,201
JBrowse link
G Tkt transketolase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TKT mRNA CTD PMID:33854195 NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,729,991...5,756,431
JBrowse link
G Tmbim6 transmembrane BAX inhibitor motif containing 6 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TMBIM6 mRNA CTD PMID:33854195 NCBI chr 7:132,405,217...132,422,492
Ensembl chr 7:132,386,134...132,422,492
JBrowse link
G Tmem268 transmembrane protein 268 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA CTD PMID:33854195 NCBI chr 5:81,990,314...82,016,970
Ensembl chr 5:81,991,367...82,016,968
JBrowse link
G Tmt1b thiol methyltransferase 1B multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TMT1B mRNA CTD PMID:33854195 NCBI chr 7:1,973,334...1,975,980
Ensembl chr 7:1,973,337...1,975,980
JBrowse link
G Tnfaip2 TNF alpha induced protein 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TNFAIP2 mRNA CTD PMID:33854195 NCBI chr 6:136,297,388...136,311,106
Ensembl chr 6:136,298,082...136,311,106
JBrowse link
G Tor3a torsin family 3, member A multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TOR3A mRNA CTD PMID:33854195 NCBI chr13:71,324,073...71,348,625
Ensembl chr13:71,324,076...71,348,624
JBrowse link
G Tp53 tumor protein p53 increases expression EXP Thiabendazole results in increased expression of TP53 mRNA CTD PMID:18539377 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
JBrowse link
G Traf3ip2 Traf3 interacting protein 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAF3IP2 mRNA CTD PMID:33854195 NCBI chr20:44,565,992...44,609,240
Ensembl chr20:44,517,242...44,609,618
JBrowse link
G Trafd1 TRAF type zinc finger domain containing 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAFD1 mRNA CTD PMID:33854195 NCBI chr12:40,826,251...40,840,169
Ensembl chr12:40,825,851...40,841,320
JBrowse link
G Trim3 tripartite motif-containing 3 increases expression EXP Thiabendazole results in increased expression of TRIM3 mRNA CTD PMID:18539377 NCBI chr 1:169,362,751...169,385,430
Ensembl chr 1:169,356,738...169,385,430
JBrowse link
G Trim34 tripartite motif-containing 34 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRIM34 mRNA CTD PMID:33854195 NCBI chr 1:168,119,043...168,130,544
Ensembl chr 1:168,119,074...168,132,059
JBrowse link
G Tsc22d3 TSC22 domain family, member 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TSC22D3 mRNA CTD PMID:33854195 NCBI chr  X:109,006,410...109,066,389
Ensembl chr  X:109,006,420...109,015,519
JBrowse link
G Uba3 ubiquitin-like modifier activating enzyme 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of UBA3 mRNA CTD PMID:33854195 NCBI chr 4:131,346,219...131,367,378
Ensembl chr 4:131,346,224...131,367,277
JBrowse link
G Ubb ubiquitin B multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBB mRNA CTD PMID:33854195 NCBI chr10:47,746,923...47,748,628
Ensembl chr10:47,727,701...47,750,335
JBrowse link
G Ubc ubiquitin C multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBC mRNA CTD PMID:33854195 NCBI chr12:36,899,673...36,905,275
Ensembl chr12:36,900,127...36,905,275
JBrowse link
G Uckl1 uridine-cytidine kinase 1-like 1 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of UCKL1 mRNA CTD PMID:33854195 NCBI chr 3:189,052,365...189,064,939
Ensembl chr 3:189,052,365...189,064,967
JBrowse link
G Ugdh UDP-glucose 6-dehydrogenase increases expression EXP Thiabendazole results in increased expression of UGDH mRNA CTD PMID:18539377 NCBI chr14:43,202,480...43,226,002
Ensembl chr14:43,202,356...43,226,629
JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 increases expression ISO Thiabendazole results in increased expression of UGT1A1 mRNA CTD PMID:39207506 NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264
JBrowse link
G Unc45a unc-45 myosin chaperone A multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UNC45A mRNA CTD PMID:33854195 NCBI chr 1:143,691,183...143,705,944
Ensembl chr 1:143,691,186...143,707,312
JBrowse link
G Uox urate oxidase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UOX mRNA CTD PMID:33854195 NCBI chr 2:238,147,130...238,183,320
Ensembl chr 2:238,083,686...238,183,370
JBrowse link
G Usp2 ubiquitin specific peptidase 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of USP2 mRNA CTD PMID:33854195 NCBI chr 8:53,308,264...53,336,800
Ensembl chr 8:53,308,303...53,336,794
JBrowse link
G Usp40 ubiquitin specific peptidase 40 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of USP40 mRNA CTD PMID:33854195 NCBI chr 9:96,055,741...96,126,766
Ensembl chr 9:96,055,741...96,126,721
JBrowse link
G Utrn utrophin increases expression ISO Thiabendazole results in increased expression of UTRN mRNA CTD PMID:22028826 NCBI chr 1:8,541,061...9,044,487
Ensembl chr 1:8,542,798...9,044,487
JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of VEGFA mRNA CTD PMID:33854195 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
JBrowse link
G Vnn3 vanin 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of VNN3 mRNA CTD PMID:33854195 NCBI chr 1:23,390,596...23,402,858
Ensembl chr 1:23,390,596...23,402,858
JBrowse link
G Vtn vitronectin multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of VTN mRNA CTD PMID:33854195 NCBI chr10:63,892,782...63,895,862
Ensembl chr10:63,892,766...63,895,860
JBrowse link
G Wdr11 WD repeat domain 11 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of WDR11 gene CTD PMID:33854195 NCBI chr 1:193,595,606...193,641,149
Ensembl chr 1:193,595,535...193,641,142
JBrowse link
G Wee1 WEE1 G2 checkpoint kinase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of WEE1 mRNA CTD PMID:33854195 NCBI chr 1:173,605,609...173,632,450
Ensembl chr 1:173,608,949...173,632,449
JBrowse link
G Wfdc9 WAP four-disulfide core domain 9 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of WFDC9 gene CTD PMID:33854195 NCBI chr 3:173,799,888...173,808,383
Ensembl chr 3:173,799,888...173,803,066
JBrowse link
G Yod1 YOD1 deubiquitinase multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of YOD1 gene CTD PMID:33854195 NCBI chr13:44,727,319...44,733,933 JBrowse link
G Zfc3h1 zinc finger, C3H1-type containing multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFC3H1 mRNA CTD PMID:33854195 NCBI chr 7:52,894,417...52,950,755
Ensembl chr 7:52,894,172...52,950,758
JBrowse link
G Zfp280d zinc finger protein 280D multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP280D mRNA CTD PMID:33854195 NCBI chr 8:81,872,108...81,961,194
Ensembl chr 8:81,873,335...81,961,201
JBrowse link
G Zfp36l2 zinc finger protein 36, C3H type-like 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP36L2 mRNA CTD PMID:33854195 NCBI chr 6:16,242,622...16,246,662
Ensembl chr 6:16,242,610...16,246,653
JBrowse link
G Zfp422 zinc finger protein 422 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP422 mRNA CTD PMID:33854195 NCBI chr 4:151,558,254...151,565,730
Ensembl chr 4:151,556,738...151,566,152
JBrowse link
G Zfp455 zinc finger protein 455 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP455 mRNA CTD PMID:33854195 NCBI chr 2:86,326,568...86,445,514
Ensembl chr 2:86,426,916...86,441,874
JBrowse link
G Zfp598 zinc finger protein 598 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP598 mRNA CTD PMID:33854195 NCBI chr10:14,198,763...14,210,773
Ensembl chr10:14,185,611...14,210,772
JBrowse link
G Zmym3 zinc finger MYM-type containing 3 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZMYM3 mRNA CTD PMID:33854195 NCBI chr  X:70,568,573...70,584,221
Ensembl chr  X:70,568,573...70,584,768
JBrowse link
G Zmym6 zinc finger MYM-type containing 6 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZMYM6 mRNA CTD PMID:33854195 NCBI chr 5:144,680,819...144,728,805
Ensembl chr 5:144,681,197...144,728,803
JBrowse link
G Zranb2 zinc finger RANBP2-type containing 2 multiple interactions EXP [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZRANB2 mRNA CTD PMID:33854195 NCBI chr 2:249,232,010...249,245,786
Ensembl chr 2:249,232,010...249,245,780
JBrowse link
thiamethoxam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Alpl alkaline phosphatase, biomineralization associated multiple interactions
increases activity
EXP [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of ALPL protein]
Thiamethoxam results in increased activity of ALPL protein
CTD PMID:30621503 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167
JBrowse link
G Anxa10 annexin A10 increases expression ISO Thiamethoxam results in increased expression of ANXA10 mRNA CTD PMID:32194361 NCBI chr16:32,505,025...32,571,961
Ensembl chr16:32,467,126...32,571,961
JBrowse link
G Ar androgen receptor affects binding ISO Thiamethoxam binds to AR protein CTD PMID:31550567 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467
JBrowse link
G Arg1 arginase 1 decreases expression ISO Thiamethoxam results in decreased expression of ARG1 mRNA CTD PMID:32194361 NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
JBrowse link
G Atf3 activating transcription factor 3 increases expression ISO Thiamethoxam results in increased expression of ATF3 mRNA CTD PMID:33533595 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression ISO Thiamethoxam results in increased expression of BAX protein CTD PMID:33533595 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression ISO Thiamethoxam results in decreased expression of BCL2 protein CTD PMID:33533595 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Bcl6 BCL6, transcription repressor decreases expression ISO Thiamethoxam results in decreased expression of BCL6 mRNA CTD PMID:33533595 NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047
JBrowse link
G Btg1 BTG anti-proliferation factor 1 increases expression ISO Thiamethoxam results in increased expression of BTG1 mRNA CTD PMID:33533595 NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406
JBrowse link
G Casp3 caspase 3 increases cleavage ISO Thiamethoxam results in increased cleavage of CASP3 protein CTD PMID:33533595 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Cat catalase increases expression
decreases expression
decreases activity
multiple interactions
ISO
EXP
Thiamethoxam results in increased expression of CAT mRNA
Thiamethoxam results in decreased expression of CAT mRNA
Thiamethoxam results in decreased activity of CAT protein
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Plant Extracts inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of CAT mRNA]
CTD PMID:30621503 PMID:33533595 PMID:34181816 PMID:36958429 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression ISO Thiamethoxam results in increased expression of CCL2 mRNA CTD PMID:33533595 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
JBrowse link
G Chrnb2 cholinergic receptor nicotinic beta 2 subunit multiple interactions EXP Thiamethoxam results in increased activity of [NACHRALPHA1 protein co-treated with CHRNB2 protein] CTD PMID:16981889 NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:177,479,091...177,491,326
JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 multiple interactions
decreases expression
EXP Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of CYP11A1 mRNA] CTD PMID:34181816 NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196
JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions
decreases expression
EXP Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of CYP17A1 mRNA] CTD PMID:34181816 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974
JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 increases expression
multiple interactions
increases activity
EXP
ISO
Thiamethoxam results in increased expression of CYP19A1 mRNA
Plant Extracts inhibits the reaction [Thiamethoxam results in increased expression of CYP19A1 mRNA]
thiamethoxam results in increased expression of CYP19A1 mRNA
thiamethoxam results in increased activity of CYP19A1 protein
CTD PMID:26464060 PMID:28750898 PMID:34181816 NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 decreases expression ISO Thiamethoxam results in decreased expression of CYP2C19 protein CTD PMID:32194361 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions ISO [NADP co-treated with CYP3A4 protein] results in increased activity of Thiamethoxam CTD PMID:16153789 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 decreases expression ISO Thiamethoxam results in decreased expression of CYP7A1 protein CTD PMID:32194361 NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression ISO Thiamethoxam results in increased expression of DDIT3 mRNA; Thiamethoxam results in increased expression of DDIT3 protein CTD PMID:33533595 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
JBrowse link
G Esr1 estrogen receptor 1 affects binding
decreases expression
ISO Thiamethoxam binds to ESR1 protein
Thiamethoxam results in decreased expression of ESR1 protein
CTD PMID:31550567 PMID:33533595 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
JBrowse link
G Foxo3 forkhead box O3 increases expression ISO Thiamethoxam results in increased expression of FOXO3 mRNA CTD PMID:33533595 NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845
JBrowse link
G Fshr follicle stimulating hormone receptor decreases expression ISO Thiamethoxam results in decreased expression of FSHR protein CTD PMID:33533595 NCBI chr 6:10,952,329...11,160,288
Ensembl chr 6:10,952,329...11,160,288
JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 decreases expression ISO Thiamethoxam results in decreased expression of G6PC1 mRNA CTD PMID:32194361 NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta decreases expression ISO Thiamethoxam results in decreased expression of GADD45B mRNA CTD PMID:33533595 NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 increases activity
multiple interactions
EXP Thiamethoxam results in increased activity of GOT1 protein
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of GOT1 protein]
CTD PMID:30621503 NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
JBrowse link
G Gpt glutamic--pyruvic transaminase decreases activity EXP thiamethoxam results in decreased activity of GPT protein CTD PMID:29197058 NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions
decreases expression
decreases activity
increases expression
EXP
ISO
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of GPX1 protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of GPX1 mRNA]
Thiamethoxam results in increased expression of GPX1 mRNA
CTD PMID:30621503 PMID:33533595 PMID:36958429 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 decreases expression
multiple interactions
EXP Thiamethoxam results in decreased expression of HSD3B1 mRNA
Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of HSD3B1 mRNA]
CTD PMID:34181816 NCBI chr 2:188,858,574...188,864,694 JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 increases expression ISO Thiamethoxam results in increased expression of HSPA5 mRNA; Thiamethoxam results in increased expression of HSPA5 protein CTD PMID:33533595 NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
JBrowse link
G Il1b interleukin 1 beta multiple interactions
increases expression
EXP Silymarin inhibits the reaction [Thiamethoxam results in increased expression of IL1B protein]
Thiamethoxam results in increased expression of IL1B mRNA; Thiamethoxam results in increased expression of IL1B protein
CTD PMID:36958429 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression
EXP Silymarin inhibits the reaction [Thiamethoxam results in increased expression of IL6 mRNA] CTD PMID:36958429 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor, type 1 decreases expression ISO Thiamethoxam results in decreased expression of ITPR1 mRNA CTD PMID:33533595 NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:142,743,334...143,066,504
JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit decreases expression ISO Thiamethoxam results in decreased expression of JUNB mRNA CTD PMID:33533595 NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218
JBrowse link
G Ldha lactate dehydrogenase A multiple interactions
increases activity
EXP [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of LDHA protein]
Thiamethoxam results in increased activity of LDHA protein
CTD PMID:30621503 NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521
JBrowse link
G Lhcgr luteinizing hormone/choriogonadotropin receptor decreases expression
multiple interactions
increases expression
ISO
EXP
Thiamethoxam results in decreased expression of LHCGR protein
Plant Extracts inhibits the reaction [Thiamethoxam results in increased expression of LHCGR mRNA]
CTD PMID:33533595 PMID:34181816 NCBI chr 6:11,415,361...11,480,834
Ensembl chr 6:11,415,415...11,478,061
JBrowse link
G Lst1 leukocyte specific transcript 1 increases expression ISO Thiamethoxam results in increased expression of LST1 mRNA CTD PMID:33533595 NCBI chr20:3,639,353...3,644,399
Ensembl chr20:3,639,341...3,642,669
JBrowse link
G Mc4r melanocortin 4 receptor decreases expression ISO Thiamethoxam results in decreased expression of MC4R mRNA CTD PMID:33533595 NCBI chr18:62,689,798...62,691,685 JBrowse link
G Mmp7 matrix metallopeptidase 7 increases expression ISO Thiamethoxam results in increased expression of MMP7 mRNA CTD PMID:33533595 NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
decreases activity
increases expression
ISO
EXP
[thiamethoxam metabolite results in decreased activity of NOS2 protein] which results in increased chemical synthesis of Formaldehyde
Silymarin inhibits the reaction [Thiamethoxam results in increased expression of NOS2 mRNA]
CTD PMID:29197058 PMID:36958429 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
JBrowse link
G Plcg2 phospholipase C, gamma 2 decreases expression ISO Thiamethoxam results in decreased expression of PLCG2 mRNA CTD PMID:33533595 NCBI chr19:62,456,196...62,592,684
Ensembl chr19:62,453,259...62,592,684
JBrowse link
G Prnp prion protein increases expression ISO Thiamethoxam results in increased expression of PRNP mRNA CTD PMID:33533595 NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:139,630,144...139,658,436
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression ISO Thiamethoxam results in decreased expression of PTGS2 mRNA CTD PMID:33533595 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
JBrowse link
G Pthlh parathyroid hormone-like hormone decreases expression ISO Thiamethoxam results in decreased expression of PTHLH mRNA CTD PMID:33533595 NCBI chr 4:181,919,400...181,930,454
Ensembl chr 4:181,919,400...181,930,454
JBrowse link
G Ptx3 pentraxin 3 increases expression ISO Thiamethoxam results in increased expression of PTX3 mRNA CTD PMID:33533595 NCBI chr 2:152,797,563...152,803,372
Ensembl chr 2:152,781,955...152,803,372
JBrowse link
G Scarb1 scavenger receptor class B, member 1 multiple interactions
decreases expression
EXP Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of SCARB1 mRNA] CTD PMID:34181816 NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980
JBrowse link
G Sesn2 sestrin 2 increases expression ISO Thiamethoxam results in increased expression of SESN2 mRNA CTD PMID:33533595 NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255
JBrowse link
G Slc22a2 solute carrier family 22 member 2 decreases activity ISO Thiamethoxam results in decreased activity of SLC22A2 protein CTD PMID:31364238 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression ISO Thiamethoxam results in increased expression of SLC7A11 mRNA CTD PMID:33533595 NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
JBrowse link
G Sod1 superoxide dismutase 1 decreases activity
decreases expression
multiple interactions
EXP Thiamethoxam results in decreased activity of SOD1 protein
Thiamethoxam results in decreased expression of SOD1 mRNA
[fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of SOD1 protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of SOD1 mRNA]
CTD PMID:30621503 PMID:36958429 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
JBrowse link
G Star steroidogenic acute regulatory protein decreases expression
multiple interactions
EXP Thiamethoxam results in decreased expression of STAR mRNA
Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of STAR mRNA]
CTD PMID:34181816 NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
JBrowse link
G Stc2 stanniocalcin 2 increases expression ISO Thiamethoxam results in increased expression of STC2 mRNA CTD PMID:33533595 NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,755,267...16,767,447
JBrowse link
G Thbs4 thrombospondin 4 decreases expression ISO Thiamethoxam results in decreased expression of THBS4 mRNA CTD PMID:33533595 NCBI chr 2:25,718,219...25,760,345
Ensembl chr 2:25,718,219...25,761,369
JBrowse link
G Thra thyroid hormone receptor alpha affects binding ISO Thiamethoxam binds to THRA protein CTD PMID:31550567 NCBI chr10:84,198,141...84,225,659
Ensembl chr10:84,197,011...84,225,657
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression
EXP Silymarin inhibits the reaction [Thiamethoxam results in increased expression of TNF mRNA]; Silymarin inhibits the reaction [Thiamethoxam results in increased expression of TNF protein]
Thiamethoxam results in increased expression of TNF mRNA; Thiamethoxam results in increased expression of TNF protein
CTD PMID:36958429 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
G Tnnt2 troponin T2, cardiac type increases secretion
multiple interactions
EXP Thiamethoxam results in increased secretion of TNNT2 protein
fenugreek seed meal inhibits the reaction [Thiamethoxam results in increased secretion of TNNT2 protein]; Polysaccharides inhibits the reaction [Thiamethoxam results in increased secretion of TNNT2 protein]
CTD PMID:30520268 NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125
JBrowse link
thiamine(1+) chloride term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 multiple interactions EXP
ISO
Thiamine inhibits the reaction [citreoviridin results in decreased phosphorylation of AKT1 protein] CTD PMID:31419397 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
JBrowse link
G Aqp7 aquaporin 7 increases expression
multiple interactions
EXP
ISO
Thiamine results in increased expression of AQP7 mRNA
Thiamine inhibits the reaction [citreoviridin results in decreased expression of AQP7 mRNA]
CTD PMID:31419397 NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618
JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions EXP
ISO
Thiamine inhibits the reaction [citreoviridin results in increased expression of BAX protein] CTD PMID:31419397 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions ISO
EXP
Thiamine inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein] CTD PMID:31419397 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Casp1 caspase 1 multiple interactions EXP Thiamine inhibits the reaction [Glycerol results in increased cleavage of CASP1 protein] CTD PMID:36690085 NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
JBrowse link
G Casp3 caspase 3 multiple interactions EXP Thiamine inhibits the reaction [Pentylenetetrazole results in increased expression of CASP3 protein] CTD PMID:33771525 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Ckb creatine kinase B multiple interactions ISO
EXP
Thiamine inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]] CTD PMID:31419397 NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478
JBrowse link
G Ckm creatine kinase, M-type multiple interactions EXP
ISO
Thiamine inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]; Thiamine inhibits the reaction [Glycerol results in increased secretion of CKM protein] CTD PMID:31419397 PMID:36690085 NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719
JBrowse link
G Cyp2c23 cytochrome P450, family 2, subfamily c, polypeptide 23 multiple interactions EXP [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP2C23 mRNA] CTD PMID:27919644 NCBI chr 1:252,838,427...252,863,081
Ensembl chr 1:252,838,433...252,863,067
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions EXP [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased activity of CYP2E1 protein]; [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP2E1 mRNA] CTD PMID:27919644 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions EXP [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP3A2 mRNA] CTD PMID:27919644 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions
increases expression
EXP
ISO
Thiamine inhibits the reaction [citreoviridin results in decreased expression of FABP4 mRNA]
Thiamine results in increased expression of FABP4 mRNA
CTD PMID:31419397 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972
JBrowse link
G Gsdmd gasdermin D multiple interactions EXP Thiamine inhibits the reaction [Glycerol results in increased cleavage of GSDMD protein] CTD PMID:36690085 NCBI chr 7:109,423,209...109,427,771
Ensembl chr 7:109,422,910...109,430,722
JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP Thiamine inhibits the reaction [Glycerol results in increased cleavage of IL1B protein] CTD PMID:36690085 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions ISO
EXP
Thiamine inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] CTD PMID:31419397 NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358
Ensembl chr16:66,574,407...66,584,358
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions EXP Thiamine inhibits the reaction [Glycerol results in increased expression of MYC protein] CTD PMID:36690085 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions ISO NFE2L2 protein affects the reaction [Thiamine results in increased expression of NQO1 mRNA] CTD PMID:29860433 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions EXP Thiamine inhibits the reaction [Glycerol results in increased expression of NLRP3 protein] CTD PMID:36690085 NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 multiple interactions
increases expression
ISO NFE2L2 protein affects the reaction [Thiamine results in increased expression of NQO1 mRNA] CTD PMID:29860433 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma increases activity
multiple interactions
EXP Thiamine results in increased activity of PPARG protein
Thiamine inhibits the reaction [citreoviridin results in decreased activity of PPARG protein]
CTD PMID:31419397 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression EXP [Thiamine deficiency results in increased expression of PTGS2 mRNA] which results in increased expression of Dinoprostone; Thiamine deficiency results in increased expression of PTGS2 mRNA CTD PMID:18481165 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
JBrowse link
G Slc19a2 solute carrier family 19 member 2 increases uptake
multiple interactions
increases expression
ISO SLC19A2 protein results in increased uptake of Thiamine
[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SLC19A2 protein] which results in decreased uptake of Thiamine
Thiamine deficiency results in increased expression of SLC19A2 mRNA; Thiamine deficiency results in increased expression of SLC19A2 protein
CTD PMID:16705148 PMID:24244374 NCBI chr13:79,135,118...79,149,316
Ensembl chr13:79,135,059...79,149,315
JBrowse link
G Slc19a3 solute carrier family 19 member 3 increases expression
increases uptake
multiple interactions
ISO Thiamine deficiency results in increased expression of SLC19A3 mRNA; Thiamine deficiency results in increased expression of SLC19A3 protein
SLC19A3 protein results in increased uptake of Thiamine
[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SLC19A3 protein] which results in decreased uptake of Thiamine
Amprolium inhibits the reaction [SLC19A3 protein results in increased uptake of Thiamine]; Chloroquine inhibits the reaction [SLC19A3 protein results in increased uptake of Thiamine]; Famotidine inhibits the reaction [SLC19A3 protein results in increased uptake of Thiamine]; Metformin inhibits the reaction [SLC19A3 protein results in increased uptake of Thiamine]; Phenformin inhibits the reaction [SLC19A3 protein results in increased uptake of Thiamine]; Verapamil inhibits the reaction [SLC19A3 protein results in increased uptake of Thiamine]
CTD PMID:16705148 PMID:24244374 PMID:26528626 NCBI chr 9:91,723,799...91,747,499
Ensembl chr 9:91,724,718...91,754,991
JBrowse link
G Slc2a2 solute carrier family 2 member 2 multiple interactions ISO Thiamine inhibits the reaction [Diethylhexyl Phthalate results in increased expression of SLC2A2 mRNA] CTD PMID:31706747 NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467
JBrowse link
G Sqstm1 sequestosome 1 multiple interactions EXP
ISO
Thiamine inhibits the reaction [citreoviridin results in decreased expression of SQSTM1 protein] CTD PMID:31419397 NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions EXP Thiamine inhibits the reaction [Glycerol results in increased expression of TLR4 protein] CTD PMID:36690085 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP Thiamine inhibits the reaction [Glycerol results in increased expression of TNF protein] CTD PMID:36690085 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
G Tnnt2 troponin T2, cardiac type multiple interactions EXP
ISO
Thiamine inhibits the reaction [citreoviridin results in increased secretion of TNNT2 protein] CTD PMID:31419397 NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125
JBrowse link
thifluzamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aars1 alanyl-tRNA synthetase 1 increases expression ISO thifluzamide results in increased expression of AARS1 mRNA CTD PMID:33512557 NCBI chr19:55,906,694...55,930,499
Ensembl chr19:55,906,702...55,930,497
JBrowse link
G Akt1 AKT serine/threonine kinase 1 decreases expression ISO thifluzamide results in decreased expression of AKT1 mRNA CTD PMID:33512557 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
JBrowse link
G Aldh7a1 aldehyde dehydrogenase 7 family, member A1 decreases expression ISO thifluzamide results in decreased expression of ALDH7A1 mRNA CTD PMID:33512557 NCBI chr18:52,208,035...52,240,293
Ensembl chr18:52,204,161...52,240,467
JBrowse link
G Aldoa aldolase, fructose-bisphosphate A increases expression ISO thifluzamide results in increased expression of ALDOA mRNA CTD PMID:33512557 NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
JBrowse link
G Anxa2 annexin A2 decreases expression ISO thifluzamide results in decreased expression of ANXA2 mRNA CTD PMID:33512557 NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631
JBrowse link
G Arhgap8 Rho GTPase activating protein 8 increases expression ISO thifluzamide results in increased expression of ARHGAP8 mRNA CTD PMID:33512557 NCBI chr 7:117,723,512...117,782,031
Ensembl chr 7:117,730,578...117,782,030
JBrowse link
G Arhgap9 Rho GTPase activating protein 9 increases expression ISO thifluzamide results in increased expression of ARHGAP9 mRNA CTD PMID:33512557 NCBI chr 7:65,034,023...65,042,336
Ensembl chr 7:65,034,144...65,042,336
JBrowse link
G Arhgef2 Rho/Rac guanine nucleotide exchange factor 2 increases expression ISO thifluzamide results in increased expression of ARHGEF2 mRNA CTD PMID:33512557 NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646
JBrowse link
G Arid4a AT-rich interaction domain 4A decreases expression ISO thifluzamide results in decreased expression of ARID4A mRNA CTD PMID:33512557 NCBI chr 6:95,258,429...95,335,987
Ensembl chr 6:95,258,429...95,329,840
JBrowse link
G Arrdc4 arrestin domain containing 4 decreases expression ISO thifluzamide results in decreased expression of ARRDC4 mRNA CTD PMID:33512557 NCBI chr 1:131,779,436...131,793,438
Ensembl chr 1:131,779,437...131,793,565
JBrowse link
G Arsg arylsulfatase G increases expression ISO thifluzamide results in increased expression of ARSG mRNA CTD PMID:33512557 NCBI chr10:94,912,094...95,063,021
Ensembl chr10:94,913,152...95,042,447
JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) increases expression ISO thifluzamide results in increased expression of ASNS mRNA CTD PMID:33512557 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050
JBrowse link
G Ass1 argininosuccinate synthase 1 increases expression ISO thifluzamide results in increased expression of ASS1 mRNA CTD PMID:33512557 NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627
JBrowse link
G Atf4 activating transcription factor 4 increases expression ISO thifluzamide results in increased expression of ATF4 mRNA CTD PMID:33512557 NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
JBrowse link
G Atf5 activating transcription factor 5 increases expression ISO thifluzamide results in increased expression of ATF5 mRNA CTD PMID:33512557 NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183
JBrowse link
G Aurkb aurora kinase B increases expression ISO thifluzamide results in increased expression of AURKB mRNA CTD PMID:33512557 NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285
JBrowse link
G Bid BH3 interacting domain death agonist decreases expression ISO thifluzamide results in decreased expression of BID mRNA CTD PMID:33512557 NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
JBrowse link
G Birc2 baculoviral IAP repeat-containing 2 decreases expression ISO thifluzamide results in decreased expression of BIRC2 mRNA CTD PMID:33512557 NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 increases expression ISO thifluzamide results in increased expression of BIRC5 mRNA CTD PMID:33512557 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
JBrowse link
G Bmf Bcl2 modifying factor decreases expression ISO thifluzamide results in decreased expression of BMF mRNA CTD PMID:33512557 NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:125,953,466...125,974,258
JBrowse link
G Bphl biphenyl hydrolase like decreases expression ISO thifluzamide results in decreased expression of BPHL mRNA CTD PMID:33512557 NCBI chr17:31,006,283...31,042,631
Ensembl chr17:31,004,972...31,042,632
JBrowse link
G Bsg basigin increases expression ISO thifluzamide results in increased expression of BSG mRNA CTD PMID:33512557 NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:10,643,789...10,651,005
JBrowse link
G C1d C1D nuclear receptor corepressor increases expression ISO thifluzamide results in increased expression of C1D mRNA CTD PMID:33512557 NCBI chr14:95,862,550...95,874,796
Ensembl chr14:95,861,978...95,874,796
JBrowse link
G C2cd5 C2 calcium-dependent domain containing 5 decreases expression ISO thifluzamide results in decreased expression of C2CD5 mRNA CTD PMID:33512557 NCBI chr 4:177,700,515...177,790,576
Ensembl chr 4:177,700,516...177,786,717
JBrowse link
G Camk2b calcium/calmodulin-dependent protein kinase II beta decreases expression ISO thifluzamide results in decreased expression of CAMK2B mRNA CTD PMID:33512557 NCBI chr14:85,059,166...85,148,121
Ensembl chr14:85,059,191...85,148,485
JBrowse link
G Cars1 cysteinyl-tRNA synthetase 1 increases expression ISO thifluzamide results in increased expression of CARS1 mRNA CTD PMID:33512557 NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:208,182,788...208,225,407
JBrowse link
G Cbx4 chromobox 4 increases expression ISO thifluzamide results in increased expression of CBX4 mRNA CTD PMID:33512557 NCBI chr10:104,835,685...104,841,727
Ensembl chr10:104,835,685...104,841,727
JBrowse link
G Ccnb2 cyclin B2 increases expression ISO thifluzamide results in increased expression of CCNB2 mRNA CTD PMID:33512557 NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682
JBrowse link
G Ccne2 cyclin E2 decreases expression ISO thifluzamide results in decreased expression of CCNE2 mRNA CTD PMID:33512557 NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:29,082,703...29,094,882
JBrowse link
G Cd24 CD24 molecule decreases expression ISO thifluzamide results in decreased expression of CD24 mRNA CTD PMID:33512557 NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785
JBrowse link
G Cdh10 cadherin 10 decreases expression ISO thifluzamide results in decreased expression of CDH10 mRNA CTD PMID:33512557 NCBI chr 2:70,355,521...70,577,880
Ensembl chr 2:70,357,217...70,578,332
JBrowse link
G Cdk1 cyclin-dependent kinase 1 increases expression ISO thifluzamide results in increased expression of CDK1 mRNA CTD PMID:33512557 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
JBrowse link
G Cdk5 cyclin-dependent kinase 5 decreases expression ISO thifluzamide results in decreased expression of CDK5 mRNA CTD PMID:33512557 NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777
JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 increases expression ISO thifluzamide results in increased expression of CDKN3 mRNA CTD PMID:33512557 NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722
JBrowse link
G Cebpb CCAAT/enhancer binding protein beta increases expression ISO thifluzamide results in increased expression of CEBPB mRNA CTD PMID:33512557 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
JBrowse link
G Cep55 centrosomal protein 55 increases expression ISO thifluzamide results in increased expression of CEP55 mRNA CTD PMID:33512557 NCBI chr 1:245,245,272...245,260,835
Ensembl chr 1:245,245,306...245,260,890
JBrowse link
G Chac1 ChaC glutathione-specific gamma-glutamylcyclotransferase 1 increases expression ISO thifluzamide results in increased expression of CHAC1 mRNA CTD PMID:33512557 NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361
JBrowse link
G Chka choline kinase alpha increases expression ISO thifluzamide results in increased expression of CHKA mRNA CTD PMID:33512557 NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:210,506,056...210,554,752
JBrowse link
G Chrna4 cholinergic receptor nicotinic alpha 4 subunit decreases expression ISO thifluzamide results in decreased expression of CHRNA4 mRNA CTD PMID:33512557 NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 increases expression ISO thifluzamide results in increased expression of CKS2 mRNA CTD PMID:33512557 NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519
JBrowse link
G Cldn5 claudin 5 decreases expression ISO thifluzamide results in decreased expression of CLDN5 mRNA CTD PMID:33512557 NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322
JBrowse link
G Clic4 chloride intracellular channel 4 increases expression ISO thifluzamide results in increased expression of CLIC4 mRNA CTD PMID:33512557 NCBI chr 5:152,737,371...152,797,118
Ensembl chr 5:152,737,371...152,797,118
JBrowse link
G Cpne3 copine 3 decreases expression ISO thifluzamide results in decreased expression of CPNE3 mRNA CTD PMID:33512557 NCBI chr 5:37,811,566...37,860,840
Ensembl chr 5:37,811,566...37,861,062
JBrowse link
G Cpsf4 cleavage and polyadenylation specific factor 4 decreases expression ISO thifluzamide results in decreased expression of CPSF4 mRNA CTD PMID:33512557 NCBI chr12:14,543,536...14,559,350
Ensembl chr12:14,543,338...14,559,350
JBrowse link
G Creg1 cellular repressor of E1A-stimulated genes 1 increases expression ISO thifluzamide results in increased expression of CREG1 mRNA CTD PMID:33512557 NCBI chr13:80,552,779...80,565,272
Ensembl chr13:80,549,933...80,565,272
JBrowse link
G Crtap cartilage associated protein increases expression ISO thifluzamide results in increased expression of CRTAP mRNA CTD PMID:33512557 NCBI chr 8:122,926,117...122,945,843
Ensembl chr 8:122,926,117...122,945,843
JBrowse link
G Cth cystathionine gamma-lyase increases expression ISO thifluzamide results in increased expression of CTH mRNA CTD PMID:33512557 NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066
JBrowse link
G Ctnnd1 catenin delta 1 decreases expression ISO thifluzamide results in decreased expression of CTNND1 mRNA CTD PMID:33512557 NCBI chr 3:90,090,025...90,141,247
Ensembl chr 3:90,090,564...90,141,189
JBrowse link
G Ctss cathepsin S decreases expression ISO thifluzamide results in decreased expression of CTSS mRNA CTD PMID:33512557 NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:185,775,296...185,803,440
JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 decreases expression ISO thifluzamide results in decreased expression of CXCR4 mRNA CTD PMID:33512557 NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
JBrowse link
G Daam1 dishevelled associated activator of morphogenesis 1 decreases expression ISO thifluzamide results in decreased expression of DAAM1 mRNA CTD PMID:33512557 NCBI chr 6:96,125,521...96,286,049
Ensembl chr 6:96,125,621...96,286,049
JBrowse link
G Dcx doublecortin decreases expression ISO thifluzamide results in decreased expression of DCX mRNA CTD PMID:33512557 NCBI chr  X:112,227,455...112,370,291
Ensembl chr  X:112,227,455...112,304,161
JBrowse link
G Ddc dopa decarboxylase decreases expression ISO thifluzamide results in decreased expression of DDC mRNA CTD PMID:33512557 NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression ISO thifluzamide results in increased expression of DDIT3 mRNA CTD PMID:33512557 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 increases expression ISO thifluzamide results in increased expression of DDIT4 mRNA CTD PMID:33512557 NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037
JBrowse link
G Depdc1b DEP domain containing 1B increases expression ISO thifluzamide results in increased expression of DEPDC1B mRNA CTD PMID:33512557 NCBI chr 2:41,605,686...41,697,207
Ensembl chr 2:41,624,922...41,697,202
JBrowse link
G Dnm1 dynamin 1 decreases expression ISO thifluzamide results in decreased expression of DNM1 mRNA CTD PMID:33512557 NCBI chr 3:36,002,535...36,055,220
Ensembl chr 3:36,002,064...36,046,289
JBrowse link
G Dpm2 dolichyl-phosphate mannosyltransferase subunit 2, regulatory increases expression ISO thifluzamide results in increased expression of DPM2 mRNA CTD PMID:33512557 NCBI chr 3:36,253,548...36,256,592 JBrowse link
G Drd2 dopamine receptor D2 decreases expression ISO thifluzamide results in decreased expression of DRD2 mRNA CTD PMID:33512557 NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:58,605,403...58,669,339
JBrowse link
G Dusp14 dual specificity phosphatase 14 increases expression ISO thifluzamide results in increased expression of DUSP14 mRNA CTD PMID:33512557 NCBI chr10:69,433,949...69,463,863
Ensembl chr10:69,426,730...69,462,837
JBrowse link
G Dusp22 dual specificity phosphatase 22 increases expression ISO thifluzamide results in increased expression of DUSP22 mRNA CTD PMID:33512557 NCBI chr17:33,989,637...34,040,021
Ensembl chr17:33,989,637...34,039,895
JBrowse link
G Dusp4 dual specificity phosphatase 4 increases expression ISO thifluzamide results in increased expression of DUSP4 mRNA CTD PMID:33512557 NCBI chr16:64,079,893...64,101,396
Ensembl chr16:64,079,893...64,093,700
JBrowse link
G Eea1 early endosome antigen 1 increases expression ISO thifluzamide results in increased expression of EEA1 mRNA CTD PMID:33512557 NCBI chr 7:32,441,281...32,608,808
Ensembl chr 7:32,441,272...32,608,476
JBrowse link
G Egr1 early growth response 1 increases expression ISO thifluzamide results in increased expression of EGR1 mRNA CTD PMID:33512557 NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
JBrowse link
G Eif1 eukaryotic translation initiation factor 1 increases expression ISO thifluzamide results in increased expression of EIF1 mRNA CTD PMID:33512557 NCBI chr10:85,747,064...85,749,447
Ensembl chr 5:25,895,968...25,896,654
Ensembl chr10:25,895,968...25,896,654
JBrowse link
G Eif2s2 eukaryotic translation initiation factor 2 subunit beta increases expression ISO thifluzamide results in increased expression of EIF2S2 mRNA CTD PMID:33512557 NCBI chr 3:163,834,846...163,855,733
Ensembl chr 3:163,834,851...163,855,570
JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 increases expression ISO thifluzamide results in increased expression of EIF4EBP1 mRNA CTD PMID:33512557 NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874
JBrowse link
G Elmod1 ELMO domain containing 1 decreases expression ISO thifluzamide results in decreased expression of ELMOD1 mRNA CTD PMID:33512557 NCBI chr 8:63,194,539...63,251,526
Ensembl chr 8:63,137,295...63,251,322
JBrowse link
G Ephb2 Eph receptor B2 decreases expression ISO thifluzamide results in decreased expression of EPHB2 mRNA CTD PMID:33512557 NCBI chr 5:154,179,065...154,360,459
Ensembl chr 5:154,179,065...154,360,615
JBrowse link
G Eps15 epidermal growth factor receptor pathway substrate 15 increases expression ISO thifluzamide results in increased expression of EPS15 mRNA CTD PMID:33512557 NCBI chr 5:129,274,487...129,374,856
Ensembl chr 5:129,274,502...129,374,856
JBrowse link
G Ero1a endoplasmic reticulum oxidoreductase 1 alpha increases expression ISO thifluzamide results in increased expression of ERO1A mRNA CTD PMID:33512557 NCBI chr15:20,974,771...21,010,170
Ensembl chr15:20,972,679...21,018,039
JBrowse link
G Etnk1 ethanolamine kinase 1 decreases expression ISO thifluzamide results in decreased expression of ETNK1 mRNA CTD PMID:33512557 NCBI chr 4:177,857,001...177,901,278
Ensembl chr 4:177,856,960...177,924,721
JBrowse link
G Ets1 ETS proto-oncogene 1, transcription factor increases expression ISO thifluzamide results in increased expression of ETS1 mRNA CTD PMID:33512557 NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021
JBrowse link
G Etv1 ETS variant transcription factor 1 decreases expression ISO thifluzamide results in decreased expression of ETV1 mRNA CTD PMID:33512557 NCBI chr 6:61,316,836...61,408,985
Ensembl chr 6:61,317,429...61,408,959
JBrowse link
G Exosc4 exosome component 4 decreases expression ISO thifluzamide results in decreased expression of EXOSC4 mRNA CTD PMID:33512557 NCBI chr 7:109,928,491...109,931,233
Ensembl chr 7:109,928,498...109,931,820
JBrowse link
G Exosc8 exosome component 8 increases expression ISO thifluzamide results in increased expression of EXOSC8 mRNA CTD PMID:33512557 NCBI chr 2:141,080,568...141,087,112
Ensembl chr 2:141,080,568...141,087,229
JBrowse link
G Fam72a family with sequence similarity 72, member A increases expression ISO thifluzamide results in increased expression of FAM72A mRNA CTD PMID:33512557 NCBI chr13:45,519,940...45,531,322
Ensembl chr13:45,519,818...45,531,324
JBrowse link
G Fgf8 fibroblast growth factor 8 decreases expression ISO thifluzamide results in decreased expression of FGF8 mRNA CTD PMID:33512557 NCBI chr 1:254,533,504...254,539,605
Ensembl chr 1:254,533,504...254,539,605
JBrowse link
G Fibin fin bud initiation factor homolog increases expression ISO thifluzamide results in increased expression of FIBIN mRNA CTD PMID:33512557 NCBI chr 3:117,396,973...117,399,244
Ensembl chr 3:117,391,724...117,399,479
JBrowse link
G Flna filamin A increases expression ISO thifluzamide results in increased expression of FLNA mRNA CTD PMID:33512557 NCBI chr  X:157,159,051...157,185,559
Ensembl chr  X:157,159,051...157,182,343
JBrowse link
G Fth1 ferritin heavy chain 1 increases expression ISO thifluzamide results in increased expression of FTH1 mRNA CTD PMID:33512557 NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214
JBrowse link
G Ftl1 ferritin light chain 1 increases expression ISO thifluzamide results in increased expression of FTL mRNA CTD PMID:33512557 NCBI chr 1:105,072,858...105,074,705
Ensembl chr  X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915
JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression ISO thifluzamide results in increased expression of GADD45A mRNA CTD PMID:33512557 NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta increases expression ISO thifluzamide results in increased expression of GADD45B mRNA CTD PMID:33512557 NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718
JBrowse link
G Galnt3 polypeptide N-acetylgalactosaminyltransferase 3 decreases expression ISO thifluzamide results in decreased expression of GALNT3 mRNA CTD PMID:33512557 NCBI chr 3:71,150,559...71,187,321
Ensembl chr 3:71,150,571...71,174,323
JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit increases expression ISO thifluzamide results in increased expression of GCLM mRNA CTD PMID:33512557 NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO thifluzamide results in increased expression of GDF15 mRNA CTD PMID:33512557 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
JBrowse link
G Gldc glycine decarboxylase decreases expression ISO thifluzamide results in decreased expression of GLDC mRNA CTD PMID:33512557 NCBI chr 1:237,296,753...237,375,620
Ensembl chr 1:237,296,753...237,375,604
JBrowse link
G Glrx glutaredoxin decreases expression ISO thifluzamide results in decreased expression of GLRX mRNA CTD PMID:33512557 NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543
JBrowse link
G Gmip Gem-interacting protein decreases expression ISO thifluzamide results in decreased expression of GMIP mRNA CTD PMID:33512557 NCBI chr16:19,634,630...19,648,916
Ensembl chr16:19,634,630...19,647,933
JBrowse link
G Gnai2 G protein subunit alpha i2 decreases expression ISO thifluzamide results in decreased expression of GNAI2 mRNA CTD PMID:33512557 NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:117,167,045...117,187,622
JBrowse link
G Gnb3 G protein subunit beta 3 decreases expression ISO thifluzamide results in decreased expression of GNB3 mRNA CTD PMID:33512557 NCBI chr 4:159,325,741...159,331,443
Ensembl chr 4:159,325,742...159,331,445
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 increases expression ISO thifluzamide results in increased expression of GOT1 mRNA CTD PMID:33512557 NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
JBrowse link
G Grb10 growth factor receptor bound protein 10 increases expression ISO thifluzamide results in increased expression of GRB10 mRNA CTD PMID:33512557 NCBI chr14:90,708,653...90,816,399
Ensembl chr14:90,708,653...90,816,387
JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 decreases expression ISO thifluzamide results in decreased expression of GRIA2 mRNA CTD PMID:33512557 NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616
JBrowse link
G Grin2d glutamate ionotropic receptor NMDA type subunit 2D decreases expression ISO thifluzamide results in decreased expression of GRIN2D mRNA CTD PMID:33512557 NCBI chr 1:105,443,317...105,483,400
Ensembl chr 1:105,444,813...105,481,236
JBrowse link
G Grm4 glutamate metabotropic receptor 4 decreases expression ISO thifluzamide results in decreased expression of GRM4 mRNA CTD PMID:33512557 NCBI chr20:5,486,024...5,574,668
Ensembl chr20:5,482,977...5,574,668
JBrowse link
G Gsr glutathione-disulfide reductase increases expression ISO thifluzamide results in increased expression of GSR mRNA CTD PMID:33512557 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
JBrowse link
G Gstm2 glutathione S-transferase mu 2 decreases expression ISO thifluzamide results in decreased expression of GSTM2 mRNA CTD PMID:33512557 NCBI chr 2:198,312,179...198,316,962 JBrowse link
G H1f0 H1.0 linker histone increases expression ISO thifluzamide results in increased expression of H1-0 mRNA CTD PMID:33512557 NCBI chr 7:112,473,280...112,475,140
Ensembl chr 7:112,473,222...112,475,006
JBrowse link
G H1f2 H1.2 linker histone, cluster member increases expression ISO thifluzamide results in increased expression of H1-2 mRNA CTD PMID:33512557 NCBI chr17:41,818,962...41,820,453
Ensembl chr17:41,779,051...41,822,317
JBrowse link
G H2bc3 H2B clustered histone 3 increases expression ISO thifluzamide results in increased expression of H2BC3 mRNA CTD PMID:33512557 NCBI chr17:41,807,913...41,808,543 JBrowse link
G Herpud1 homocysteine inducible ER protein with ubiquitin like domain 1 increases expression ISO thifluzamide results in increased expression of HERPUD1 mRNA CTD PMID:33512557 NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081
JBrowse link
G Hes5 hes family bHLH transcription factor 5 decreases expression ISO thifluzamide results in decreased expression of HES5 mRNA CTD PMID:33512557 NCBI chr 5:170,804,511...170,807,988
Ensembl chr 5:170,803,940...170,806,021
JBrowse link
G Hhip Hedgehog-interacting protein increases expression ISO thifluzamide results in increased expression of HHIP mRNA CTD PMID:33512557 NCBI chr19:44,768,038...44,856,878
Ensembl chr19:44,767,536...44,862,795
JBrowse link
G Hist1h2ah histone cluster 1 H2A family member H increases expression ISO thifluzamide results in increased expression of H2AC11 mRNA CTD PMID:33512557 NCBI chr17:41,812,378...41,812,875
Ensembl chr17:41,797,862...41,812,946
JBrowse link
G Hist1h2al1 histone cluster 1 H2A family like 1 increases expression ISO thifluzamide results in increased expression of H2AC6 mRNA CTD PMID:33512557 NCBI chr17:47,403,701...47,404,167 JBrowse link
G Hist1h2bd histone cluster 1 H2B family member D increases expression ISO thifluzamide results in increased expression of H2BC5 mRNA CTD PMID:33512557 NCBI chr17:47,488,627...47,489,008 JBrowse link
G Hmox1 heme oxygenase 1 increases expression ISO thifluzamide results in increased expression of HMOX1 mRNA CTD PMID:33512557 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
JBrowse link
G Hnrnpm heterogeneous nuclear ribonucleoprotein M decreases expression ISO thifluzamide results in decreased expression of HNRNPM mRNA CTD PMID:33512557 NCBI chr 7:15,140,877...15,178,871
Ensembl chr 7:15,129,287...15,178,871
JBrowse link
G Hsd17b8 hydroxysteroid (17-beta) dehydrogenase 8 decreases expression ISO thifluzamide results in decreased expression of HSD17B8 mRNA CTD PMID:33512557 NCBI chr20:4,828,571...4,830,635
Ensembl chr20:4,828,608...4,830,634
JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 increases expression ISO thifluzamide results in increased expression of HSPA8 mRNA CTD PMID:33512557 NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
JBrowse link
G Hyou1 hypoxia up-regulated 1 increases expression ISO thifluzamide results in increased expression of HYOU1 mRNA CTD PMID:33512557 NCBI chr 8:53,602,882...53,614,998
Ensembl chr 8:53,602,604...53,614,997
JBrowse link
G Ide insulin degrading enzyme increases expression ISO thifluzamide results in increased expression of IDE mRNA CTD PMID:33512557 NCBI chr 1:244,415,495...244,516,925
Ensembl chr 1:244,416,343...244,514,526
JBrowse link
G Idh3a isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha increases expression ISO thifluzamide results in increased expression of IDH3A mRNA CTD PMID:33512557 NCBI chr 8:63,867,882...63,887,223
Ensembl chr 8:63,867,820...63,887,223
JBrowse link
G Ifi44 interferon-induced protein 44 decreases expression ISO thifluzamide results in decreased expression of IFI44 mRNA CTD PMID:33512557 NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:243,286,052...243,306,877
JBrowse link
G Ifitm2 interferon induced transmembrane protein 2 decreases expression ISO thifluzamide results in decreased expression of IFITM2 mRNA CTD PMID:33512557 NCBI chr 1:205,481,168...205,482,348 JBrowse link
G Ifitm3 interferon induced transmembrane protein 3 decreases expression ISO thifluzamide results in decreased expression of IFITM3 mRNA CTD PMID:33512557 NCBI chr 1:205,540,649...205,541,758
Ensembl chr 1:205,481,168...205,547,920
JBrowse link
G Ifrd1 interferon-related developmental regulator 1 increases expression ISO thifluzamide results in increased expression of IFRD1 mRNA CTD PMID:33512557 NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131
JBrowse link
G Ikzf1 IKAROS family zinc finger 1 decreases expression ISO thifluzamide results in decreased expression of IKZF1 mRNA CTD PMID:33512557 NCBI chr14:90,468,696...90,556,522
Ensembl chr14:90,469,172...90,557,574
JBrowse link
G Inhbe inhibin subunit beta E increases expression ISO thifluzamide results in increased expression of INHBE mRNA CTD PMID:33512557 NCBI chr 7:65,061,531...65,064,519
Ensembl chr 7:65,061,531...65,064,519
JBrowse link
G Ipo5 importin 5 increases expression ISO thifluzamide results in increased expression of IPO5 mRNA CTD PMID:33512557 NCBI chr15:104,397,626...104,447,985
Ensembl chr15:104,397,276...104,447,985
JBrowse link
G Irf1 interferon regulatory factor 1 increases expression ISO thifluzamide results in increased expression of IRF1 mRNA CTD PMID:33512557 NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947
JBrowse link
G Isl1 ISL LIM homeobox 1 decreases expression ISO thifluzamide results in decreased expression of ISL1 mRNA CTD PMID:33512557 NCBI chr 2:49,813,618...49,823,442
Ensembl chr 2:49,813,618...49,823,442
JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor, type 1 increases expression ISO thifluzamide results in increased expression of ITPR1 mRNA CTD PMID:33512557 NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:142,743,334...143,066,504
JBrowse link
G Itpr2 inositol 1,4,5-trisphosphate receptor, type 2 decreases expression ISO thifluzamide results in decreased expression of ITPR2 mRNA CTD PMID:33512557 NCBI chr 4:180,759,325...181,165,361
Ensembl chr 4:180,760,442...181,164,763
JBrowse link
G Jmjd6 jumonji domain containing 6, arginine demethylase and lysine hydroxylase increases expression ISO thifluzamide results in increased expression of JMJD6 mRNA CTD PMID:33512557 NCBI chr10:102,539,935...102,545,986
Ensembl chr10:102,539,894...102,545,986
JBrowse link
G Kars1 lysyl-tRNA synthetase 1 decreases expression ISO thifluzamide results in decreased expression of KARS1 mRNA CTD PMID:33512557 NCBI chr19:56,867,096...56,886,151
Ensembl chr19:56,867,096...56,886,073
JBrowse link
G Kcnq2 potassium voltage-gated channel subfamily Q member 2 decreases expression ISO thifluzamide results in decreased expression of KCNQ2 mRNA CTD PMID:33512557 NCBI chr 3:188,572,345...188,631,391
Ensembl chr 3:188,572,926...188,631,302
JBrowse link
G Kdelr2 KDEL endoplasmic reticulum protein retention receptor 2 increases expression ISO thifluzamide results in increased expression of KDELR2 mRNA CTD PMID:33512557 NCBI chr12:16,252,424...16,270,737
Ensembl chr12:16,252,424...16,270,719
JBrowse link
G Kif13a kinesin family member 13A decreases expression ISO thifluzamide results in decreased expression of KIF13A mRNA CTD PMID:33512557 NCBI chr17:17,972,227...18,154,763
Ensembl chr17:17,972,325...18,154,760
JBrowse link
G Kif20a kinesin family member 20A increases expression ISO thifluzamide results in increased expression of KIF20A mRNA CTD PMID:33512557 NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,504,072...26,512,909
JBrowse link
G Klhl24 kelch-like family member 24 decreases expression ISO thifluzamide results in decreased expression of KLHL24 mRNA CTD PMID:33512557 NCBI chr11:94,348,024...94,382,085
Ensembl chr11:94,351,157...94,382,050
JBrowse link
G L1cam L1 cell adhesion molecule decreases expression ISO thifluzamide results in decreased expression of L1CAM mRNA CTD PMID:33512557 NCBI chr  X:156,748,597...156,775,116
Ensembl chr  X:156,748,597...156,775,077
JBrowse link
G Lamp3 lysosomal-associated membrane protein 3 increases expression ISO thifluzamide results in increased expression of LAMP3 mRNA CTD PMID:33512557 NCBI chr11:94,657,817...94,726,451
Ensembl chr11:94,661,399...94,726,195
JBrowse link
G Lmod1 leiomodin 1 decreases expression ISO thifluzamide results in decreased expression of LMOD1 mRNA CTD PMID:33512557 NCBI chr13:49,305,693...49,347,970
Ensembl chr13:49,305,830...49,348,116
JBrowse link
G Loxl1 lysyl oxidase-like 1 decreases expression ISO thifluzamide results in decreased expression of LOXL1 mRNA CTD PMID:33512557 NCBI chr 8:67,587,636...67,612,224
Ensembl chr 8:67,587,636...67,612,224
JBrowse link
G Lpcat1 lysophosphatidylcholine acyltransferase 1 decreases expression ISO thifluzamide results in decreased expression of LPCAT1 mRNA CTD PMID:33512557 NCBI chr 1:31,594,621...31,644,946
Ensembl chr 1:31,594,622...31,644,946
JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta increases expression ISO thifluzamide results in increased expression of MAP1LC3B mRNA CTD PMID:33512557 NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358
Ensembl chr16:66,574,407...66,584,358
JBrowse link
G Map2 microtubule-associated protein 2 decreases expression ISO thifluzamide results in decreased expression of MAP2 mRNA CTD PMID:33512557 NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
JBrowse link
G Map6 microtubule-associated protein 6 decreases expression ISO thifluzamide results in decreased expression of MAP6 mRNA CTD PMID:33512557 NCBI chr 1:162,980,339...163,046,548
Ensembl chr 1:162,980,181...163,046,548
JBrowse link
G Mdk midkine increases expression ISO thifluzamide results in increased expression of MDK mRNA CTD PMID:33512557 NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743
JBrowse link
G Me1 malic enzyme 1 increases expression ISO thifluzamide results in increased expression of ME1 mRNA CTD PMID:33512557 NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275
JBrowse link
G Metrn meteorin, glial cell differentiation regulator decreases expression ISO thifluzamide results in decreased expression of METRN mRNA CTD PMID:33512557 NCBI chr10:15,321,200...15,323,218
Ensembl chr10:15,321,200...15,323,642
JBrowse link
G Mok MOK protein kinase increases expression ISO thifluzamide results in increased expression of MOK mRNA CTD PMID:33512557 NCBI chr 6:135,645,018...135,675,894
Ensembl chr 6:135,645,018...135,676,174
JBrowse link
G Msi2 musashi RNA-binding protein 2 decreases expression ISO thifluzamide results in decreased expression of MSI2 mRNA CTD PMID:33512557 NCBI chr10:73,640,960...74,007,497
Ensembl chr10:73,646,139...74,007,552
JBrowse link
G Mt-nd6 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 decreases expression ISO thifluzamide results in decreased expression of ND6 mRNA CTD PMID:33512557 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,531...14,049
JBrowse link
G Mt2 metallothionein 2 increases expression ISO thifluzamide results in increased expression of MT2A mRNA CTD PMID:33512557 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase increases expression ISO thifluzamide results in increased expression of MTHFD2 mRNA CTD PMID:33512557 NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350
JBrowse link
G Myb MYB proto-oncogene, transcription factor decreases expression ISO thifluzamide results in decreased expression of MYB mRNA CTD PMID:33512557 NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:17,759,309...17,792,547
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor increases expression ISO thifluzamide results in increased expression of MYC mRNA CTD PMID:33512557 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
JBrowse link
G Myl4 myosin, light chain 4 decreases expression ISO thifluzamide results in decreased expression of MYL4 mRNA CTD PMID:33512557 NCBI chr10:89,949,733...89,985,308
Ensembl chr10:89,949,404...89,985,308
JBrowse link
G Nav1 neuron navigator 1 decreases expression ISO thifluzamide results in decreased expression of NAV1 mRNA CTD PMID:33512557 NCBI chr13:49,418,755...49,671,117
Ensembl chr13:49,418,755...49,671,004
JBrowse link
G Ncan neurocan decreases expression ISO thifluzamide results in decreased expression of NCAN mRNA CTD PMID:33512557 NCBI chr16:19,335,907...19,362,371
Ensembl chr16:19,335,907...19,362,371
JBrowse link
G Nefl neurofilament light chain decreases expression ISO thifluzamide results in decreased expression of NEFL mRNA CTD PMID:33512557 NCBI chr15:46,477,330...46,481,203
Ensembl chr15:46,458,204...46,482,515
JBrowse link
G Nek2 NIMA-related kinase 2 increases expression ISO thifluzamide results in increased expression of NEK2 mRNA CTD PMID:33512557 NCBI chr13:105,936,809...105,950,054
Ensembl chr13:105,936,788...105,950,056
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression ISO thifluzamide results in increased expression of NQO1 mRNA CTD PMID:33512557 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
JBrowse link
G Nr2f1 nuclear receptor subfamily 2, group F, member 1 decreases expression ISO thifluzamide results in decreased expression of NR2F1 mRNA CTD PMID:33512557 NCBI chr 2:9,776,179...9,785,924
Ensembl chr 2:9,776,179...9,785,924
JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 increases expression ISO thifluzamide results in increased expression of NR3C1 mRNA CTD PMID:33512557 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
JBrowse link
G Nr4a2 nuclear receptor subfamily 4, group A, member 2 decreases expression ISO thifluzamide results in decreased expression of NR4A2 mRNA CTD PMID:33512557 NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:62,098,743...62,106,769
JBrowse link
G Nrcam neuronal cell adhesion molecule decreases expression ISO thifluzamide results in decreased expression of NRCAM mRNA CTD PMID:33512557 NCBI chr 6:67,129,723...67,425,510
Ensembl chr 6:67,129,801...67,430,539
JBrowse link
G Nrxn1 neurexin 1 decreases expression ISO thifluzamide results in decreased expression of NRXN1 mRNA CTD PMID:33512557 NCBI chr 6:8,931,360...10,077,381
Ensembl chr 6:8,935,523...10,077,374
JBrowse link
G Olfml2b olfactomedin-like 2B decreases expression ISO thifluzamide results in decreased expression of OLFML2B mRNA CTD PMID:33512557 NCBI chr13:85,402,151...85,439,342
Ensembl chr13:85,402,169...85,439,342
JBrowse link
G Ormdl3 ORMDL sphingolipid biosynthesis regulator 3 decreases expression ISO thifluzamide results in decreased expression of ORMDL3 mRNA CTD PMID:33512557 NCBI chr10:84,086,317...84,092,673
Ensembl chr10:84,086,317...84,093,548
JBrowse link
G P4ha2 prolyl 4-hydroxylase subunit alpha 2 increases expression ISO thifluzamide results in increased expression of P4HA2 mRNA CTD PMID:33512557 NCBI chr10:38,743,894...38,772,741
Ensembl chr10:38,743,894...38,772,993
JBrowse link
G Pcdh8 protocadherin 8 increases expression ISO thifluzamide results in increased expression of PCDH8 mRNA CTD PMID:33512557 NCBI chr15:61,607,521...61,612,090
Ensembl chr15:61,607,521...61,612,097
JBrowse link
G Pdgfb platelet derived growth factor subunit B decreases expression ISO thifluzamide results in decreased expression of PDGFB mRNA CTD PMID:33512557 NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343
JBrowse link
G Pebp1 phosphatidylethanolamine binding protein 1 decreases expression ISO thifluzamide results in decreased expression of PEBP1 mRNA CTD PMID:33512557 NCBI chr12:44,946,307...44,967,890
Ensembl chr12:44,963,675...44,971,780
JBrowse link
G Peg10 paternally expressed 10 decreases expression ISO thifluzamide results in decreased expression of PEG10 mRNA CTD PMID:33512557 NCBI chr 4:33,809,026...33,822,224
Ensembl chr 4:33,817,190...33,819,166
Ensembl chr 4:33,817,190...33,819,166
JBrowse link
G Phgdh phosphoglycerate dehydrogenase increases expression ISO thifluzamide results in increased expression of PHGDH mRNA CTD PMID:33512557 NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:188,595,700...188,624,789
JBrowse link
G Phlda1 pleckstrin homology-like domain, family A, member 1 decreases expression ISO thifluzamide results in decreased expression of PHLDA1 mRNA CTD PMID:33512557 NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542
JBrowse link
G Pink1 PTEN induced kinase 1 decreases expression ISO thifluzamide results in decreased expression of PINK1 mRNA CTD PMID:33512557 NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950
JBrowse link
G Plcb3 phospholipase C beta 3 decreases expression ISO thifluzamide results in decreased expression of PLCB3 mRNA CTD PMID:33512557 NCBI chr 1:213,572,499...213,589,585
Ensembl chr 1:213,574,166...213,589,583
JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 increases expression ISO thifluzamide results in increased expression of PMAIP1 mRNA CTD PMID:33512557 NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382
JBrowse link
G Pou4f2 POU class 4 homeobox 2 decreases expression ISO thifluzamide results in decreased expression of POU4F2 mRNA CTD PMID:33512557 NCBI chr19:46,390,958...46,394,599
Ensembl chr19:46,390,958...46,394,599
JBrowse link
G Ppp1r17 protein phosphatase 1, regulatory subunit 17 decreases expression ISO thifluzamide results in decreased expression of PPP1R17 mRNA CTD PMID:33512557 NCBI chr 4:86,544,024...86,560,839
Ensembl chr 4:86,544,121...86,560,835
JBrowse link
G Prr11 proline rich 11 increases expression ISO thifluzamide results in increased expression of PRR11 mRNA CTD PMID:33512557 NCBI chr10:72,396,127...72,440,643
Ensembl chr10:72,398,667...72,418,275
JBrowse link
G Psat1 phosphoserine aminotransferase 1 increases expression ISO thifluzamide results in increased expression of PSAT1 mRNA CTD PMID:33512557 NCBI chr 1:222,623,553...222,646,187
Ensembl chr 1:222,623,556...222,655,693
JBrowse link
G Ptprf protein tyrosine phosphatase, receptor type, F decreases expression ISO thifluzamide results in decreased expression of PTPRF mRNA CTD PMID:33512557 NCBI chr 5:137,027,376...137,109,405
Ensembl chr 5:137,028,164...137,095,426
JBrowse link
G Rab31 RAB31, member RAS oncogene family decreases expression ISO thifluzamide results in decreased expression of RAB31 mRNA CTD PMID:33512557 NCBI chr 9:112,693,596...112,828,104
Ensembl chr 9:112,693,597...112,828,092
JBrowse link
G Rbx1 ring-box 1 decreases expression ISO thifluzamide results in decreased expression of RBX1 mRNA CTD PMID:33512557 NCBI chr 7:114,870,893...114,881,194
Ensembl chr 7:114,870,972...114,881,191
JBrowse link
G Reln reelin decreases expression ISO thifluzamide results in decreased expression of RELN mRNA CTD PMID:33512557 NCBI chr 4:13,628,440...14,055,201
Ensembl chr 4:13,628,399...14,055,162
JBrowse link
G Rpl28 ribosomal protein L28 increases expression ISO thifluzamide results in increased expression of RPL28 mRNA CTD PMID:33512557 NCBI chr 1:78,080,945...78,083,532
Ensembl chr 1:78,080,945...78,083,771
JBrowse link
G Rpsa ribosomal protein SA increases expression ISO thifluzamide results in increased expression of RPSA mRNA CTD PMID:33512557 NCBI chr 8:128,728,761...128,732,736
Ensembl chr 8:128,728,862...128,732,737
JBrowse link
G Rsl24d1 ribosomal L24 domain containing 1 increases expression ISO thifluzamide results in increased expression of RSL24D1 mRNA CTD PMID:33512557 NCBI chr 8:82,733,627...82,742,632
Ensembl chr 8:82,733,649...82,744,497
JBrowse link
G Rxylt1 ribitol xylosyltransferase 1 increases expression ISO thifluzamide results in increased expression of RXYLT1 mRNA CTD PMID:33512557 NCBI chr 7:59,656,274...59,668,140
Ensembl chr 7:59,656,276...59,668,050
JBrowse link
G Satb1 SATB homeobox 1 decreases expression ISO thifluzamide results in decreased expression of SATB1 mRNA CTD PMID:33512557 NCBI chr 9:4,916,958...5,010,359
Ensembl chr 9:4,917,215...4,989,925
JBrowse link
G Sel1l SEL1L adaptor subunit of SYVN1 ubiquitin ligase increases expression ISO thifluzamide results in increased expression of SEL1L mRNA CTD PMID:33512557 NCBI chr 6:116,466,163...116,510,436
Ensembl chr 6:116,466,163...116,510,578
JBrowse link
G Sema6a semaphorin 6A decreases expression ISO thifluzamide results in decreased expression of SEMA6A mRNA CTD PMID:33512557 NCBI chr18:42,237,227...42,358,540
Ensembl chr18:42,237,228...42,358,540
JBrowse link
G Sephs2 selenophosphate synthetase 2 increases expression ISO thifluzamide results in increased expression of SEPHS2 mRNA CTD PMID:33512557 NCBI chr 1:191,323,637...191,325,955
Ensembl chr 1:191,323,641...191,325,955
JBrowse link
G Serpine2 serpin family E member 2 increases expression ISO thifluzamide results in increased expression of SERPINE2 mRNA CTD PMID:33512557 NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:88,573,149...88,637,202
JBrowse link
G Sesn2 sestrin 2 increases expression ISO thifluzamide results in increased expression of SESN2 mRNA CTD PMID:33512557 NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255
JBrowse link
G Sgcb sarcoglycan, beta decreases expression ISO thifluzamide results in decreased expression of SGCB mRNA CTD PMID:33512557 NCBI chr14:34,917,663...34,932,661
Ensembl chr14:34,912,628...34,933,666
JBrowse link
G Slc17a6 solute carrier family 17 member 6 decreases expression ISO thifluzamide results in decreased expression of SLC17A6 mRNA CTD PMID:33512557 NCBI chr 1:110,348,447...110,388,499
Ensembl chr 1:110,348,447...110,388,498
JBrowse link
G Slc1a2 solute carrier family 1 member 2 decreases expression ISO thifluzamide results in decreased expression of SLC1A2 mRNA CTD PMID:33512557 NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:109,459,630...109,605,249
JBrowse link
G Slc1a4 solute carrier family 1 member 4 increases expression ISO thifluzamide results in increased expression of SLC1A4 mRNA CTD PMID:33512557 NCBI chr14:98,718,646...98,761,672
Ensembl chr14:98,730,450...98,761,790
JBrowse link
G Slc2a6 solute carrier family 2 member 6 decreases expression ISO thifluzamide results in decreased expression of SLC2A6 mRNA CTD PMID:33512557 NCBI chr 3:30,746,472...30,753,287
Ensembl chr 3:30,745,995...30,753,287
JBrowse link
G Slc38a1 solute carrier family 38, member 1 increases expression ISO thifluzamide results in increased expression of SLC38A1 mRNA CTD PMID:33512557 NCBI chr 7:129,612,414...129,681,727
Ensembl chr 7:129,617,387...129,681,778
JBrowse link
G Slc3a2 solute carrier family 3 member 2 increases expression ISO thifluzamide results in increased expression of SLC3A2 mRNA CTD PMID:33512557 NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:215,033,601...215,048,064
JBrowse link
G Slc6a3 solute carrier family 6 member 3 decreases expression ISO thifluzamide results in decreased expression of SLC6A3 mRNA CTD PMID:33512557 NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:31,537,990...31,578,962
JBrowse link
G Slc7a5 solute carrier family 7 member 5 increases expression ISO thifluzamide results in increased expression of SLC7A5 mRNA CTD PMID:33512557 NCBI chr19:66,843,808...66,872,412
Ensembl chr19:66,843,808...66,872,412
JBrowse link
G Slit2 slit guidance ligand 2 decreases expression ISO thifluzamide results in decreased expression of SLIT2 mRNA CTD PMID:33512557 NCBI chr14:66,829,661...67,168,517
Ensembl chr14:66,829,661...67,167,146
JBrowse link
G Snai2 snail family transcriptional repressor 2 increases expression ISO thifluzamide results in increased expression of SNAI2 mRNA CTD PMID:33512557 NCBI chr11:99,686,934...99,690,349
Ensembl chr11:99,686,934...99,690,349
JBrowse link
G Spag5 sperm associated antigen 5 increases expression ISO thifluzamide results in increased expression of SPAG5 mRNA CTD PMID:33512557 NCBI chr10:63,693,300...63,714,813
Ensembl chr10:63,696,466...63,714,811
JBrowse link
G Spc25 SPC25 component of NDC80 kinetochore complex increases expression ISO thifluzamide results in increased expression of SPC25 mRNA CTD PMID:33512557 NCBI chr 3:74,337,872...74,396,825
Ensembl chr 3:74,383,548...74,396,718
JBrowse link
G Spdef SAM pointed domain containing ets transcription factor decreases expression ISO thifluzamide results in decreased expression of SPDEF mRNA CTD PMID:33512557 NCBI chr20:5,773,236...5,787,685
Ensembl chr20:5,773,231...5,787,689
JBrowse link
G Spred2 sprouty-related, EVH1 domain containing 2 increases expression ISO thifluzamide results in increased expression of SPRED2 mRNA CTD PMID:33512557 NCBI chr14:98,350,577...98,452,143
Ensembl chr14:98,350,290...98,452,143
JBrowse link
G Srsf10 serine and arginine rich splicing factor 10 increases expression ISO thifluzamide results in increased expression of SRSF10 mRNA CTD PMID:33512557 NCBI chr 5:153,372,307...153,386,520
Ensembl chr 5:153,372,316...153,386,513
JBrowse link
G Sst somatostatin decreases expression ISO thifluzamide results in decreased expression of SST mRNA CTD PMID:33512557 NCBI chr11:90,461,546...90,462,823
Ensembl chr11:90,461,546...90,462,823
JBrowse link
G Sytl1 synaptotagmin-like 1 increases expression ISO thifluzamide results in increased expression of SYTL1 mRNA CTD PMID:33512557 NCBI chr 5:150,736,425...150,746,840
Ensembl chr 5:150,736,425...150,746,840
JBrowse link
G Taf9 TATA-box binding protein associated factor 9 increases expression ISO thifluzamide results in increased expression of TAF9 mRNA CTD PMID:33512557 NCBI chr 2:33,528,388...33,532,395
Ensembl chr 2:33,531,368...33,536,078
JBrowse link
G Tcf4 transcription factor 4 decreases expression ISO thifluzamide results in decreased expression of TCF4 mRNA CTD PMID:33512557 NCBI chr18:65,216,840...65,563,186
Ensembl chr18:65,216,849...65,558,401
JBrowse link
G Tfdp1 transcription factor Dp-1 decreases expression ISO thifluzamide results in decreased expression of TFDP1 mRNA CTD PMID:33512557 NCBI chr16:82,864,220...82,903,166
Ensembl chr16:82,864,226...82,902,996
JBrowse link
G Tgfb3 transforming growth factor, beta 3 decreases expression ISO thifluzamide results in decreased expression of TGFB3 mRNA CTD PMID:33512557 NCBI chr 6:111,435,170...111,457,646
Ensembl chr 6:111,435,170...111,456,946
JBrowse link
G Tmem97 transmembrane protein 97 decreases expression ISO thifluzamide results in decreased expression of TMEM97 mRNA CTD PMID:33512557 NCBI chr10:63,936,276...63,945,359
Ensembl chr10:63,936,271...63,945,818
JBrowse link
G Tnc tenascin C decreases expression ISO thifluzamide results in decreased expression of TNC mRNA CTD PMID:33512557 NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131
JBrowse link
G Top2a DNA topoisomerase II alpha increases expression ISO thifluzamide results in increased expression of TOP2A mRNA CTD PMID:33512557 NCBI chr10:84,441,954...84,473,093
Ensembl chr10:84,441,954...84,473,366
JBrowse link
G Tpi1 triosephosphate isomerase 1 decreases expression ISO thifluzamide results in decreased expression of TPI1 mRNA CTD PMID:33512557 NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:159,301,562...159,305,413
JBrowse link
G Tpx2 TPX2, microtubule nucleation factor increases expression ISO thifluzamide results in increased expression of TPX2 mRNA CTD PMID:33512557 NCBI chr 3:161,778,709...161,820,941
Ensembl chr 3:161,778,742...161,820,724
JBrowse link
G Trib3 tribbles pseudokinase 3 increases expression ISO thifluzamide results in increased expression of TRIB3 mRNA CTD PMID:33512557 NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802
JBrowse link
G Trim13 tripartite motif-containing 13 decreases expression ISO thifluzamide results in decreased expression of TRIM13 mRNA CTD PMID:33512557 NCBI chr15:39,909,587...39,948,719
Ensembl chr15:39,902,284...39,958,892
JBrowse link
G Tsc22d3 TSC22 domain family, member 3 increases expression ISO thifluzamide results in increased expression of TSC22D3 mRNA CTD PMID:33512557 NCBI chr  X:109,006,410...109,066,389
Ensembl chr  X:109,006,420...109,015,519
JBrowse link
G Ttk Ttk protein kinase increases expression ISO thifluzamide results in increased expression of TTK mRNA CTD PMID:33512557 NCBI chr 8:93,632,678...93,672,664
Ensembl chr 8:93,634,319...93,672,664
JBrowse link
G Tubb2a tubulin, beta 2A class IIa decreases expression ISO thifluzamide results in decreased expression of TUBB2A mRNA CTD PMID:33512557 NCBI chr17:31,002,186...31,006,057
Ensembl chr17:30,983,387...31,006,838
JBrowse link
G Tubb2b tubulin, beta 2B class IIb decreases expression ISO thifluzamide results in decreased expression of TUBB2B mRNA CTD PMID:33512557 NCBI chr17:30,953,086...30,956,133
Ensembl chr17:30,952,923...30,955,990
JBrowse link
G Tubb3 tubulin, beta 3 class III decreases expression ISO thifluzamide results in decreased expression of TUBB3 mRNA CTD PMID:33512557 NCBI chr19:68,365,687...68,374,741
Ensembl chr19:68,365,587...68,374,740
JBrowse link
G Tut7 terminal uridylyl transferase 7 decreases expression ISO thifluzamide results in decreased expression of TUT7 mRNA CTD PMID:33512557 NCBI chr17:4,854,553...4,908,758
Ensembl chr17:4,855,936...4,909,070
JBrowse link
G Txndc5 thioredoxin domain containing 5 increases expression ISO thifluzamide results in increased expression of TXNDC5 mRNA CTD PMID:33512557 NCBI chr17:26,495,467...26,523,608
Ensembl chr17:26,490,047...26,523,597
JBrowse link
G Txnip thioredoxin interacting protein decreases expression ISO thifluzamide results in decreased expression of TXNIP mRNA CTD PMID:33512557 NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731
JBrowse link
G Txnrd1 thioredoxin reductase 1 increases expression ISO thifluzamide results in increased expression of TXNRD1 mRNA CTD PMID:33512557 NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817
JBrowse link
G Txnrd2 thioredoxin reductase 2 increases expression ISO thifluzamide results in increased expression of TXNRD2 mRNA CTD PMID:33512557 NCBI chr11:96,024,321...96,072,475
Ensembl chr11:96,024,324...96,072,475
JBrowse link
G Ubb ubiquitin B increases expression ISO thifluzamide results in increased expression of UBB mRNA CTD PMID:33512557 NCBI chr10:47,746,923...47,748,628
Ensembl chr10:47,727,701...47,750,335
JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C increases expression ISO thifluzamide results in increased expression of UBE2C mRNA CTD PMID:33512557 NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:173,925,934...173,932,678
JBrowse link
G Uhrf1 ubiquitin-like with PHD and ring finger domains 1 decreases expression ISO thifluzamide results in decreased expression of UHRF1 mRNA CTD PMID:33512557 NCBI chr 9:1,220,162...1,241,792
Ensembl chr 9:1,222,063...1,241,792
JBrowse link
G Vegfa vascular endothelial growth factor A increases expression ISO thifluzamide results in increased expression of VEGFA mRNA CTD PMID:33512557 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
JBrowse link
G Vegfd vascular endothelial growth factor D decreases expression ISO thifluzamide results in decreased expression of VEGFD mRNA CTD PMID:33512557 NCBI chr  X:33,704,582...33,740,305
Ensembl chr  X:33,706,055...33,740,167
JBrowse link
G Vim vimentin increases expression ISO thifluzamide results in increased expression of VIM mRNA CTD PMID:33512557 NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
JBrowse link
G Wars1 tryptophanyl-tRNA synthetase 1 increases expression ISO thifluzamide results in increased expression of WARS1 mRNA CTD PMID:33512557 NCBI chr 6:133,540,463...133,571,645
Ensembl chr 6:133,539,744...133,571,645
JBrowse link
G Wdtc1 WD and tetratricopeptide repeats 1 decreases expression ISO thifluzamide results in decreased expression of WDTC1 mRNA CTD PMID:33512557 NCBI chr 5:150,775,358...150,843,558
Ensembl chr 5:150,775,358...150,824,307
JBrowse link
G Xbp1 X-box binding protein 1 increases expression ISO thifluzamide results in increased expression of XBP1 mRNA CTD PMID:33512557 NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706
JBrowse link
G Zeb2 zinc finger E-box binding homeobox 2 decreases expression ISO thifluzamide results in decreased expression of ZEB2 mRNA CTD PMID:33512557 NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:49,624,028...49,754,323
JBrowse link
tiazofurine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Kras KRAS proto-oncogene, GTPase multiple interactions
decreases expression
ISO Guanosine inhibits the reaction [tiazofurin results in decreased expression of KRAS] CTD PMID:9381980 NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor decreases expression
multiple interactions
ISO tiazofurin results in decreased expression of MYC
Guanosine inhibits the reaction [tiazofurin results in decreased expression of MYC]
CTD PMID:9381980 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
JBrowse link
vosaroxin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions ISO vosaroxin inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to ARNT protein]] CTD PMID:29800573 NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546
JBrowse link
G Casp3 caspase 3 increases activity ISO vosaroxin results in increased activity of CASP3 protein CTD PMID:29800573 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions
decreases expression
ISO dorsomorphin inhibits the reaction [vosaroxin results in decreased expression of HIF1A protein]; SIRT3 protein inhibits the reaction [vosaroxin results in decreased expression of HIF1A protein]; vosaroxin inhibits the reaction [Oxygen deficiency affects the localization of HIF1A protein]; vosaroxin inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to ARNT protein]] CTD PMID:29800573 NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
JBrowse link
G Idh2 isocitrate dehydrogenase (NADP(+)) 2 increases activity
multiple interactions
ISO vosaroxin results in increased activity of IDH2 protein
SIRT2 protein affects the reaction [vosaroxin results in increased activity of IDH2 protein]
CTD PMID:29800573 NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:143,439,323...143,467,248
JBrowse link
G Sirt2 sirtuin 2 multiple interactions ISO SIRT2 protein affects the reaction [vosaroxin results in increased activity of IDH2 protein]; SIRT2 protein affects the reaction [vosaroxin results in increased activity of SOD2 protein] CTD PMID:29800573 NCBI chr 1:93,181,472...93,204,499
Ensembl chr 1:93,181,224...93,204,499
JBrowse link
G Sirt3 sirtuin 3 multiple interactions ISO SIRT3 protein inhibits the reaction [vosaroxin results in decreased expression of HIF1A protein] CTD PMID:29800573 NCBI chr 1:205,371,703...205,394,145
Ensembl chr 1:205,371,710...205,394,076
JBrowse link
G Sod2 superoxide dismutase 2 increases activity
multiple interactions
ISO vosaroxin results in increased activity of SOD2 protein
SIRT2 protein affects the reaction [vosaroxin results in increased activity of SOD2 protein]
CTD PMID:29800573 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 20870
    chemical entity 20868
      atom 20868
        nonmetal atom 20776
          sulfur atom 18042
            sulfur molecular entity 18042
              organosulfur compound 17759
                organosulfur heterocyclic compound 10096
                  thiazoles 1815
                    1,3-thiazoles 1248
                      (1S,2R)-1-amino-1-(1,3-thiazol-2-yl)propan-2-ol 0
                      (2R,4S)-2-[(1R)-1-\{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino\}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid 0
                      (2S)-(\{(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl\}amino)(4-fluorophenyl)acetic acid 0
                      (2S)-2-(\{(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl\}amino)-2-(4-fluorophenyl)-N-[(4-nitrophenyl)sulfonyl]acetamide 0
                      (2S)-2-amino-4-(methylsulfanyl)-1-(1,3-thiazol-2-yl)butane-1,1-diol 0
                      (2S)-3-(2-amino-1,3-thiazol-4-yl)-2-methylpropanal 0
                      (2S)-N-\{(1R,2R)-1-benzyl-2-hydroxy-3-[(\{4-[(E)-(hydroxyimino)methyl]phenyl\}sulfonyl)(2-methylpropyl)amino]propyl\}-3-methyl-2-\{3-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-oxoimidazolidin-1-yl\}butanamide 0
                      (2S,4S,5R)-1-(4-tert-butylbenzoyl)-2-isobutyl-5-(1,3-thiazol-2-yl)pyrrolidine-2,4-dicarboxylic acid 0
                      (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2R)-3-[(1,3-benzodioxol-5-ylsulfonyl)(2-methylpropyl)amino]-2-hydroxy-1-\{4-[(2-methyl-1,3-thiazol-4-yl)methoxy]benzyl\}propyl]carbamate 0
                      (4-\{3-[(6,7-diethoxyquinazolin-4-yl)amino]phenyl\}-1,3-thiazol-2-yl)methanol 0
                      (5R)-2-sulfanyl-5-[4-(trifluoromethyl)benzyl]-1,3-thiazol-4(5H)-one 0
                      (5Z)-5-[(5-ethylfuran-2-yl)methylidene]-2-\{[(S)-(4-fluorophenyl)(1H-tetrazol-5-yl)methyl]amino\}-1,3-thiazol-4(5H)-one 0
                      (6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-hydroxyimino-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                      (E)-2-[[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]hydrazinylidene]methyl]benzoic acid 0
                      (\{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino\}methyl)boronic acid 0
                      (\{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino\}methyl)phosphonic acid 0
                      1,3-thiazol-2-amine 0
                      1,3-thiazole-2-carbaldehyde + 0
                      1,3-thiazolecarboxamide + 0
                      1,3-thiazolemonocarboxylic acid + 28
                      1,3-thiazolium cation + 38
                      1-(3-(2,4-dimethylthiazol-5-yl)-4-oxo-2,4-dihydroindeno[1,2-c]pyrazol-5-yl)-3-(4-methylpiperazin-1-yl)urea 0
                      1-(4-\{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl\}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone + 0
                      1-(4-chlorophenyl)-3-[4-methyl-2-(thiophen-2-yl)-1,3-thiazol-5-yl]urea 0
                      1-(4-methoxybenzyl)-3-(5-nitro-1,3-thiazol-2-yl)urea 15
                      1-(butan-2-ylidene)-2-[4-(4-chlorophenyl)thiazol-2-yl]hydrazine 0
                      1-[4-(4-chlorophenyl)thiazol-2-yl]-2-(pentan-3-ylidene)hydrazine 0
                      1-[4-(4-chlorophenyl)thiazol-2-yl]-2-(propan-2-ylidene)hydrazine 0
                      1-[5-t-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-phenylmethoxyethyl)-1,3-thiazol-2-yl]urea 0
                      1-allyl-4-hydroxy-2-oxo-N-(1,3-thiazol-2-yl)-1,2-dihydroquinoline-3-carboxamide 0
                      1-allyl-4-hydroxy-2-oxo-N-(4-phenyl-1,3-thiazol-2-yl)-1,2-dihydroquinoline-3-carboxamide 0
                      2,3,4-trimethyl-1,3-thiazol-3-ium 0
                      2,4,5-trimethylthiazole 0
                      2-(2-amino-1,3-thiazol-4-yl)-2-(1-carboxy-1-methylethoxyimino)acetylaminomethylboronic acid 0
                      2-(2-carboxy-4-methylthiazol-5-yl)ethyl phosphate 0
                      2-(3-\{[4-(hydroxyamino)-2-methylpyrimidin-5-yl]methyl\}-4-methyl-2,3-dihydro-1,3-thiazol-5-yl)ethyl trihydrogen diphosphate 0
                      2-(3-\{[4-amino-2-(trifluoromethyl)pyrimidin-5-yl]methyl\}-4-methyl-1,3-thiazol-3-ium-5-yl)ethyl phosphate 0
                      2-(4-\{5-[(1H-benzimidazol-2-ylamino)methyl]thiophen-2-yl\}-1,3-thiazol-2-yl)guanidine 0
                      2-(6-methoxy-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-N-[4-(piperazin-1-yl)pyridin-3-yl]-1,3-thiazole-4-carboxamide 0
                      2-[(1R)-1-methylpropyl]-1,3-thiazole 0
                      2-[(2E)-3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-2-(1,2-dihydroxyethylidene)-4-methyl-2,3-dihydro-1,3-thiazol-5-yl]ethyl trihydrogen diphosphate 0
                      2-[(2E)-3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-2-(1-hydroxyethylidene)-4-methyl-2,3-dihydro-1,3-thiazol-5-yl]ethyl trihydrogen diphosphate 0
                      2-[(ethanesulfonyl)amino]-5-fluoro-4-[4-methyl-5-oxo-3-(trifluoromethyl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzene-1-carbothioamide + 0
                      2-[5-(benzylamino)-2-(methylsulfanyl)-6-oxopyrimidin-1(6H)-yl]-N-[(1S)-4-carbamimidamido-1-(1,3-thiazol-2-ylcarbonyl)butyl]acetamide 0
                      2-[5-amino-2-(3-methylphenyl)-6-oxopyrimidin-1(6H)-yl]-N-[(1S)-4-carbamimidamido-1-(1,3-thiazol-2-ylcarbonyl)butyl]acetamide 0
                      2-[N(2)-\{[(1R)-1-(4-bromophenyl)ethyl]carbamoyl\}-N(5)-carbamoyl-L-ornithyl-L-valyl-N(5)-(diaminomethyl)-L-ornithyl]-1,3-thiazole 0
                      2-\{2-[(1R)-1-[3-(cyclopropyloxy)-4-(difluoromethoxy)phenyl]-2-(1-oxidopyridin-3-yl)ethyl]-1,3-thiazol-5-yl\}-1,1,1,3,3,3-hexafluoropropan-2-ol 0
                      2-\{2-[(1S)-1-[3-(cyclopropyloxy)-4-(difluoromethoxy)phenyl]-2-(1-oxidopyridin-3-yl)ethyl]-1,3-thiazol-5-yl\}-1,1,1,3,3,3-hexafluoropropan-2-ol 0
                      2-\{3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-2-oxo-2,3-dihydro-1,3-thiazol-5-yl\}ethyl trihydrogen diphosphate 0
                      2-amino-4-fluoro-5-[(1-methyl-1H-imidazol-2-yl)sulfanyl]-N-1,3-thiazol-2-ylbenzamide 0
                      2-amino-5-methyl-1,3-thiazole 0
                      2-amino-Delta(2)-thiazoline-4-carboxylic acid + 0
                      2-carboxy-4-methyl-5-[(2-phosphonooxy)ethylidene]-2,5-dihydrothiazole + 0
                      2-chlorothiazole + 452
                      2-formamidophenyl-2'-thiazolylketone 0
                      2-isobutylthiazole 0
                      2-isopropyl-4-methylthiazole 0
                      3,4,5-trimethyl-1,3-thiazole 0
                      3,4-dimethyl-1,3-thiazolium 0
                      3-[(2,2-dimethylpropanoyl)amino]-N-1,3-thiazol-2-ylpyridine-2-carboxamide 0
                      3-[(3,5-dibromo-4-hydroxyphenyl)carbonyl]-2-ethyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]-1-benzofuran-6-sulfonamide 0
                      3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-2-\{(1S)-1-hydroxy-1-[(R)-hydroxy(methoxy)phosphoryl]ethyl\}-5-(2-\{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy\}ethyl)-4-methyl-1,3-thiazol-3-ium 0
                      3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-\{[(S)-hydroxy(phosphonoamino)phosphoryl]oxy\}ethyl)-4-methyl-1,3-thiazol-3-ium 0
                      3-[(\{5-[(2-amino-1,3-thiazol-4-yl)methyl]-4-ethyl-1,2,4-triazol-3-yl\}sulfanyl)methyl]-N-(2,3-dimethylphenyl)benzamide 0
                      3-\{[(4R,5S,6S,7R)-4,7-dibenzyl-3-(cyclopropylmethyl)-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]methyl\}-N-1,3-thiazol-2-ylbenzamide 0
                      3-\{[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino\}phenol 0
                      3-hydroxy-3-(thiazol-2-yl)indolin-2-one 0
                      3-methyl-1,3-thiazolium 0
                      4,5-dihydro-1,3-thiazol-2-amine 0
                      4-(2,4-dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyrimidin-2-amine 0
                      4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-amine 0
                      4-(2-amino-4-methyl-1,3-thiazol-5-yl)-N-(3-nitrophenyl)pyrimidin-2-amine 0
                      4-(\{4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl\}amino)phenol 0
                      4-[(5-isopropyl-1,3-thiazol-2-yl)amino]benzenesulfonamide 0
                      4-[2-(2-methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one + 0
                      4-\{[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino\}-N-1,3-thiazol-2-ylbenzenesulfonamide 0
                      4-amino-2-[(3-chlorophenyl)amino]-5-[(4-fluorophenyl)carbonyl]-1,3-thiazol-3-ium 0
                      4-hydroxy-1-isobutyl-N-(4-methyl-1,3-thiazol-2-yl)-2-oxoquinoline-3-carboxamide 0
                      4-hydroxy-1-isobutyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxoquinoline-3-carboxamide 0
                      4-hydroxy-1-isopentyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxoquinoline-3-carboxamide 0
                      4-hydroxy-1-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydro-3-quinolinecarboxamide 0
                      4-methyl-1,3-thiazol-2-amine 0
                      4-methyl-5-(2-phosphonooxyethyl)thiazole + 0
                      4-methyl-5-\{(2E)-2-[(4-morpholin-4-ylphenyl)imino]-2,5-dihydropyrimidin-4-yl\}-1,3-thiazol-2-amine 0
                      4-methyl-N-\{(5Z)-5-[(5-methylfuran-2-yl)methylidene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl\}benzenesulfonamide 0
                      4-methylaeruginoic acid 0
                      4-methylthiazole 0
                      4EGI-1 0
                      5-(2-hydroxyethyl)-1,3-thiazole + 0
                      5-(2-hydroxyethyl)-4-methylthiazole 0
                      6-methoxycamalexin 0
                      AMPK activator PT 1 0
                      Cefteram pivoxil 0
                      Disperse Blue 124 0
                      GW 501516 + 65
                      GW 501516 sulfone 0
                      GW 501516 sulfoxide + 0
                      HA15 0
                      LCL161 5
                      LY-221481 0
                      LimKi 3 0
                      N'-[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]-N,N-dimethylbenzene-1,4-diamine 0
                      N(2)-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]-N-butyl-3,3-dimethoxyalaninamide 0
                      N(2)-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]-N-butyl-L-alaninamide 0
                      N(2)-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]-N-butyl-L-cysteinamide 0
                      N(2)-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]-N-butyl-L-serinamide 0
                      N(2)-\{[(1R)-1-(4-bromophenyl)ethyl]carbamoyl\}-L-asparaginyl-N-\{(1S)-4-carbamimidamido-1-[(S)-(2S)-2,3-dihydro-1,3-thiazol-2-yl(hydroxy)methyl]butyl\}-L-valinamide 0
                      N(4)-acetylsulfathiazole 0
                      N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)-1-(N,N-dimethylglycyl)piperidine-4-carboxamide 0
                      N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide 0
                      N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)piperidine-4-carboxamide 0
                      N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)tetrahydro-2H-pyran-4-carboxamide 0
                      N-(carboxymethyl)-3-cyclohexyl-D-alanyl-N-[(4-carbamimidoyl-1,3-thiazol-2-yl)methyl]-L-prolinamide 0
                      N-(morpholin-4-ylsulfonyl)-L-phenylalanyl-3-(2-amino-1,3-thiazol-4-yl)-N-\{(1R,2R,3S)-1-[(1R)-cyclohex-3-en-1-ylmethyl]-2,3-dihydroxy-5-methylhexyl\}-L-alaninamide 0
                      N-[(1S)-1-\{[(1S)-4-[(diaminomethyl)amino]-1-(1,3-thiazol-2-ylcarbonyl)butyl]carbamoyl\}-2-methylpropyl]-4-methylpentanamide 0
                      N-[(1S)-1-\{[(1S)-4-carbamimidamido-1-(1,3-thiazol-2-ylcarbonyl)butyl]carbamoyl\}-2-methylpropyl]-2-(3-chlorophenyl)-2-oxoacetamide 0
                      N-[(1S)-4-carbamimidamido-1-(1,3-thiazol-2-ylcarbonyl)butyl]-2-[2-(3,4-dichlorophenyl)-5-[(1-methylethyl)amino]-6-oxopyrimidin-1(6H)-yl]acetamide 0
                      N-[(1S)-4-carbamimidamido-1-(1,3-thiazol-2-ylcarbonyl)butyl]-2-[2-(3-methylphenyl)-6-oxo-5-[(quinolin-8-ylmethyl)amino]pyrimidin-1(6H)-yl]acetamide 0
                      N-[(2Z)-5-(1-methylethyl)-1,3-thiazol-2(3H)-ylidene]-2-pyridin-3-ylacetamide 0
                      N-[(2Z)-5-\{4-chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl\}-4-methyl-1,3-thiazol-2(3H)-ylidene]acetamide 0
                      N-[4,5-bis(4-hydroxyphenyl)-1,3-thiazol-2-yl]hexanamide 0
                      N-[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]-N'-hydroxyimidoformamide 0
                      N-[5-(1-naphthylmethyl)-1,3-thiazol-2-yl]cyclohexanecarboxamide 0
                      N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide + 0
                      N-\{(1S)-4-carbamimidamido-1-[(S)-hydroxy(1,3-thiazol-2-yl)methyl]butyl\}-N(2)-carbamoyl-L-valinamide 0
                      N-\{[(3S,5S)-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-3-yl]methyl\}-1,3-thiazole-4-carboxamide 0
                      N-\{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl\}-G-dR-G-dD-dD-dD-NH2 0
                      N-\{[4-(1,1-dioxido-3-oxo-2,3-dihydro-1,2-thiazol-5-yl)phenyl]acetyl\}-L-phenylalanyl-4-(1,1-dioxido-3-oxo-2,3-dihydro-1,2-thiazol-5-yl)-L-phenylalaninamide 0
                      N-cyclopentyl-N'-1,3-thiazol-2-yloxalamide 0
                      N-succinylsulfathiazole 4
                      Niridazole 0
                      Nithiazide 0
                      Pulicatin C 0
                      Pulicatin D 0
                      Pulicatin E 0
                      RO4927350 0
                      SBL-398 0
                      SQ 26,992 0
                      SSTC3 0
                      Thiazolylethylamine 0
                      XV638 0
                      YM-216391 0
                      [(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-\{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)pent-2-enoyl]amino\}-3-[(carbamoyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 0
                      \{(2Z)-4-amino-2-[(4-methoxyphenyl)imino]-2,3-dihydro-1,3-thiazol-5-yl\}(4-methoxyphenyl)methanone 0
                      abafungin 0
                      althiomycin 0
                      aminotipyr 0
                      apratoxin A 1
                      apratoxin B 0
                      apratoxin C 0
                      benzyl [(1S)-1-\{[2-(\{2-[(1S)-1-\{[(benzyloxy)carbonyl]amino\}-3-methylbutyl]-1,3-thiazol-4-yl\}carbonyl)hydrazino]carbonyl\}-3-methylbutyl]carbamate 0
                      bi-1,3-thiazole + 0
                      bistratamide I 0
                      camalexin + 3
                      cefcapene 0
                      cefditoren pivoxil 0
                      cefetamet pivoxil 0
                      cefodizime 0
                      cefoselis + 2
                      cefotaxime 5
                      ceftaroline + 5
                      ceftaroline fosamil + 0
                      ceftriaxone 16
                      cinalukast 0
                      clothianidin + 403
                      cobicistat + 10
                      colibactin 0
                      curacozole 0
                      cyclopentylidene-[4-(4-chlorophenyl)thiazol-2-yl]hydrazone 0
                      cystothiazole A 0
                      dCeMM4 0
                      dabrafenib + 30
                      dasatinib (anhydrous) + 0
                      dicloromezotiaz 0
                      dihydrocamalexic acid + 0
                      dolastatin 10 0
                      dysidenin 1
                      epothilone + 5
                      ethyl 2-[4-(2H-1,4-benzothiazin-3-yl)piperazin-1-yl]-1,3-thiazole-4-carboxylate 0
                      famotidine + 65
                      fenmezoditiaz 0
                      fluensulfone 1
                      halicin 0
                      isavuconazole 0
                      ixabepilone 0
                      masitinib 9
                      meloxicam 35
                      mirabegron 8
                      myxothiazol 12
                      nizatidine 2
                      pateamine 0
                      phthalylsulfathiazole 0
                      pulicatin F 0
                      pulicatin G 0
                      ravuconazole 0
                      ritonavir + 117
                      sulfathiazole + 4
                      tenonitrozole 0
                      tert-butyl [2-(1,3-thiazol-2-ylcarbamoyl)pyridin-3-yl]carbamate 0
                      thiabendazole 338
                      thiamethoxam + 56
                      thiazole + 0
                      thiazole-5-carboxamide 0
                      thifluzamide 241
                      tiapyrachlor 0
                      tiazofurine 2
                      varlitinib 0
                      venturamide A 0
                      venturamide B 0
                      vosaroxin 7
Path 2
Term Annotations click to browse term
  CHEBI ontology 20870
    subatomic particle 20868
      composite particle 20868
        hadron 20868
          baryon 20868
            nucleon 20868
              atomic nucleus 20868
                atom 20868
                  main group element atom 20791
                    p-block element atom 20791
                      carbon group element atom 20724
                        carbon atom 20719
                          organic molecular entity 20719
                            organic molecule 20663
                              organic cyclic compound 20413
                                organic heterocyclic compound 19385
                                  heteroarene 17445
                                    monocyclic heteroarene 15186
                                      azole 14616
                                        thiazoles 1815
                                          1,3-thiazoles 1248
                                            (1S,2R)-1-amino-1-(1,3-thiazol-2-yl)propan-2-ol 0
                                            (2R,4S)-2-[(1R)-1-\{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino\}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid 0
                                            (2S)-(\{(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl\}amino)(4-fluorophenyl)acetic acid 0
                                            (2S)-2-(\{(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl\}amino)-2-(4-fluorophenyl)-N-[(4-nitrophenyl)sulfonyl]acetamide 0
                                            (2S)-2-amino-4-(methylsulfanyl)-1-(1,3-thiazol-2-yl)butane-1,1-diol 0
                                            (2S)-3-(2-amino-1,3-thiazol-4-yl)-2-methylpropanal 0
                                            (2S)-N-\{(1R,2R)-1-benzyl-2-hydroxy-3-[(\{4-[(E)-(hydroxyimino)methyl]phenyl\}sulfonyl)(2-methylpropyl)amino]propyl\}-3-methyl-2-\{3-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-oxoimidazolidin-1-yl\}butanamide 0
                                            (2S,4S,5R)-1-(4-tert-butylbenzoyl)-2-isobutyl-5-(1,3-thiazol-2-yl)pyrrolidine-2,4-dicarboxylic acid 0
                                            (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2R)-3-[(1,3-benzodioxol-5-ylsulfonyl)(2-methylpropyl)amino]-2-hydroxy-1-\{4-[(2-methyl-1,3-thiazol-4-yl)methoxy]benzyl\}propyl]carbamate 0
                                            (4-\{3-[(6,7-diethoxyquinazolin-4-yl)amino]phenyl\}-1,3-thiazol-2-yl)methanol 0
                                            (5R)-2-sulfanyl-5-[4-(trifluoromethyl)benzyl]-1,3-thiazol-4(5H)-one 0
                                            (5Z)-5-[(5-ethylfuran-2-yl)methylidene]-2-\{[(S)-(4-fluorophenyl)(1H-tetrazol-5-yl)methyl]amino\}-1,3-thiazol-4(5H)-one 0
                                            (6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-hydroxyimino-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 0
                                            (E)-2-[[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]hydrazinylidene]methyl]benzoic acid 0
                                            (\{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino\}methyl)boronic acid 0
                                            (\{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino\}methyl)phosphonic acid 0
                                            1,3-thiazol-2-amine 0
                                            1,3-thiazole-2-carbaldehyde + 0
                                            1,3-thiazolecarboxamide + 0
                                            1,3-thiazolemonocarboxylic acid + 28
                                            1,3-thiazolium cation + 38
                                            1-(3-(2,4-dimethylthiazol-5-yl)-4-oxo-2,4-dihydroindeno[1,2-c]pyrazol-5-yl)-3-(4-methylpiperazin-1-yl)urea 0
                                            1-(4-\{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl\}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone + 0
                                            1-(4-chlorophenyl)-3-[4-methyl-2-(thiophen-2-yl)-1,3-thiazol-5-yl]urea 0
                                            1-(4-methoxybenzyl)-3-(5-nitro-1,3-thiazol-2-yl)urea 15
                                            1-(butan-2-ylidene)-2-[4-(4-chlorophenyl)thiazol-2-yl]hydrazine 0
                                            1-[4-(4-chlorophenyl)thiazol-2-yl]-2-(pentan-3-ylidene)hydrazine 0
                                            1-[4-(4-chlorophenyl)thiazol-2-yl]-2-(propan-2-ylidene)hydrazine 0
                                            1-[5-t-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-phenylmethoxyethyl)-1,3-thiazol-2-yl]urea 0
                                            1-allyl-4-hydroxy-2-oxo-N-(1,3-thiazol-2-yl)-1,2-dihydroquinoline-3-carboxamide 0
                                            1-allyl-4-hydroxy-2-oxo-N-(4-phenyl-1,3-thiazol-2-yl)-1,2-dihydroquinoline-3-carboxamide 0
                                            2,3,4-trimethyl-1,3-thiazol-3-ium 0
                                            2,4,5-trimethylthiazole 0
                                            2-(2-amino-1,3-thiazol-4-yl)-2-(1-carboxy-1-methylethoxyimino)acetylaminomethylboronic acid 0
                                            2-(2-carboxy-4-methylthiazol-5-yl)ethyl phosphate 0
                                            2-(3-\{[4-(hydroxyamino)-2-methylpyrimidin-5-yl]methyl\}-4-methyl-2,3-dihydro-1,3-thiazol-5-yl)ethyl trihydrogen diphosphate 0
                                            2-(3-\{[4-amino-2-(trifluoromethyl)pyrimidin-5-yl]methyl\}-4-methyl-1,3-thiazol-3-ium-5-yl)ethyl phosphate 0
                                            2-(4-\{5-[(1H-benzimidazol-2-ylamino)methyl]thiophen-2-yl\}-1,3-thiazol-2-yl)guanidine 0
                                            2-(6-methoxy-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-N-[4-(piperazin-1-yl)pyridin-3-yl]-1,3-thiazole-4-carboxamide 0
                                            2-[(1R)-1-methylpropyl]-1,3-thiazole 0
                                            2-[(2E)-3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-2-(1,2-dihydroxyethylidene)-4-methyl-2,3-dihydro-1,3-thiazol-5-yl]ethyl trihydrogen diphosphate 0
                                            2-[(2E)-3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-2-(1-hydroxyethylidene)-4-methyl-2,3-dihydro-1,3-thiazol-5-yl]ethyl trihydrogen diphosphate 0
                                            2-[(ethanesulfonyl)amino]-5-fluoro-4-[4-methyl-5-oxo-3-(trifluoromethyl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzene-1-carbothioamide + 0
                                            2-[5-(benzylamino)-2-(methylsulfanyl)-6-oxopyrimidin-1(6H)-yl]-N-[(1S)-4-carbamimidamido-1-(1,3-thiazol-2-ylcarbonyl)butyl]acetamide 0
                                            2-[5-amino-2-(3-methylphenyl)-6-oxopyrimidin-1(6H)-yl]-N-[(1S)-4-carbamimidamido-1-(1,3-thiazol-2-ylcarbonyl)butyl]acetamide 0
                                            2-[N(2)-\{[(1R)-1-(4-bromophenyl)ethyl]carbamoyl\}-N(5)-carbamoyl-L-ornithyl-L-valyl-N(5)-(diaminomethyl)-L-ornithyl]-1,3-thiazole 0
                                            2-\{2-[(1R)-1-[3-(cyclopropyloxy)-4-(difluoromethoxy)phenyl]-2-(1-oxidopyridin-3-yl)ethyl]-1,3-thiazol-5-yl\}-1,1,1,3,3,3-hexafluoropropan-2-ol 0
                                            2-\{2-[(1S)-1-[3-(cyclopropyloxy)-4-(difluoromethoxy)phenyl]-2-(1-oxidopyridin-3-yl)ethyl]-1,3-thiazol-5-yl\}-1,1,1,3,3,3-hexafluoropropan-2-ol 0
                                            2-\{3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-2-oxo-2,3-dihydro-1,3-thiazol-5-yl\}ethyl trihydrogen diphosphate 0
                                            2-amino-4-fluoro-5-[(1-methyl-1H-imidazol-2-yl)sulfanyl]-N-1,3-thiazol-2-ylbenzamide 0
                                            2-amino-5-methyl-1,3-thiazole 0
                                            2-amino-Delta(2)-thiazoline-4-carboxylic acid + 0
                                            2-carboxy-4-methyl-5-[(2-phosphonooxy)ethylidene]-2,5-dihydrothiazole + 0
                                            2-chlorothiazole + 452
                                            2-formamidophenyl-2'-thiazolylketone 0
                                            2-isobutylthiazole 0
                                            2-isopropyl-4-methylthiazole 0
                                            3,4,5-trimethyl-1,3-thiazole 0
                                            3,4-dimethyl-1,3-thiazolium 0
                                            3-[(2,2-dimethylpropanoyl)amino]-N-1,3-thiazol-2-ylpyridine-2-carboxamide 0
                                            3-[(3,5-dibromo-4-hydroxyphenyl)carbonyl]-2-ethyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]-1-benzofuran-6-sulfonamide 0
                                            3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-2-\{(1S)-1-hydroxy-1-[(R)-hydroxy(methoxy)phosphoryl]ethyl\}-5-(2-\{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy\}ethyl)-4-methyl-1,3-thiazol-3-ium 0
                                            3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-\{[(S)-hydroxy(phosphonoamino)phosphoryl]oxy\}ethyl)-4-methyl-1,3-thiazol-3-ium 0
                                            3-[(\{5-[(2-amino-1,3-thiazol-4-yl)methyl]-4-ethyl-1,2,4-triazol-3-yl\}sulfanyl)methyl]-N-(2,3-dimethylphenyl)benzamide 0
                                            3-\{[(4R,5S,6S,7R)-4,7-dibenzyl-3-(cyclopropylmethyl)-5,6-dihydroxy-2-oxo-1,3-diazepan-1-yl]methyl\}-N-1,3-thiazol-2-ylbenzamide 0
                                            3-\{[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino\}phenol 0
                                            3-hydroxy-3-(thiazol-2-yl)indolin-2-one 0
                                            3-methyl-1,3-thiazolium 0
                                            4,5-dihydro-1,3-thiazol-2-amine 0
                                            4-(2,4-dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]pyrimidin-2-amine 0
                                            4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-amine 0
                                            4-(2-amino-4-methyl-1,3-thiazol-5-yl)-N-(3-nitrophenyl)pyrimidin-2-amine 0
                                            4-(\{4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl\}amino)phenol 0
                                            4-[(5-isopropyl-1,3-thiazol-2-yl)amino]benzenesulfonamide 0
                                            4-[2-(2-methyl-1,3-thiazol-4-yl)ethyl]-3-(non-8-en-1-yl)oxetan-2-one + 0
                                            4-\{[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino\}-N-1,3-thiazol-2-ylbenzenesulfonamide 0
                                            4-amino-2-[(3-chlorophenyl)amino]-5-[(4-fluorophenyl)carbonyl]-1,3-thiazol-3-ium 0
                                            4-hydroxy-1-isobutyl-N-(4-methyl-1,3-thiazol-2-yl)-2-oxoquinoline-3-carboxamide 0
                                            4-hydroxy-1-isobutyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxoquinoline-3-carboxamide 0
                                            4-hydroxy-1-isopentyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxoquinoline-3-carboxamide 0
                                            4-hydroxy-1-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydro-3-quinolinecarboxamide 0
                                            4-methyl-1,3-thiazol-2-amine 0
                                            4-methyl-5-(2-phosphonooxyethyl)thiazole + 0
                                            4-methyl-5-\{(2E)-2-[(4-morpholin-4-ylphenyl)imino]-2,5-dihydropyrimidin-4-yl\}-1,3-thiazol-2-amine 0
                                            4-methyl-N-\{(5Z)-5-[(5-methylfuran-2-yl)methylidene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl\}benzenesulfonamide 0
                                            4-methylaeruginoic acid 0
                                            4-methylthiazole 0
                                            4EGI-1 0
                                            5-(2-hydroxyethyl)-1,3-thiazole + 0
                                            5-(2-hydroxyethyl)-4-methylthiazole 0
                                            6-methoxycamalexin 0
                                            AMPK activator PT 1 0
                                            Cefteram pivoxil 0
                                            Disperse Blue 124 0
                                            GW 501516 + 65
                                            GW 501516 sulfone 0
                                            GW 501516 sulfoxide + 0
                                            HA15 0
                                            LCL161 5
                                            LY-221481 0
                                            LimKi 3 0
                                            N'-[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]-N,N-dimethylbenzene-1,4-diamine 0
                                            N(2)-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]-N-butyl-3,3-dimethoxyalaninamide 0
                                            N(2)-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]-N-butyl-L-alaninamide 0
                                            N(2)-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]-N-butyl-L-cysteinamide 0
                                            N(2)-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]-N-butyl-L-serinamide 0
                                            N(2)-\{[(1R)-1-(4-bromophenyl)ethyl]carbamoyl\}-L-asparaginyl-N-\{(1S)-4-carbamimidamido-1-[(S)-(2S)-2,3-dihydro-1,3-thiazol-2-yl(hydroxy)methyl]butyl\}-L-valinamide 0
                                            N(4)-acetylsulfathiazole 0
                                            N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)-1-(N,N-dimethylglycyl)piperidine-4-carboxamide 0
                                            N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide 0
                                            N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)piperidine-4-carboxamide 0
                                            N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)tetrahydro-2H-pyran-4-carboxamide 0
                                            N-(carboxymethyl)-3-cyclohexyl-D-alanyl-N-[(4-carbamimidoyl-1,3-thiazol-2-yl)methyl]-L-prolinamide 0
                                            N-(morpholin-4-ylsulfonyl)-L-phenylalanyl-3-(2-amino-1,3-thiazol-4-yl)-N-\{(1R,2R,3S)-1-[(1R)-cyclohex-3-en-1-ylmethyl]-2,3-dihydroxy-5-methylhexyl\}-L-alaninamide 0
                                            N-[(1S)-1-\{[(1S)-4-[(diaminomethyl)amino]-1-(1,3-thiazol-2-ylcarbonyl)butyl]carbamoyl\}-2-methylpropyl]-4-methylpentanamide 0
                                            N-[(1S)-1-\{[(1S)-4-carbamimidamido-1-(1,3-thiazol-2-ylcarbonyl)butyl]carbamoyl\}-2-methylpropyl]-2-(3-chlorophenyl)-2-oxoacetamide 0
                                            N-[(1S)-4-carbamimidamido-1-(1,3-thiazol-2-ylcarbonyl)butyl]-2-[2-(3,4-dichlorophenyl)-5-[(1-methylethyl)amino]-6-oxopyrimidin-1(6H)-yl]acetamide 0
                                            N-[(1S)-4-carbamimidamido-1-(1,3-thiazol-2-ylcarbonyl)butyl]-2-[2-(3-methylphenyl)-6-oxo-5-[(quinolin-8-ylmethyl)amino]pyrimidin-1(6H)-yl]acetamide 0
                                            N-[(2Z)-5-(1-methylethyl)-1,3-thiazol-2(3H)-ylidene]-2-pyridin-3-ylacetamide 0
                                            N-[(2Z)-5-\{4-chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl\}-4-methyl-1,3-thiazol-2(3H)-ylidene]acetamide 0
                                            N-[4,5-bis(4-hydroxyphenyl)-1,3-thiazol-2-yl]hexanamide 0
                                            N-[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]-N'-hydroxyimidoformamide 0
                                            N-[5-(1-naphthylmethyl)-1,3-thiazol-2-yl]cyclohexanecarboxamide 0
                                            N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide + 0
                                            N-\{(1S)-4-carbamimidamido-1-[(S)-hydroxy(1,3-thiazol-2-yl)methyl]butyl\}-N(2)-carbamoyl-L-valinamide 0
                                            N-\{[(3S,5S)-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-3-yl]methyl\}-1,3-thiazole-4-carboxamide 0
                                            N-\{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl\}-G-dR-G-dD-dD-dD-NH2 0
                                            N-\{[4-(1,1-dioxido-3-oxo-2,3-dihydro-1,2-thiazol-5-yl)phenyl]acetyl\}-L-phenylalanyl-4-(1,1-dioxido-3-oxo-2,3-dihydro-1,2-thiazol-5-yl)-L-phenylalaninamide 0
                                            N-cyclopentyl-N'-1,3-thiazol-2-yloxalamide 0
                                            N-succinylsulfathiazole 4
                                            Niridazole 0
                                            Nithiazide 0
                                            Pulicatin C 0
                                            Pulicatin D 0
                                            Pulicatin E 0
                                            RO4927350 0
                                            SBL-398 0
                                            SQ 26,992 0
                                            SSTC3 0
                                            Thiazolylethylamine 0
                                            XV638 0
                                            YM-216391 0
                                            [(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-\{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)pent-2-enoyl]amino\}-3-[(carbamoyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 0
                                            \{(2Z)-4-amino-2-[(4-methoxyphenyl)imino]-2,3-dihydro-1,3-thiazol-5-yl\}(4-methoxyphenyl)methanone 0
                                            abafungin 0
                                            althiomycin 0
                                            aminotipyr 0
                                            apratoxin A 1
                                            apratoxin B 0
                                            apratoxin C 0
                                            benzyl [(1S)-1-\{[2-(\{2-[(1S)-1-\{[(benzyloxy)carbonyl]amino\}-3-methylbutyl]-1,3-thiazol-4-yl\}carbonyl)hydrazino]carbonyl\}-3-methylbutyl]carbamate 0
                                            bi-1,3-thiazole + 0
                                            bistratamide I 0
                                            camalexin + 3
                                            cefcapene 0
                                            cefditoren pivoxil 0
                                            cefetamet pivoxil 0
                                            cefodizime 0
                                            cefoselis + 2
                                            cefotaxime 5
                                            ceftaroline + 5
                                            ceftaroline fosamil + 0
                                            ceftriaxone 16
                                            cinalukast 0
                                            clothianidin + 403
                                            cobicistat + 10
                                            colibactin 0
                                            curacozole 0
                                            cyclopentylidene-[4-(4-chlorophenyl)thiazol-2-yl]hydrazone 0
                                            cystothiazole A 0
                                            dCeMM4 0
                                            dabrafenib + 30
                                            dasatinib (anhydrous) + 0
                                            dicloromezotiaz 0
                                            dihydrocamalexic acid + 0
                                            dolastatin 10 0
                                            dysidenin 1
                                            epothilone + 5
                                            ethyl 2-[4-(2H-1,4-benzothiazin-3-yl)piperazin-1-yl]-1,3-thiazole-4-carboxylate 0
                                            famotidine + 65
                                            fenmezoditiaz 0
                                            fluensulfone 1
                                            halicin 0
                                            isavuconazole 0
                                            ixabepilone 0
                                            masitinib 9
                                            meloxicam 35
                                            mirabegron 8
                                            myxothiazol 12
                                            nizatidine 2
                                            pateamine 0
                                            phthalylsulfathiazole 0
                                            pulicatin F 0
                                            pulicatin G 0
                                            ravuconazole 0
                                            ritonavir + 117
                                            sulfathiazole + 4
                                            tenonitrozole 0
                                            tert-butyl [2-(1,3-thiazol-2-ylcarbamoyl)pyridin-3-yl]carbamate 0
                                            thiabendazole 338
                                            thiamethoxam + 56
                                            thiazole + 0
                                            thiazole-5-carboxamide 0
                                            thifluzamide 241
                                            tiapyrachlor 0
                                            tiazofurine 2
                                            varlitinib 0
                                            venturamide A 0
                                            venturamide B 0
                                            vosaroxin 7
paths to the root